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Overutilization of Emergency Departments (ED) is a major problem among the health care 
providers in the United States. In this research, a machine learning-based predictive model for 
predicting ED high utilizers will be designed based on a set of existing and proposed facilities and 
the population and social determinant of health (SDOH) factors influencing utilization. The 
purpose of the model will be to alert the healthcare systems and government organizations by 
identifying the reasons for overutilization of the medical services among the people in a particular 
community. Also, the novel coronavirus disease 2019 (COVID-19) developed in Whunan city, 
China has spread quickly to the other parts of the world. It has become a serious health threat to 
the United States. Moreover, in this research study, the clinical and social characteristics that are 
responsible for the quick spread of COVID-19 disease across the Louisiana state will be identified. 
The purpose of this study is to identify what kind of population gets COVID 19 and providing real 
time care decisions to minimize the risk of an individual acquiring COVID-19. The patient data 
from Electronic Health Records (EHR) of Francis Missionaries of our Lady Health System 
(FMOLHS) is geocoded and mapped into ArcGIS software. The socioeconomic factors and social 
vulnerability Index (SVI) variables available from various online sources are joined to the 
geocoded patient data with the help of spatial joining techniques available in the ArcGIS software. 
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Chapter 1. Introduction 
1.1. Background 
Franciscan Missionaries of Our Lady Health System (FMOLHS) is one of the leading health care 
in Louisiana and Missippi with 1,747 licensed beds and has ten hospitals within the system [1]. 
Our Lady of the Lake Regional Medical Center (OLOL RMC) in Baton Rouge has two hospitals 
associated with it and serves more than 850K patients annually [2]. OLOL clinics are located 
throughout Louisiana, although there is a significant concentration in the Baton Rouge 
metropolitan area. The Our Lady of the Lake Physician Group (LPG) provide many services such 
as emergency services, primary care, cancer care, diabetes & nutrition center, critical care to the 
people living in Louisiana [3].  OLOL is affiliated with Louisiana State University Health Network 
(LSUHN), made up of members of Louisiana State University Health Science Center (LSUHSC) 
across LA. LSUHN provides 30 specialties (Allergy & Immunology, Behavioral Science Center, 
Cardiology, Neurology, Surgery, and so on) to meet patient healthcare needs.  LSUHN consists of 
9 clinics across LA with 1 clinic in Baton Rouge [4]. A common Electronic Health Record (EHR) 
is maintained by all FMOLHS affiliated hospitals and clinics including OLOL RMC. 
The primary motivation for this thesis was the development of template procedures for 
FMOLHS analysts to integrate Geographic Information Systems (GIS) and geospatial analysis and 
machine learning into their research. In collaboration with OLOL RMC staff, two geospatial-based 
research problems of current interest to the FMOLHS were identified, each covering different 
elements of analysis. Each of the problems addressed are also important research contributions in 
their own right. 
For one of the problems, we designed a machine learning-based predictive classification model 
for predicting ED high utilizers based on the multiple ED facilities available in LA and the 
population and social determinant of health (SDOH) factors influencing utilization. The purpose 
of the model is to help healthcare systems and government organizations in identifying the reasons 
for overutilization of the medical services among the people in a particular community. For 
decades, Emergency Departments (ED) use in the United States (US) has been increasing steadily 
at a rate faster than the US population growth [5]. According to the Healthcare Cost and Utilization 
Project (HCUP), ED high utilizers are defined as patients with 4 or more visits per year to the ED 
[6]. 
There is a dramatic increase of 66.4% and 28.5% in the number of ED visits covered by 
Medicaid and Medicare respectively between 2006 and 2014 [7]. Hospital closures in a particular 
area or region are one of the reasons for ED overcrowding. Lee et al. [8] says that the closure of 
the central hospitals in New York state led to ED overcrowding in other hospitals because ED 
visits from closed hospitals were redistributed to nearby hospitals. Erik et al. [9] state that to make 
progress in the health outcomes SDOH factors should be addressed by including them in ED visit 
dataset. So, a technique will be needed by the hospitals to identify the reasons for ED over-
utilization. 
 In the second problem, we analyze the clinical and social characteristics of Coronavirus 
Disease 2019 (COVID-19) affected patients in order to identify which populations in LA have an 
increased risk of getting COVID-19, to support real time care decisions. Severe Acute Respiratory 
Syndrome Coronavirus 2 (SARS-CoV-2) is the virus that caused COVID-19 in the US. The first 
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COVID case in the US was reported on January 21, 2020 [10]. According to Centers for Disease 
Control and Prevention (CDC), as of July 8, 2020, 2,982,900 cases are reported across the US with 
131,065 deaths [11]. Retrospective studies on COVID-19 cases showed an increased severity of 
illness in the elderly population of age greater than 60 [12,13]. As per CDC, population in the age 
category of 85 and more have been hospitalized 13 times more when compared to 18-29 years age 
group [14]. Additionally, research studies indicate that underlying medical conditions have a 
greater risk for severe illness with COVID-19 disease [15-18]. As per CDC, few of the underlying 
medical conditions that are responsible for severe illness are Cancer, Chronic Kidney Disease, 
Heart Conditions, Obesity, Smoking, Immunocompromised state, Chronic Obstructive Pulmonary 
Disease [14]. 
The SDOH factors such as crowded housing, race, poverty level, ethnicity, physical 
environment (e.g., homelessness, smoke exposure) can have considerable effect on the COVID-
19 health outcomes (test result(‘Positive/Negative’), Living _Status (‘Alive/Deceased’) [19]. The 
effect of COVID-19 is high when the social inequalities are associated with underlying medical 
conditions [20].  LA experienced increase in the Covid cases between March 31-April 7 due to 
Mardi Grass celebrations occurred on February 25th in New Orleans city. According to CDC, as 
of July 8, 2020, LA state reported 68,263 cases with a total of 3,319 deaths [11]. Among 64 
parishes in LA, Jefferson has 15% of total cases in LA, Orleans reported 12%, and East Baton 
Rouge has 9.1% [21]. These parishes have highest number of cases when compared to other 
parishes in LA [21]. Hence it is necessary to identify the characteristics of population in LA who 
are at higher risk of acquiring the disease. 
 According to the World Health Organization (WHO) [22], “the SDOH are the conditions in 
which people are born, grow, live, work and age.” Padarthy et al. [23] analyzed other studies and 
drew conclusions such as 60% of the persons’ health status is determined by behavior and social 
factors such as socioeconomic status (SES), employment, food insecurity, education, community 
cohesion and more, 10% by clinical care, and 30% by their genetics.  These counts prove the 
importance of SDOH factors in the health perspective. Table 1.1 gives a brief overview of the 
various categories and subcategories on SDOH factors. According to U.S News & World Report, 
2019, out of 50 states in the US, rank (1 is First; 50 is Last) of Louisiana (LA) sate is reported as 
50 by considering health care (16%), education (15.8%), economy (13.8%), infrastructure 
(12.9%), opportunity (12.7%), fiscal stability (10.5%), crime & collections (9.9%), natural 
environment (8.4%) categories out of 50 states in the US [24]. In this scenario, we can see that the 
SDOH factors like health care, education, economy, crime & collections, natural environment 
together sum up to 63.9% in ranking of LA. By this we can see that LA is not in a good condition 
in most of the aspects of SDOH categories. Moreover, Brunt [25] explains that Community Health 
Records (CHR) should contain data about the communities that include social, physical, and 
lifestyle determinants of health. By including such data provides an opportunity to improve 
community health. 
 This research study will utilize patient data of OLOL RMC, a medical center in Louisiana and 
affiliated to FMOLHS. Patient data will be integrated with population, Social Vulnerability Index 
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1.2. Problem Statement 
ED overcrowding is one of the major issues in the health care industry in the US [27]. People 
across the US are using ED services for non-emergency medical needs which leads to ED 
overutilization, huge demand for various medical services, and financial loss [28]. Claire et al. 
[29], says that chronic conditions are the widespread cause for ED overcrowding. According to 
AHRQ, in the 2011 annual year, 3.3 million adults were readmitted to the hospital in 30 days in 
the US and costed to $41.3 billion for the hospitals [30]. Moreover, according to the representatives 
of OLOL RMC ED overutilization is also a major issue in EBRP and EDs of FMOLHS faces many 
problems with ED patients visiting for non-emergency medical needs. Also, closure of hospitals 
is one of the reasons for ED overcrowding [8]. For example, in consultation with representatives 
of OLOL RMC the closure of medical centers namely Earl K. Long Hospital/ED, Baton Rouge 
General Mid-City ED, and Champion Medical Center between 2013 and 2017 changed the EBRP 
health care landscape leaving the northern part of the city without close emergency health care 
services or after-hour urgent care clinics such as UC. This led to the overutilization of other health 
care providers including FMOLHS ED. Baton Rouge General’s Mid City ED experienced large 
financial losses as most of the population visited the ED more due to the closure of Earl K. Long 
Medical Center, which is one of the major reasons for its closure [31]. To overcome the gap in 
emergency health care services in the parish and enable closer health care facilities to the residents, 
OLOL North Baton Rouge ED (OLOL NBR ED) was inaugurated on November 15, 2017. Also, 
according to Louisiana Department of Health (LDH), COVID-19 patients death rate is high in the 
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population having underlying conditions such as Hypertension, Diabetes, Cardiac Disease, 
Chronic Kidney Disease, Obesity, and Congestive Heart Failure (CHF) [32]. As per the CDC, the 
non-Hispanic black persons, Hispanics and Latinos, and American Indians/Alaska Natives, show 
higher rates of hospitalization or death (approximately 5 times, 4 times, 5 times more respectively) 
due to COVID-19 when compared to non-Hispanic white [33]. According to National Center for 
Health Statistics (NCHS), Table 1.2 shows the comparison of COVID-19 deaths in LA to total 
deaths in US the by Age and Sex [34]. 
Table 1.2. Comparison of COVID Deaths by Age and Sex [as of July 8, 2020] 
Age and Sex 
Characteristics 









Under-1 to 14 0.03    0  0.02    0 
15-24 0.80    0 0.10    0 
25-44 3.18    3.10    1.58    3.28    
45-64 21.09  22.19  11.91 16.42  
65 and Over 74.90  74.71  86.40  80.30  
In Table 1.2, we can see that approximately 2.33 % of total US COVID deaths are reported in LA 
[34]. Moreover, the population with the age category of 65 and above contribute around 77.11% 
of total COVID deaths in LA [34]. The male gender death rate is 6.54 % higher than female death 
rate in LA [34]. Hence, it is essential to understand and study the clinical characteristics and SDOH 
factors that are causing an increase in the risk of the LA population to acquire COVID-19 disease 
with the help of COVID patient data available in FMOLHS. The other research focus is to predict 
ED high utilizers in advance whenever there is a hospital closure/opening, new services initiation 
with the help of EHR maintained by all the FMOLHS affiliated hospitals and clinics including 
OLOL RMC in order to prevent ED overcrowding and financial loss by providing valuable care, 
primary care, services to the people in a geographical area that has frequent use of emergency and 
medical services. 
Several research studies have focused on predicting ED visits as an ordinal variable (High, 
Medium, Low) considering multiple ED locations with the help of machine learning models such 
as multivariate logistic regression, decision trees (DT), and boosted decision trees such as Adaptive 
Boosting (AdaBoost) [35,36]. Table 1.3 provides details such as task, multiple ED locations, 
existing facilities, inputs, methods used and output of some recent studies that developed predictive 
models in healthcare to prevent the ED utilization problem. 
Models in Table 1.3 take data from past years available in EHRs and predict ED utilization for 
the coming years. Moreover, ED prediction outcome of the models finds strong correlation with 
all predictor variables except for distance present in EHR data for frequent ED use [35,36]. Pereira 
et al. [36] says that approaching the objective as a regression problem is equally meaningful 
because the model developed could predict the ED utilization rate as a real value instead of an 
ordinal variable (High/Low/Medium). 
Additionally, the EHRs structured data can contain selected lifestyle and social domains such 
as race, ethnicity, preferred language, alcohol drinking, and smoking status to predict the ED 
utilizations rates [37]. Also, unstructured data (e.g., free-text clinical notes) contain information 
on selected environmental and social domains such as housing issue, social connection/isolation, 
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and income/financial resource strain [37]. This research study strengthens to use machine learning 
techniques and routinely available EHR data to develop the predictive model. Also, focuses on 
including significant SDOH factors and other factors such as fire rates, locations of food stores 
(grocery stores and convenience stores), health care facilities (ED, clinics, primary care, and UC 
services), and pharmacies into the EHRs’ for identifying the percentage of utilization of services 
provided in medical care.  
Table 1.3. Summary of Predictive Models for ED Prediction 
Study  
Characteristics 
ED Utilization  
Likelihood in Indiana [35] 







Yes Yes No 
Existing 
Facilities only? 
Yes Yes Yes 
Inputs Used 
Age, Sex, Visits, Chief 
Complaints, Distance 
between hospital and patient's 
home 
Frequencies (Total ED 
visits, Total Hospital 
admissions) per patient, 
Gender, Age, Race, 
Distance between 
hospital and patient's 
home, Medical (sev0, 





total cost, ED visit 












Frequent vs low ED Users 
Classification 
Future ED Visits for 
each patient 
(High/Medium/Low) 
ED Visit count as a 
real value 
 
Limitations 1. SDOH factors were not 
included 
2.Didn't include patients who 
did not use ED 
3.EHR data from other sites 
cannot use the developed 
model 
1. SDOH factors were not included 
2.EHR data from other sites cannot use the 
developed model  
 
1.3. Research Objectives 
The specific goals for this research work include: 
• Develop and validate a machine learning / neural network model for predictive 
classification of ED high utilizers as (Yes/No) to multiple ED facilities available in LA 
and identify correlations between the SDOH factors and the other independent variables 
influencing the utilization of FMOLHS ED. 
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• Perform a retrospective study and spatial analysis to identify which patient demographics, 
clinical characteristics and SDOH factors are responsible for increasing the risk of 
general population acquiring or dying due to COVID-19. 
• Develop and document procedures by which FMOLHS and LSU HSC may utilize 



























Chapter 2. Literature Review 
2.1. ED Utilization Predictive Models 
Machine learning models are used by researchers to predict the medical services utilized by the 
patients in advance to reduce the major issues such as ED overutilization and financial loss [39]. 
Various machine learning techniques could be used to predict the ED high utilizers and prevent 
the closure of the hospitals due to ED overcrowding [40]. Predictive modeling allows the hospitals 
for proper allocation of resources and could prevent the over usage of resources [36].  
 Vest et al. [41], performed a case study on ED revisit prediction for a 30-day time period using 
two-class boosted decision tree algorithms. The outcome was a revisit to ED within 2, 7, 14 or 30 
days. The data sample includes data from an urban safety-net hospital across a state in the US. In 
this study ED revisits are predicted by including 5 different classes of information i.e., 5 different 
models including 1) SDOH measures only; 2) Current EHR information only; 3) current and 
historical EHR information; 4) Health Information Exchange (HIE) information; 5) all available 
information. Table 2.2 gives the details about each class. Moreover, Comorbidity Index Score is 
used to categorize comorbidities of patients based on International Classification of Diseases 
(ICD) codes. For each model, five-fold cross validation is used by dividing the data into training 
sample (80%) and test sample (20%). Area Under Curve (AUC) score, Accuracy, Precision, Recall 
and F1 score are used to evaluate the models by the classes of information. Table 2.1 gives details 
about evaluation metrics. True Positive (TP), True Negative (TN), False Positive (FP) and False 
Negative (FN). 
Table 2.1. Evaluation Metrics for classification tasks [42] 
Metric Explanation Range 
Accuracy 𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
 



























[0-1], 1- is perfect 
classifier 
AUC Area under curve of sensitivity vs 
specificity 
[0-1], 1- best 
performance 
 In Table 2.2, the model using all classes of information was the best model for predicting ED 
revisits because of highest AUC score around 74 % and F1 score around 49%. But the model with 
only SDOH information has least AUC score around 61% and F1 score around 7% when compared 
to other models in this case study. The ED revisits are more among racial and ethnic minorities. 
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Also, the ED was revisited mostly for non-emergency reasons, high chronic diseases, low SES and 
higher crime rates. The models shown in Table 2.2 used limited number of potential measures (e.g. 
primary care, clinical experience, health literacy are not used) within each information class. Also, 
the results of the model cannot be generalized to non-urban population. 
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 Jianmin et al. [35] performed a case study by developing a multivariate logistic regression 
model for predicting frequent use of ED care for the years 2009 and 2010 from the available 
electronic registration data of 96 institutions in the state of Indiana, US, from 2008. The model 
was developed by including age, sex, visits in 2008, chief complaints with 11 different categories 
such as Respiratory, Gastrointestinal, Neurologic, Skin, Undifferentiated Infection (UDI), 
Lymphatic, Influenza-like illness (ILI), Dental, Pain, Musculoskeletal, Alcohol, and zip code 
centroid straight-line distances between patient’s location and hospital facility. The outcome was 
a binary variable (frequent vs low use classification of ED users). In this case study 9 multivariate 
logistic regression models were developed with cut off for frequent ED users starting from 8 to 16 
ED visits. The AUC score, Positive Predictive Value (PPV), sensitivity, and specificity are used 
in evaluating the developed multivariate logistic regression models. In this study, 2.8 million 
patients in the overall 3-year study period generated 7.4 million ED visits. The model with >=8 
visits has AUC score around 84%, F1 score around 36% and the model with >= 16 visits has AUC 
score around 92%, F1 score around 35%. The AUC score increased with the increase in the 
threshold of ED visits i.e. from 8,9,10 and so on to 16 ED. The age between 25 and 44 years, 
female gender, pain, musculoskeletal, respiratory, and gastrointestinal chief complaints 
contributed more to the ED visits. Moreover, alcohol accounted for 0.5% of total ED visits. The 
model developed does not include population who did not use ED, patients’ SES data, and EHR 
data from other sites cannot use the model. Hence, the model is overrated.  
 Pereira et al. [36] also performed a case study for the prediction of future frequent ED users as 
a classification task with ordinal values such as high, medium, and low in California state. The 
research was done with decision trees (DT), boosted decision trees (AdaBoost) and logistic 
regression (LR) supervised machine learning models by using discharge data records from 
California-licensed hospitals for the years 2009 and 2010 and evaluated the predictive accuracy 
for the years 2010-2011, 2011-2012, and 2012-2013. The training and testing on these models is 
performed such that it predicts whether the patient is a low-frequency user(≤ 1 ED visit), medium-
frequency (2-4 ED visits), & a high-frequency (≥ 5 ED Visits) by considering different groups of 
features such as the number of hospital admissions, demographic features such as age, sex, race, 
the distance between patient and hospital location such as dist1≤5 , 5<dist2≤20, dist3>20( 
measured in miles), medical comorbidities(presence of two chronic diseases) of patients and 
severity such as SEV0: the percentage of ED visits with no presence of 
(Complication/Comorbidity)CC or MCC (Major Complication/Comorbidity); SEV 1: the 
percentage of ED visits with presence of CC; SEV 2: the percentage of ED visits with presence of  
MCC; are included. ICD9 diagnoses codes in the EHR records are mapped to the comorbidity 
features in Table 2.3. The analysis of the features indicates that including distance is only 
moderately helpful in predicting ED visits. Moreover, including the past EHR data, demographic 
information, severity, and comorbidity features is very beneficial. As per the evaluation metrics 
(AUC, precision, sensitivity), the results of three models (LR, DT, and AdaBoost) were consistent 
across the three years for three classes (low, medium, and high). But the LR model showed higher 
AUC scores for all three classes with very minimal difference when compared to other models. 
Moreover, according to this case study predicting moderate ED users is difficult when compared 
to low and high ED users. Also, in this research paper, it was stated that approaching the objective 
as a regression problem is equally meaningful.  
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Table 2.3. Comorbidity Features [36] 
Comorbidities Name ICD9 codes [43] 
AIDS HIV and AIDS V08 and 042 
ALCOHOL Alcohol Abuse 305.0 
ANEMDEF Deficiency anemia 281.0 -281.9 
ARTH Rheumatoid arthritis 714 
BLDLOSS Blood loss anemia 280.0 
CHF Congestive heart failure 428.0 – 428.9 
CHRNLUNG Chronic pulmonary disease 416 
COAG Coagulation deficiency 286.7 
DEPRESS Depression 311 
DM 




Diabetes w/ chronic 
complications 
249.1-249.9, 250.1-259.9 
DRUG Drug abuse 305.00-305.93 
HTN Hypertension, uncomplicated 
401.0 – 401.9 401 -405 
 
HTNCX Hypertension, complicated 
401.0 – 401.9 401-405 
 
Hypothy Hypothyroidism 243, 244 
LIVER Liver disease 571 
LYMPH Lymphoma 202.0-202.9 
LYTES Fluid and electrolyte disorders 276 
METS Metastatic Cancer 197.0 
NEURO Other Neurological IV80.09 
OBESE Obesity 278 
PARA Paralysis 342.0-342.9, 344.0-344.9 
PERIVASC Peripheral vascular disorder 443 
PSYCH Psychoses 290-299 
PULMCIRC Pulmonary circulation disorder 415-417 
RENFAIL Renal Failure 584.5, 586 
TUMOR Solid tumor without metastasis 200 
ULCER Chronic peptic ulcer disease IV12.71, 533.0-533.9 
UNCLASS 
don’t correspond to any 
comorbidity 
NA 
VALVE Valvular disease 746.83 
WGHTLOSS Weight loss 783.2 
Additionally, there are many papers [44,45] on predicting ED visits, UC, ED use among 
children with epilepsy, etc. and so on. All of these are using supervised machine learning with 
classification. The evaluation metrics are AUC, PPV, and Sensitivity. On further research on 
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applying machine learning models as a regression problem will enable us to predict the ED 
utilization rate as a continuous value instead of classification labels.  
In a research paper, Qiao et al. [38] found that non-linear models capture better performance 
than linear models in prediction of ED visits based on EHR data. Non-linear models such as 
XGBoost, Recurrent Neural network (RNN) have a complex model structure and strong fitting 
ability. So, these models are used to solve the problem of making better predictions when complex 
correlations are involved [38]. In this paper, both linear and non-linear models are used to predict 
two tasks. Task 1 is predicting ER Visit count (a real value) as regression and task 2 is predicting 
ED Visit (Yes or No) as classification. The features included are gender, age, chronic conditions, 
patient-hospital visit count and total cost, ER visit count, cost & count. The feature dataset contains 
6 thousand patients, 0.1 million visits and hundreds of unique diagnose codes from a single 
hospital. The validation set, training set, and testing set are divided in the proportion of 1:8:1. 
Finally, the evaluation of the models is done through R-squared value (It is a statistical measure to 
identify how close the data are to the fitted regression line) as part of regression evaluation metrics. 
Also, AUC (measure of quality of classification models) value as part of classification evaluation 
metrics. So, for task 1 RNN model gave good results with R-Squared value around 34% whereas 
for task 2 XGBoost model gave good results with AUC value around 70%. 
2.2. Healthcare Prediction Models  
There are research papers on using prediction models in the healthcare such as predicting the 
patient length of stay (LOS) is determined using Artificial Neural Networks (ANN) by Muhammet 
et al. [46]. Here, patient LOS is predicted using input factors such as patient age, sex, mode of 
arrival (walk-in patients (foot, special car, stretcher), ambulance vehicle (car, helicopter, etc..), 
ambulance patients), treatment unit (5 different areas based on acuity level), medical tests and 
inspection in an emergency department. The dataset is taken from a single hospital emergency 
department in the eastern part of Turkey. A total data of 1500 ED patients who were treated in the 
department in October and November 2010 are considered. The correlation between the variables 
is conducted to identify strong, weak, and medium correlations with a test probability value(P-
value). Different learning rates, momentums are used with various learning algorithms such as 
Quasi-Newton, Online-Back Propagation and Levenberg-Marquardt [46]. The best fit model is 
chosen with the lowest absolute error. By predicting accurate patient LOS enables the ED 
management to have correct resource allocations and appropriate utilization of the resources. But 
this paper shows an R-squared value of 63% for ANN model with Levenberg-Marquardt training 
algorithm. This is not an ideal prediction as it is less than 80%. So, other techniques such as logistic 
regression, support vector machine, and multiple linear regression are suggested [46].  
 Choi et al. [39], performed a case study on early detection of heart failure using data from a 
health system. The RNN, logistic regression, support vector machine, k-nearest neighbor machine 
learning models are used to predict the heart failure based on the input variables. The input data 
set has demographics, tobacco and alcohol consumption, clinical and laboratory values, ICD-9 
codes, and prescription information. Finally, the RNN model has showed good AUC score around 
88% for 18-month observation window when compared to other models in this case study. 
 Benjamin et al. [47], says that six machine learning models are used to predict systolic blood 
pressure, body mass index, waist circumference, and telomere length. They are two Ordinary Least 
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Squares (OLS) regression models (minimal, theory-based). The other four models are linear 
regression, penalized regressions, random forests, neural networks. The data is from Health and 
Retirement Study (HRS). Also, the R-squared value was considered to estimate the best fit model. 
In this paper, neural networks are the best fit model with R-squared value between 40-60% whereas 
for other models it is less than 30%. 
 As per the literature review of various researchers, the major findings are approaching the 
research objective as a regression task. Also, using linear models such as regression analysis and 
nonlinear machine learning models such as neural networks for complex relationships. However, 
as per the literature review the SDOH factors were not included and the developed models were 
not used in different locations. Hence, in this research study, the population and social determinant 
of health (SDOH) factors influencing utilization will be included in the model development. 
Therefore, it strengthens to use machine learning models such as neural networks, multivariate 
regression. So, prediction of ED high utilizers, risk of readmission within 30 days for CHF, and 
correlated factors in using the medical services will be done using machine learning techniques 
and prevent the ED overcrowding by providing valuable care to the patients in order to reduce 
frequent visits to ED. 
2.3. SDOH Factors Affecting ED Utilization 
Andrieni [48] says that “Social determinants of health affect every aspect of healthcare. We’re 
learning that we have to address not only clinical factors that affect the patient’s health but also 
the nonclinical ones if we are going to successfully treat patients.” Johns Hopkins University 
(JHU) researchers identified lack of insurance, lack of primary care physician, psychiatric illness, 
substance abuse, cognitive/physical impairment and difficulty understanding discharge 
instructions as risk factors associated with high ED use among three hospitals in the US [49].  
Various studies have mentioned that population who are about to become homeless or already 
homeless utilize ED more when compared to the general population [50,51]. For example, Hwang 
et al. [52] found that the homeless population visits ED 8 times more than the non-homeless 
counterparts. Doran et al. [53] mentioned that the public uses ED, not for health crisis alone but 
also during their life crises. Also, the author conducted a study on a cross-sectional data sample of 
625 ED patients, from a single hospital center. Table 2.4 compares the study results with the 
general population in the US. 
Table 2.4. Comparing ED Patients versus General Population 
SDOH Factors 




General Population  
US Pop.: 325.7 
million 
Food Insecurity 40% 11.1% [54] 
Homeless 34% 0.17% [55] 
Didn’t Meet 
Essential Expenses 
42% 18% [56] 
Money Concerns 28% 7% [56] 
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Moreover, Heath et al [57], mentioned that experiencing a social barrier led to more healthcare 
utilization i.e. patients with food insecurity visited ED more than two times in 12 months when 
compared to non-food insecurity people. Also, patients who reported public safety issues are 
admitted to ED 3.2 times more than the people without public safety issues [57]. Finally, the 
outcome was that the high rates of social needs are among people, including homelessness, food 
insecurity, and inability to afford medications and basic needs [53]. According to Axelson et al. 
[58], food insecurity, low literacy, economic insecurity, housing and homelessness and 
neighborhood & access to safety are the main SDOH factors that are responsible for frequent ED 
utilization.  
Surveys play the main role in identifying the SDOH factors that are responsible for frequent 
ED visits [59]. The outcome measures of the survey are age, gender, ethnicity, employment, 
housing status, insurance, access to food and the choice between buying food and medicine. The 
conclusion was most of the ED patients have food insecurity and hunger when compared to other 
factors of SDOH. Griffey et al. [60] analyzed that health literacy (capacity to obtain, process, and 
understand basic health information and services to make correct health decisions) plays the main 
role in ED visits and concluded that the increasing order of ED visits is inadequate health literacy> 
marginal health literacy> adequate health literacy. Runyan, C.N, [61], informed that the National 
Academy of Medicine recommended 12 SDOH domains into the electronic health records as part 
of primary care. They are ethnicity/race, tobacco use, alcohol use, residential address, educational 
attainment, financial resources, stress, depression, physical activity, social isolation, intimate 
partner violence, and neighborhood median household income. 
 Boston Medical Center [62] developed a social needs screener as part of EHR which captures 
SDOH data to have an improvement in the outcome of patients. Also, Fenton [63] stated that 85% 
of physicians believe patients social needs are as important as their medical conditions. As per the 
special report by Sukel [48] a study was performed by Kash and Colleagues on SDOH. In the 
report, the predictive model techniques were used to determine which SDOH factors are most 
helpful to predict avoidable hospital readmission by using EHRs’ data and data from the area 
deprivation index (ADI)—census data that looks at common socioeconomic factors. Therefore, 
SDOH factors are influencing an individual decision to visit the ED for non-urgent conditions [28]. 
2.4. Retrospective Studies of COVID-19  
Price-Haywood, E.G., et al [64] conducted a retrospective study on the COVID-19 positive tested 
patient data of Ochsner Health in LA between March 1 and April,11, 2020. This study included 
demographic characteristics such as age, sex, race, ethnic group, and insurance plan); chronic 
conditions associated to ICD-10 codes (E66, Z72.0, J45, J44, E10, I10, I50, I25, N18, Z94, K70); 
other clinical characteristics such as Body Mass Index (BMI, calculated by dividing weight by 
height); outpatient medications such as immunosuppressants, glucocorticoids, chemotherapy, and 
immune modulators; diagnosis codes related to primary care, Urgent care and ED during COVID-
19 testing; diagnosis codes linked to inpatient encounters; Zip codes to identify low-income areas. 
In this case study, 3481 COVID-19 positive patients are included in which 60% are female, 70.4% 
are black non-Hispanic, 29.6% are white non-Hispanic. 
A multivariable analysis was performed, and the results showed that black ethnicity Covid 
patients, increasing age, high Charlson Comorbidity Index (higher score implies less healthy), 
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public insurance (Medicaid or Medicare), residence in low-income area, obesity factors are highly 
correlated with increase of hospital admissions [64]. Though the black ethnicity Covid patients 
showed a higher percentage of COVID deaths, the blacks ethnicity comprises only 31% of Ochsner 
Health's patient population. Price-Haywood, E.G., et al [64] mentioned that black ethnicity Covid 
patients was not associated with higher in-hospital mortality than white ethnicity Covid patients in 
their health care system. 
 Kim, S.J.; et al [65] has done spatial analysis of COVID-19 deaths for identifying spatial 
clusters of social vulnerability and health risk factors in Chicago. In this study, the author 
performed spatial autocorrelation for percentage of African American COVID-19 death rate. The 
Chicago state has 268 deaths and in those 62.8% are African Americans. In this case study, it was 
mentioned that African American communities are affected by multiple chronic diseases before 
the COVID-19 pandemic and due to which they have high mortality rate in Chicago. The spatial 
analysis showed that increase in social vulnerability is highly associated with health inequity. 
 A research study [66] mentioned the importance of including SDOH data with the COVID-19 
data.  The socioeconomic position (SEP) is largely related with the COVID disease and mortality. 
SEP plays a vital role in the COVID-19 outbreak either directly or indirectly through occupation, 
living conditions, health related behaviors, presence of comorbidities and immune functioning. 
For example, a person who has the occupation that requires to interact with many people such as 
retail staff, cleaners, healthcare workers, living conditions such as low-income, crowded housing 
and, low education will be associated with many risk factors that might increase the risk of 
acquiring COVID-19. Though we have studies on the importance of SEP, the influence of these 
factors on COVID-19 transmission from person to person, severity, and outcomes is not known. 
Hence, we are integrating FMOLHS COVID-19 patient data with the SDOH data to identify the 
















Chapter 3. Methodology 
A retrospective study is performed by taking data from various platforms and medical records of 
FMOLHS to gather the datasets of patients in LA. The collected patient data from EHR of 
FMOLHS is integrated with population and SDOH-related factors available through public sources 
such as census data discussed in Section 3.1.3. The ED high utilizers classification predictive 
model is developed with the help of machine learning techniques. Also, the COVID-19 tested 
patients clinical characteristics and social factors that are responsible for the increase in the spread 
of the disease are analyzed spatially using ArcGIS. Further statistical analysis was performed to 
identify correlations between the various factors including SDOH and the other independent 
variables influencing the utilization of FMOLHS ED and responsible for the FMOLHS COVID-
19 deaths. The detailed description of data collection, preparation, analysis and methodology are 
explained in this chapter. 
3.1. Data Collection and Preparation 
A common EHR is maintained by all the hospitals including OLOL RMC affiliated to FMOLHS 
for storing patient’s data and sensitive information. The EHRs of the hospital contains all the EMR 
of the patients and Protected Health Information (PHI) in a password protected excel sheet linked 
to Study Identification Number (SIN) such as Address, Date of Birth (DOB), Full Name, and 
Medical Record Number (MRN). An electronic search of the EHR data is performed using Epic 
and Cerner software’s in FMOLHS to get the needful patient data. Using the electronic search 
capability, all the ED visit information is obtained according to the filter applied. This information 
contains patient demographic details such as name, medical record number, date of birth, age, sex, 
ethnicity, payer type, and address. Also, includes clinical information such as date of ED visit, 
ICD9 and ICD10 codes, and disposition of ED visit (admit or no admit). Additionally, an electronic 
search is performed to get information related to patients diagnosed with COVID-19. This dataset 
contains all the demographic and clinical information mentioned above along with type of visit 
(Inpatient or outpatient).  Women and minorities are included in the datasets. Adult patient and 
child patient data is included in the ED visit information but the patients under the age of 18 are 
excluded from COVID-19 dataset. 
 In this research study data is collected from various platforms and primary portion of the data 
is collected from EHR of FMOLHS, census data and community information available through 
US Census Bureau, American Community Survey (ACS), publicly available community 
information like shape files, and health related geographic data. This research is approved by 
Franciscan Missionaries of our Lady University (FMOLU) with IRB number 10102 approved on 
06/28/2018, LSUHSC with IRB number 2018-151 approved on 10/04/2018 and, LSU with 
Institutional Review Board (IRB) number 4299 approved on 10/24/2019. The IRB approval letters 
From OLOL RMC, FMOLU, LSUHSC, LSU are shown in Appendix A, Appendix B, Appendix 
C, and Appendix D respectively. The waiver letter from Health Insurance Portability and 
Accountability Act of 1996 (HIPAA) Authorization from LSUHSC is shown in Appendix E. 
3.1.1. ED Patient Data from EHR of FMOLHS 
In this research study patient data related to ED visits affiliated with FMOLHS were obtained from 
the EHR for ED visits between January 2015 and January 2020. This ED data contains the 
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information of patients visited ED at least once between January 2015 and January 2020. Table 
3.1 shows the information contained in a single row of ED EHR dataset.  
 MRN is a unique identification number. This number is specific to each organization such as 
FMOLHS has its own format for the number. It is used to store and get details of patient medical 
records. Also, the purpose of ICD is to identify health related conditions with a common language 
at any health care organization. 
Table 3.1. Information in Each ED Patient Record 
Category Details 
Admission Date of admission 
Date of discharge 
time of visit 
Health center visited 
Length of Stay 
Admit Status 
PHI  MRN 
First name 
Last Name 
Date of Birth 
Address 





Financial Class (Medicaid, insurance coverage etc..) 
3.1.2. COVID Patient Data from EHR of FMOLHS 
Data on patients tested for SARS-CoV-2 between March 13 and June 15, 2020 across the 
FMOLHS affiliated hospitals and clinics (include LPG, LSU Health and Baton Rouge Clinic) was 
obtained from the EHR. Table 3.2 shows the information contained in a single row of this ED EHR 
dataset.  
Table 3.2. Information in Each COVID Patient Record 
Category Details 
Admission Hospital Unit 
Hospital Admission and Discharge Dates 
Ordering Department, Ordering Date 
Lab, Collection Date, Admit Type  
Test (SARS-CoV-2 PCR, SARS-CoV-2 RNA) 
Result (Positive, Negative)  
PHI  MRN, First name 
Last Name, Date of Birth, Address 
Other Race, Ethnicity, Gender, BMI (Height/Weight), 
Discharge Disposition, Living (Alive, Deceased) 
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3.1.3. Census Data and Social Vulnerability Data 
Census data, community information, social vulnerability are obtained through various online 
sources. This information is imported into the GIS as geospatial layers. The brief explanation of 
community information and context measures that were included and their respective online 
sources are shown below: 
Community information: Community information is publicly available through online 
sources such as US Census data and the American Community Survey (ACS). Demographic 
composition, education level, employment sectors, occupations, food, household composition, 
housing conditions and vehicle access across census tract, census block group and census block 
level are considered as part of community information.  Additionally, information related to census 
tracts, zip codes, census block groups, and census blocks are publicly available through US Census 
Topographically Integrated Geographic Encoding and Referencing (TIGER) in the form of shape 
files. These shape files are easily imported into the GIS system as layers.  
 Social Vulnerability Data: According to CDC, Social Vulnerability is defined as the degree 
to which a community exhibits certain social conditions, including high poverty, low percentage 
of vehicle access, or crowded households, may affect that community’s ability to prevent human 
suffering and financial loss in the event of disaster [67].  The Agency for Toxic Substance and 
Disease Registry’s (ATSDR’s) Geospatial Research, Analysis & Services Program (GRASP) 
created Centers for Disease Control and Prevention Social Vulnerability Index (CDC SVI or SVI).  
This SVI is useful to what extent and in which social factors the U.S census tracts are vulnerable 
and would need support before, during, and after a hazardous event or disease outbreak [67]. In 
this research study, we have included the SVI data for LA downloaded from CDC’S SVI Data as 
a shape file with the help of ArcGIS. Also, the sources that are used to get each variable and their 
descriptions are available in the SVI Documentation PDF. 
 3.1.3.1. SVI Data to FMOLHS Patient data 
Table 3.3 shows the CDC’S SVI Data included in the research study. This data is collected at 
census tract level of LA. For each field calculation and specific table names of data refer to the 
SVI Documentation PDF. 
 3.1.3.2. ACS Data to FMOLHS Patient data 
Table 3.4 shows the American Community Survey (ACS) included in the research study. This data 
is collected by 2018 ACS 5-Year Estimates Data Profiles at census tract level of LA. Additionally, 
the Rural-Urban Commuting Area (RUCA) primary (Prim_RUCA) codes that differentiates each 
US census tracts were integrated to the FMOLHS patient data. These codes are the measures of 
population density, urbanization, and daily commuting in the US census tracts [68].  
3.1.4. Software Required 
In this research study, ArcGIS Desktop (Version 10.6.1) a GIS tool is used to map the patient’s 
data (geocoded addresses), census data, community information, and SDOH factors available from 
various online public sources such as CDC’S SVI Data and American Community Survey. Also, 
SPSS software (Version 26) is used for statistical analysis purposes, i.e., to identify the correlations 
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between the independent variables (inputs provided) and the outcomes. Python 3.7 version is used 
to develop the prediction model by using Random Forests, Regular Gradient Boost, XGBoost, 
Neural Networks machine learning techniques. Also, the needful libraries are imported in python 





E_TOTPOP Population estimate, 2014- 2018 ACS 
EP_POV Percentage of persons below poverty estimate 
EP_UNEMP Unemployment Rate estimate 
EP_PCI Per capita income estimate, 2014- 2018 ACS 
EP_NOHSDP Percentage of persons with no high school diploma (age 25+) estimate 
EP_AGE65 Percentage of persons aged 65 and older estimate, 2014- 2018 ACS 
EP_AGE17 Percentage of persons aged 17 and younger estimate, 2014- 2018 ACS 
EP_DISABL Percentage of civilian noninstitutionalized population with a disability estimate, 2014-2018 
ACS 
EP_SNGPNT Percentage of single parent households with children under 18 estimate, 2014- 2018 ACS  
EP_MINRTY Percentage minority (all persons except white, non-Hispanic) estimate, 2014-2018 ACS 
EP_LIMENG 
Percentage of persons (age 5+) who speak English "less than well" estimate, 2014- 2018 
ACS 
EP_MUNIT Percentage of housing in structures with 10 or more units estimate, SVI 
EP_MOBILE Percentage of mobile homes estimate, DP04 
EP_CROWD Percentage of occupied housing units with more people than rooms estimate, SVI & DP04 
EP_NOVEH Percentage of households with no vehicle available estimate, DP04 
EP_GROUPQ Percentage of persons in institutionalized group quarters estimate, 2014- 2018 ACS 
RPL_THEME1 Percentile ranking for Socioeconomic theme summary. (Sum of percentile rank of 
EP_POV, EP_UNEMP, EP_PCI, EP_NOHSD) 
RPL_THEME2 Percentile ranking for Household Composition theme summary. (Sum of percentile rank of 
EP_AGE65, EP_AGE17, EP_DISABL, EP_SNGPNT) 
RPL_THEME3 Percentile ranking for Minority Status/Language theme. (Sum of percentile rank of 
EP_MINRTY, EP_LIMENG) 
RPL_THEME4 Percentile ranking for Housing Type/ Transportation theme. (Sum of percentile rank of 
EP_MUNIT, EP_MOBILE, EP_CROWD, EP_NOVEH) 
RPL_THEMES Overall percentile ranking (Sum of all RPL THEMES) 
EP_UNINSUR Adjunct variable - Percentage uninsured in the total civilian noninstitutionalized population 
estimate, 2014- 2018 ACS 









Percentage of persons (age 16+) with Management, business, 
science, and arts occupations 
DP03_0027PE 
EP_OCC_SER Percentage of persons (age 16+) with Service occupations DP03_0028PE 
EP_OCC_SAL_OFF Percentage of persons (age 16+) with Sales and Office occupations DP03_0029PE 
EP_OCC_NRCM 
Percentage of persons (age 16+) with Natural resources, 
construction, and maintenance occupations 
DP03_0030PE 
EP_OCC_PTMM 
Percentage of persons with Production, transportation, and 




3.1.5. Integrating FMOLHS patient data to Census data 
Geocoding is the process of converting any physical address into latitude and longitude 
coordinates. As part of this research study, Texas A&M University Geoservices [70] are used to 
geocode the FMOLH’s patient’s address. By using ArcGIS software, the census data such as 
census tract information, state, parish name, SVI data, ACS data are loaded into the tool as shape 
or layer filed. Now, the geocoded patient’s data is also loaded into the tool with the help of latitude 
and longitude coordinates. Spatial Join and Attribute Join techniques are used to map the census 
related information to the FMOLHS patient data. 
 ED Visits Dataset: The FMOLHS ED Visit data set contains all the ED visits between EHR 
between January 2015 and January 2020. The patient visits between January 2015 and January 
2016 are mapped with 2016 LA SVI data and 2010 LA Primary RUCA codes whereas the patient 
visits between January 2017 and January 2020 are mapped with 2018 LA SVI data and 2010 LA 
Primary RUCA codes. 
 COVID-19 Dataset: The FMOLHS COVID-19 data set contains the COVID-19 disease 
patients’ information between March 13 and May 6, 2020. This data is mapped to 2018 LA SVI 
data, 2018 ACS 5-Year Estimates DP03 data Profiles and 2010 LA Primary RUCA codes. 
The Attribute tables of these layers are exported to csv/excel files. These files can be imported into 
SPSS software and save as .sav files to perform the statistical analysis. 
3.1.6. FMOLHS ED Patient Data 
The FMOLHS ED Patients visits data set has more than 839K (839,684) patient visits. As part of 
this research study, after consulting with FMOLHS staff, we counted the ED visits of a patient 
(ED_Unnecessary_Visits) with Admit status as ED Discharge, because the visit to ED with Admit 
status as Admitted is considered to be a valid visit and the patient should get treated in ED. Out of 
839K ED Visits between the 2015-2019 years, approximately 545K (545,008) are unique patient 
visits. These unique patients are filtered based on MRN and year of visit. For example, if the 
combination of MRN and year exists more than once in a year then duplicate record is removed 
from the data set and Length of Stay (LOS), ED_Unnecessary_Visits value for each patient in a 
year is summed in the dataset to maintain a unique record. In this research study, the features that 
are considered as dependent and independent variables for predicting ED high utilizers are shown 
in Table 3.5. Additionally, in the Section 3.1.3 the details of census data (SVI and ACS) data 
sources are explained. Moreover, the specific data field descriptions that is integrated to the ED 
patient visits data and are shown in Table 3.3 and Table 3.4. 
 In Table 3.5, the dependent variable ED_Unnecessary_Visits is calculated based on the Admit 
field. If the Admit field value is ED Discharge then the visit to ED by a patient is counted and 
considered as an inappropriate visit. Therefore, the ED_Unnecessary_Visits field value is 0 if the 
Admit field value is Admitted. This implies that the patient visits to ED are appropriate. Moreover, 
the dependent variable ED_HighUtilizers is derived based on ED_Unnecessary_Visits. If the 
ED_Unnecessary_Visits field value is 4 or more per year, the patient is treated as ED high utilizer 
(1) and (0) vice versa. The Independent variables LOS is calculated as the difference in days 
between hospital discharge and hospital admission dates whereas Age is calculated based on 
patient’s date of birth and hospital admission date. Also, if the MRN and Year of a patient Urgent 
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Care Visit (UC_Visits) matches with the MRN and year of ED Visit then the MRN is counted and 
the count per year is assigned to UC_Visits field. The same calculation is done for Primary Care 
Visits (PC_Visits) per year. In the FMOLHS ED Visits data set we have 391K (391,243) “ED 
Discharge” records and 153K “Admitted” records. As we are looking at ED_Unnecessary_Visits, 
we removed the 153K “Admitted” status records from the dataset. Appendix F shows the specific 
values for the categorical variables included in the feature selection and their frequencies  
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 Appendix F data shows that Black ethnicity patients visit the ED for unnecessary reasons 1.6% 
more than Whites. FMOLHS patients between 21-50 age visits ED for unnecessary reasons 38.7% 
more than patients with age above 60. Also, patients with Medicaid visit ED 16.5 % more than 
Private Insurance patients. According to year wise percentages we can see that the unnecessary 
visits to ED have increased from 2015-2017, decreased 1.3% from 2017-2018, and increased 4.2% 
from 2018-2019. Hence, we integrated the SVI and ACS data to analyze the social factors that are 
leading to increase in the non- emergency visits to ED and identify the High Utilizers. 
 3.1.6.1. ED Unnecessary Visits and High Utilizers Data 
Figure 3.1 shows the distribution of overall ED_Unnecessary_Visits count of FMOLHS ED 
patients in LA with respect to year, insurance category, age, race, gender, and RUCA codes. From 
these bar charts we can see that approximately more than 95% of ED unnecessary visits count per 
year in FMOLHS are between 1 to 3 but more than 70% of these visits are 1. Less than 4 % of the 
entire ED Unnecessary visits have count between 4 to 10 and very few of the patients (less than 





b) Financial Class 
Figure 3.1. LA ED Patient Population Unnecessary Visits Count Distribution With a) Year, b) 









  f) 
Prim_RUCA 
Figure 3.1. (cont’d) LA ED Patient Population Unnecessary Visits Count Distribution With a) 
Year, b) Financial Class, c) Age, d) Race, e) Gender f) Prim_RUCA 
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After understanding/studying the year wise FMOLHS ED visits data based on the ED 
unnecessary visits (calculated per year), we observed that same patient visited the ED across the 
years 2015-2019 more than once. To study the ED High Utilizers, the data is filtered based on 
MRN and removed the duplicates across the years. If a patient has visited multiple times across 
the years, then the latest information of the data is considered for the unique patient record. By 
removing the duplicates across the years, we now have total of 419,398 unique records across the 
years. Out of 419,398 records we have 297,154 “ED Discharge records” and 122,244 “Admitted” 
records. As discussed in earlier sections, we considered a patient as ED High Utilizer based on ED 
Unnecessary Visits per year. We removed the 122K “Admitted” records. Figure 3.2 shows the 
distribution of FMOLHS ED High Utilizers count in LA with respect to year, insurance category, 
age, race, gender and, Primary RUCA. In the FMOLHS ED patient visits dataset, ED unnecessary 
visits between 1 to 3 are considered as Not-ED High Utilizer (denoted by “0”) and 4 -100 ED 
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Figure 3.2. LA Not-High (0) and High (1) ED Utilizer’s Patient Population Visits Count 






f) Primary RUCA 
 
Figure 3.2. (cont’d) LA Not-High (0) and High (1) ED Utilizer’s Patient Population Visits Count 
Distribution with a) Year, b) Financial Class, c) Age, d) Race, e) Gender f) Primary RUCA 
Out of 297K ED Discharge patients there are 10,996 ED High Utilizers. From the first graph in 
Figure 3.2 we can observe that among the total ED High utilizers 22.35%, 19.43%, 13.52%, 
19.88%, 24.82% are in 2019, 2018, 2017, 2016, and 2015, respectively. In the second graph 
Medicaid insurance category patients’ attributes to 56.68% of all ED high utilizers. Next, the third 
graph interprets that the patients between the age of 21-50 contributes to 50.41%. Based on fourth 
graph black ethnicity patients are 49.18% whereas white ethnicity patients are 43.05%. Also, the 
fifth graph tells that female ED high utilizers are 13.12% more than male patients. The final graph 
shows that 85.87% of all the ED high utilizers are from metropolitan area core. These statistics 
indicate that black ethnicity people, female gender, with increasing age, having insurance category 
as Medicaid and, coming from metropolitan are cores are utilizing the FMOLHS ED more. 
3.1.7. COVID Patient Data 
The FMOLHS registry of patients tested for SARS-CoV-2 between March 13th, 2020 to June 15th, 
2020 SARS-CoV-2 between March 13th, 2020 to June 15th, 2020 contains 18,415 people. Among 
these tested patients 2,938 people had a positive test result. In this research study, we included the 
patients with a LA address. In total for LA, 18,083 were tested and 2,902 were positive. After 
looking at the distribution of the COVID test data we identified that children (anyone under the 18 
years of age) are going to present very different from adults. For example, their BMI is much 
lower, Charlson Predictive Mortality Index (CPMI) indicates the 10-year predictive survival score 
and is very high when compared to adults. They do not have the comorbidities at the same rate as 
adults, the percentage of children coming from institutions (nursing homes, rehab, jail, or mental 
health) is negligible when compared to adults (For example, in FMOLHS COVID dataset we have 
only one patient record under 18 coming from prison).  Hence, for this retrospective study we 
included a total of 16,472 patients tested for COVID-19, out of which 2,758 were tested positive. 
 3.1.7.1. Assigning Clinical Data to COVID Patient Data 
As discussed in earlier sections that underlying problem history, SDOH factors of an individual 
might increase the severity and chance of acquiring COVID-19. In this retrospective study, we  
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have included the 1,214 different problems grouped into 16 categories shown in Table 3.6. 
Additionally, CPMI is obtained from FMOLHS' Epic software. A score of 0 indicates that the 
patient survival chance is very less in the next 10 years and the higher score indicates that there is 
very less of mortality in the next 10 years. In our research study, this score is mapped to the COVID 
patient’s dataset.  In addition, the general patient demographics such as age, gender, race, ethnicity, 
financial class are also available in the dataset. 
Table 3.6. Problem List and Associated Category 
Problem List Category 
Auto immune diseases Auto immune 
Cerebrovascular Disease CEVD 
Chronic Kidney Disease CKD 
Cirrhosis Liver Disease CLD 
Cardiovascular Disease CVD 
Diabetes Diabetes 
En-Stage Renal Disease ESRD 
Hepatitis B Hep B 
Hepatitis C Hep C 
Huma Immunodeficiency Virus HIV 
Hypertension HTN 
Immunodeficiency diseases Immunocompromised 
BMI, Morbid Obesity related diseases Obesity 
Exceeding BMI range Overweight 
Peripheral vascular disease PVD 
Asthma, Bronchial and, all respiratory diseases Respiratory 
 3.1.7.2. Mapping Institutions to COVID Patient Data 
Institutionalized patients are the patients who cannot live independently and stay in different 
institutions such as Nursing Homes, Rehab, Mental Health, Group Home and, Senior Living 
Homes. Additionally, people who are staying in prison are also considered as institutionalized 
patients. In this research study, we have people coming from 115 different institutions across LA 
to FMOLHS affiliated hospital and clinics for the SARS-CoV-2 test. We identified different 
institutional groups by grouping the people staying in Nursing Homes, Senior Living and, Group 
Homes as Nursing Home, people from Rehab, Mental Health as Mental Health/Rehab, people from 
Prison, Jail as Jail/Prison. After grouping, if the address of the patient registered at the time of visit 
matches with the institution address from the list of 115 institutions then we mapped that particular 
institution name, institution group (1-Nursing Home, 2-Mental Health/Rehab, 3-Prison\Jail) to the 
patient and assigned a variable as institutionalized (Yes/No) to differentiate institutionalized and 
non-institutionalized patients. By doing so, in total of 16472 patients, we noticed that there are 
1709 institutionalized patients. Table 3.7 shows the distribution of institutionalized and non-
institutionalized patients based on COVID test result (Positive, Negative). Also, for the analysis 
we are including the SVI and ACS data to only non-institutionalized patients because people who 
are institutionalized do not reflect the social and demographic characteristics of the neighborhoods 
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their institution is located in. Moreover, the institutionalized patient population are treated as 
separate population in the US census data. 
Table 3.7. COVID Positive and Negative Counts 
Category Positive Negative 
Institutionalized 554 1,155 
Non-Institutionalized 2,204 12,559 
 3.1.7.3. Variables in COVID Dataset 
Table 3.8 shows the list of fields/variables available in the COVID Patient dataset 
Table 3.8. Factors in COVID Patient Data 
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Table 3.8. (cont’d) Factors in COVID Patient Data 




































The COVID positive-tested patient's data are filtered based on the test result (‘Positive’).  As 
discussed earlier in this research study, the institutionalized positive patients are treated as separate 
population. Hence, we have two data sets one is institutionalized COVID positive patient data set 
and the other dataset is non-institutionalized COVID positive patient data. This split is done based 
on Institutionalized field (‘Yes’/’No’).  Appendix G shows the categorical variables and their 
respective frequency counts of COVID positive institutionalized patients. Appendix H shows the 
categorical variables and their respective frequency counts of COVID positive institutionalized 
patients. 
From Appendix G data we observe that institutionalized patients who are tested positive for 
COVID-19 diseases are above age 60 (84%), admitted in hospital (50.7%), coming from Nursing 
Homes (89.2%), female gender (50.9%), never smoked (48.9%), white or Caucasian (46.4%), 
Black or African (43.7%), having underlying conditions such as HTN (86.5%), Diabetes (45.3 %), 
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CVD (36.5%), CKD (30.5%), CEVD (26.7%), Respiratory (20.2%), Obesity (19.1 %), PVD (8.8 
%) and, other problems such as Overweight, Immunocompromised, HIV, Hep_B, Hep_C, ESRD, 
CLD, Auto_immune are less than 3%. This implies the age factor and the underlying conditions 
such as HTN, Diabetes, CVD are showing more impact on the institutionalized patients to acquire 
COVID-19. Moreover, 20.25% of FMOLHS COVID institutionalized positive patients are dead. 
 From Appendix H data we observe that the non-institutionalized patients who are tested 
positive for COVID-19 diseases are between 21-50 (45%), above age 50 (51.4%), admitted in 
hospital (28.1%), ED (25.6%), female gender (59.1%), never smoked (66.5%), white or Caucasian 
(29.6%), Black or African (59.5%), having underlying conditions such as HTN (48.8%), Diabetes 
(28.3 %), CVD (12.8%), CKD (10.7%), CEVD (6%), Obesity (26.5%), Respiratory (10.2%), and 
other problems such as PVD, Overweight, Immunocompromised, HIV, Hep_B, Hep_C, ESRD, 
CLD, Auto_immune are less than 3%. This implies the age factor and the underlying conditions 
such as HTN, Diabetes, CVD are showing more impact on the non-institutionalized patients to 
acquire COVID-19. 7.4 % of FMOLHS COVID non-institutionalized positive patients are dead. 
3.1.8. Spatial Analysis 
In this research study, we analyzed the patterns of number of ED High Utilizers (‘Yes/No’), 
COVID positive tested patients based on Institutionalized (‘Yes/No’). For, this we used Spatial 
Autocorrelation (Global Moran’s I) tool. This tool helps us to measure the spatial autocorrelation 
based on feature locations and the attribute values. The spatial autocorrelation tool calculates Index 
value, z-score, and p-value to evaluate the significance of index [71]. 
The Moran’s I statistic for spatial autocorrelation is shown by the equation below: 
𝐼 =









where, 𝑧𝑖 is the deviation of an attribute for feature 𝑖 from its mean (𝑥𝑖 − 𝑋 ̅), 𝜔𝑖, 𝑗 is the spatial 
weight between feature 𝑖 and 𝑗, 𝑛 is equal to the total number of features, and 𝑆0 is the aggregate 
of all the spatial weights:   






The z-score for the statistic is computed as: 




where, 𝐸[𝐼] and 𝑉[𝐼] values are:  




                  𝑉[𝐼] = 𝐸[𝐼2] − 𝐸[𝐼]2 
Z-scores represent the number of standard deviations from the mean, and the p-value is a 
probability that that a sample observation occurs this far from the mean (compared against the 
chosen test significance level  to determine significance of the test results). If a test's =0.05, if 
the observed test result has p-value ≤ 0.05, then the results are statistically significant whereas if 
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p-value > 0.05, then the results are not statistically significant. In spatial autocorrelation tool, p-
value is used to check whether the observed spatial pattern is the result of random process [72]. 
Moreover, the higher the Z value (its absolute value) or the lower the p value, the more significant 
the detected spatial autocorrelation pattern is. Also, Moran’s Index varies between −1 and +1. A 
value near +1 indicates that the attributes are clustered; and a value near −1 indicates that the 
attributes are dispersed. If a Moran’s I is close to 0, it indicates a random pattern or absence of 
spatial autocorrelation [71]. 
 Also, the Hot Spot Analysis is used to identify if high or low values cluster spatially.  For this 
we used the Hot Spot Analysis (Getis-Ord Gi*) tool in ArcGIS software. This tool helps us to 
identify statistically significant spatial clusters of high values (hot spots) and low values (cold 
spots).  Moreover, it calculates z-score, p-value, and a confidence level bin field (Gi_Bin) [73]. 
 The Getis-Ord local statistic is given as: 
𝐺𝑖
∗ =  














where 𝑥𝑗 is the attribute value for feature j, 𝑤𝑖,𝑗 is the spatial weight between feature I and j, n is 
equal to the total number of features and: 











− (𝑋)̅̅ ̅2 
The 𝐺𝑖
∗ statistic is Z-score. Table 3.9 shows different confidence levels for identifying the hot/cold 
spots. 
Table 3.9. Z-score and p-values for Different Confidence Levels 
Z-score p-value Confidence level Gi Bin 
<-1.65 or >+1.65 <0.10 90% -1 or 1 
<-1.96 or >+1.96 <0.05 95% -2 or 2 
<-2.58 or >+2.58 <0.01 99% -3 or 3 
The positive Z-score and small p-value indicates a spatial clustering of high values (identified as 
hot spots) and the Gi Bin value will be in the range of 1 to 3. However, negative Z-score indicates 
spatial clustering of low values (identified as cold spots) and the Gi Bin value will be in the range 
of -3 to -1.  If we cannot reject the null hypothesis then the Gi Bin value is “0” and it is Not 
Significant. Also, we have another spatial technique called Anselin Local Moran's I Cluster-Outlier 
analysis and is different from Hot Spot analysis explained earlier. In this analysis, we can identify 
statistically significant spatial clusters such as High-High (HH) or Low-Low (LL) and outliers 
such as High-Low (HL) or, Low-High (LH).  In this analysis, the high positive Z-score indicates 
surrounding features have similar values (HH or LL clusters). A low negative Z-score surrounding 
features have dissimilar values (HL or, LH outliers). If the null hypothesis cannot be rejected then, 
it is Not Significant. Anselin Local Moran's I Cluster-Outlier analysis is preferred over Hot Spot 
analysis only if we want to know abnormal trends in an area and to identify spatial outliers. For 
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example, if we want to identify the features that have high values in cold spot neighborhoods or 
features that have low values in high spot neighborhoods then Anselin Local Moran's I Cluster-
Outlier analysis can be used [74]. 
3.2. Correlation Analysis and Feature Selection Procedures 
SPSS software (version 26) was used to apply statistical techniques in order to analyze the 
correlation between the dependent and Independent variables mentioned in Table 3.5 and the 
correlation between the variables in Table 3.8 with respect to COVID result (‘Positive/Negative’), 
Living Status (‘Alive/Dead’). In this research study, for studying the relation between numeric 
dependent variable (ED_Unnecessary_Visits) and other numeric independent variables, 
Spearman/Pearson correlation techniques can be used. 
3.2.1. Pearson Correlation  
The Pearson correlation technique is a bivariate analysis useful in studying the strength and 
direction of the linear relationship between two numeric (continuous) parameters. This can be done 
by using “Correlate” option in Analyze menu in SPSS. The Pearson correlation coefficient (r) lies 
between -1 to 1. The negative (-ve) sign indicates that the dependent variables decrease with 
increase in independent variable and vice versa for positive (+ve) sign. The following assumptions 
should be satisfied to perform the person correlation. 
• All variables should be continuous variables 
• Linear relationship between the two variables (using “Chart Builder” option in Graphs in 
SPSS) 
• No significant outliers (using “Explore” option in Analysis in SPSS) 
• All the variables should be normally distributed. (This was tested using Shapiro-Wilk test 
of normality in SPSS). 
Table 3.10 shows the Pearson’s (r) Correlation Coefficient Scale 




0.00 No association between the two variables 
0.01–0.19 
No or negligible association between the 
variables 
0.2–0.39 Weak association between the variables 
0.4–0.69 Medium association between the variables 
0.70–1.0 Strong association between the variables 
Though the variables are continuous, there is no linear relationship between the dependent and 
sample of independent variables. This is shown in the scatterplots shown in Figure 3.3 between 
dependent (ED_Unnecessary_Year, ED_High Utilizers) and EP_MINRITY independent variable. 
Moreover, there is no linear relationship between COVID_result (‘Positive (1)/’Negative (0)’), 
Living Status (‘Alive/Dead’) and EP_MINRITY factor. This is shown in the scatterplots shown in 
Figure 3.4 . Hence, the Pearson correlation score might not be appropriate with this analysis.  
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3.2.2. Spearman Correlation 
The Spearman rank-order correlation (Spearman correlation 𝒓𝒔) was used to find the correlation 
between two ordinal or two continuous variables. Spearman is a nonparametric measure whereas 
Pearson is a parametric measure. The range of 𝒓𝒔 is same as r discussed in Section 3.2.1. This can 
be done by using the “Correlate” option in Analyze menu in SPSS. This analysis is used when the 
data violates the assumptions of Pearson. The following assumptions should be satisfied to perform 
the Spearman correlation analysis. 
• The variables should be ordinal or scale. 
• The variables can be monotonically related to another variable. This implies if one 
variable increases the other variable should either increase or decrease (using “Chart 
Builder” option in Graphs in SPSS) 
 The variables are scale variables and some of the independent variables either increased or 
decreased with the increase in dependent variable. This is shown in the scatterplots shown in  
Figure 3.3 and Figure 3.4. Hence, we can use the Spearman correlation analysis. 
3.2.3. Eta Coefficient Test 
The Eta Coefficient test is a statistical method used to find the association between an independent 
categorical variable (e.g., gender, race), and a dependent scale variable (e.g., a continuous value 
such as 0, 1, 2, and so on) [75]. The Eta Coefficient is asymmetric and is used to find the nonlinear 
association between a categorical and a scale variable. Moreover, the association score criteria are 
same as Pearson’s correlation coefficient discussed in Table 3.10. The following are assumptions 
of the Eta Coefficient test [75]. 
• The data must be nonlinear or curvilinear variables (using “Chart Builder” option in 
Graphs in SPSS) 
• The data must be asymmetric (Using “Descriptive Statistics->Frequencies” option in 
Analyze in SPSS) 
• The dependent variable should be scale or interval level 
• The independent variables should be categorical with two or more 
• There must be independence of observations, so there is no relationship between the 
groups or between the observations in each group [75]. 
In Figure 3.3 and Figure 3.4, we can see that the sample of data is nonlinear. The data in the ED 
visits dataset and COVID dataset is asymmetric. This is shown in the histograms shown in  Figure 
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Figure 3.6 (cont’d) COVID Data Histograms 
3.3. ED Predictive Model Development 
Van Kuijk et al [76] indicates that predictive modelling is used in developing tools for prediction 
of the most likely value of a continuous measure or the probability of the occurrence of an event; 
predictive methods include classification, regression, and time series modeling. This research 
study considers that a patient from each census tract/block group may visit (once, or more than 
once) different ED in LA for various reasons. The output of the model is to predict whether a 
patient is likely to be an ED high utilizer (‘Yes/No’) of ED facilities affiliated to FMOLHS that 
are available in LA. The research question addressed here is: 
• Develop and validate a machine learning / neural network model for predictive 
classification of ED high utilizers as (Yes/No) to multiple ED facilities available in LA 
and identify correlations between the SDOH factors and the other independent variables 
influencing the utilization of FMOLHS ED. 
 In this research study, we are considering the FMOLHS unique ED patients between January 
2015- January 2020 from all the cities in Louisiana. The geocoded patient data is imported into 
ArcGIS software as point layer data using the latitude and longitude coordinates of each patient's 
address. Also, the SVI data shapefile is imported into the ArcGIS software. By using spatial join 
query between the point layer of patient visits dataset and SVI polygon layer, each patient is 
mapped with the SVI data related factors based on the patient address. Now, the entire patient data 
mapped to the SVI data is exported from the attribute table. For this research objective, we are 
using the unique ED High Utilizers data. 
 Before developing the model, to understand the influence of independent variables on the 
dependent variables shown in Table 3.5, correlation analysis is performed using Spearman 
correlation and Eta Coefficient test statistical techniques. As discussed in Section 3.1.6.1, the 
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unique ED High Utilizers (10,996) patient records obtained from FMOLHS affiliated hospitals in 
LA between 2015-2019 are added to the randomly selected 10,996 patient records who are not ED 
High Utilizers. This dataset is used to obtain the correlation scores. Moreover, feature selection of 
independent variables is done by considering the correlation scores. In this scenario, the 
independent variables which has correlation score as 0 with respect to the dependent variable are 
unrelated and removed. Independent variables which have correlation score other than 0 with 
respect to the dependent variable were considered for analyzing the feature importance among the 
independent variables. Also, if there were multiple independent variables highly correlated with 
each other, then we selected only one variable among them and eliminated the rest of the variables. 
Finally, ranks were assigned to the independent variables based on the correlation score with 
respect to dependent variable; the results are discussed in Section 4.1. For example, rank 1 is 
assigned to the variable that has high correlation score and the least ranking variables are removed 
from the dataset. 
 The machine learning task is a classification task. To predict the ED_High Utilizers dependent 
variable we considered the unique “ED Discharge” patient visits filtered based on MRN. In the 
process of developing the ED High Utilizers predictive classification model, we have randomly 
selected 10,996 patient records who are not ED High Utilizers and added to the ED High Utilizers 
dataset to make the model learn the difference between ED High Utilizers and Non-High Utilizers. 
The correlated independent variables (factors) identified are added to the two prediction models. 
3.3.1. Preprocessing 
To perform machine learning-specific preprocessing and develop the predictive classification 
models, Python version 3.7 was used. We imported the FMOLHS ED patient visits dataset with 
the help of the Pandas Python library. 
The StandardScaler method from the Python sklearn library, sklearn.preprocessing, was used 
to normalize input variable values to have a mean of 0 and standard deviation of 1. 
SPSS was used to perform dummy coding of the categorical variables. By clicking on the 
“Variable View” tab and navigating to “Values” column the categorical variables are manually 
converted to numerical codes such as 0,1,2. Additionally, the nulls/Not Applicable values are 
categorized as” Missing data/Unknown/Other” and converted to numerical codes. The codes 
assigned to the values in the categorical variables are shown in Appendix F. 
The Python codes for the three machine learning models including preprocessing and 
validation are shown in Appendix J, Appendix K, and Appendix L. 
3.3.2. Neural Networks 
Neural networks represent sets of neurons which are connected. Generally, neurons are a non-
linear parameterized function of its input variables and its value is its output. Therefore, a network 
of neurons is the composition of the nonlinear functions of two or more neurons [77].  The simple 
neural network structure is shown in Figure 3.7. From Figure 3.7 we can see that neuron like 
structure is presented with an input layer, hidden layer, and an output layer. The input vector goes 
through weighted connections, intermediate nodes, and then the weights are learned in order to 
obtain correct outputs. The neural network machine learning algorithm is capable of learning 




Figure 3.7. Neural Network; Source Image: Neural network example.svg, Wikipedia [78] 
We imported MLPClassifier from sklearn.neural_network to train the model to predict the 
dependent variable (ED_High Utilizers). In this scenario we defined the following parameters for 
the MLPClassifier [79]  
• Input layer: The number of features in the dataset (20) and bias (1) are considered as 
number of nodes in input layer (number of nodes:21) 
• Hidden layer:  hidden layer sizes (number of layers:3, number of nodes in each layer: 20) 
• Output layer: The two outcomes of the target variable are considered as number of nodes 
in output layer (number of nodes:2; one node corresponds to ED-High Utilizer (1) and the 
other one corresponds to Not ED High Utilizer (0)) 
• Activation function for the hidden layers is the rectified linear unit function, returns f(x) = 
max (0, x) (activation: ‘relu’) 
•  MLPClassifier supports multi-class classification by applying ‘Softmax’ (It is a 
generalization of the logistic function to multiple dimensions) as the activation function for 
output layer. 
• The stochastic gradient descent solver is used for weight optimization (solver: ‘sgd)’. This 
solver calculates the error derivative (contribution) of each weight and for each training 
data instance and calculate the update of weight values to reduce future errors.  
• Regularization term on weights (alpha=0.3). This reduces the overfitting by constraining 
the magnitude of weights. 
• The learning rate for weight updates (learning_rate=’adaptive’).  keeps the learning rate 
changing. The limit to the weight changes is ‘learning_rate_init’.  
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• The initial learning rate used (learning_rate_init=0.3). This limit is used to control the 
amount of weight change during training of the model. 
• Momentum for gradient descent update. The momentum is used to avoid or move out of 
the local minima. This will eventually reduce the error function to reach the global minima. 
(momentum=0.4). 
• The maximum number of iterations (max_iter=1000); for solver=’sgd’ it indicates the 
maximum number of times the training dataset is repeatedly applied. Learning may stop 
earlier if convergence is reached.  
3.3.3. Random Forests 
Random forest is a supervised learning technique and uses decision tree model for parametrization, 
but it integrates a sampling technique, a subspace method, and an ensemble approach to optimize 
the model building. It can be applied to both classification and regression problems [80]. 
Moreover, the random forest algorithm is based on bagging approach. Bagging is a way to decrease 
the variance in the prediction by generating additional data for training from dataset using 
combinations with repetitions to produce multi-sets of the original data. This algorithm is 
bootstrapping the data by randomly choosing subsamples for each iteration of growing trees. The 
growing happens in parallel which is a key difference between XGBoost and random forests 
[81,82,83].  The characteristics of random forest algorithm are shown in Figure 3.8. 
 
Figure 3.8. Characteristics of Random Forest 
We imported the RandomForestClassifier from sklearn.ensemble to train the model to predict the 
dependent variables. In this scenario we defined the following parameters for the 
RandomForestClassifier [84]. 
• The number of trees in the forest (n_estimators=1800) 




• The maximum depth to which the nodes are expanded (max_depth=90) 
• The minimum number of samples required to split an internal node in the decision tree 
(min_samples_split=2) 
• The minimum number of samples required at leaf nodes in the decision tree 
(min_samples_leaf=1) 
• The number of features considered when looking at best split (max_features='auto'); for 
auto max_features=sqrt(n_features) 
• Bootstrap sampling (smaller sample that is bootstrapped from larger sample) is used for 
building a tree (bootstrap='True') 
• This random_state field value is used to control both the randomness of the bootstrapping 
of the samples used when building trees (if bootstrap=True) and the sampling of the 
features to consider when looking for the best split at each node (if max_features < 
n_features). (random_state=12) 
3.3.4. XGBoost 
In XGBoost individual decision trees are created using multiple cores to improve training time 
performance. Decision trees are also organized in a way that reduces lookup times when the trained 
model is applied. XGBoost increases the performance and decreases the training time of the 
models [85]. This is a relatively new algorithm and is utilizing the concept of gradient tree boosting 
and use trees in a sequential learning process as weak learners. Boosting is an iterative technique 
which adjusts the weight of an observation based on the last classification [81,82]. Moreover, by 
introducing regularization parameters we can reduce overfitting. The characteristics of XGBoost 
algorithm are shown in Figure 3.9. 
 
Figure 3.9 Characteristics of XGBoost 
 We imported XGBClassifier from XGBoost in order to train the model to predict the dependent 
variables. In this scenario we defined the following parameters for the XGBClassifier [86]. 
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• Global bias, the initial prediction score of all instance (base_score=0.5) 
• Subsample ratio of the training instances (subsample=1) 
• Colsample_bylevel is the subsample ratio of columns for each level. Subsampling occurs 
once for every new depth level reached in a tree. Columns are subsampled from the set of 
columns chosen for the current tree. (colsample_bylevel=1) 
• Colsample_bynode is the s the subsample ratio of columns for each node (split). 
Subsampling occurs once every time a new split is evaluated. Columns are subsampled 
from the set of columns chosen for the current level. (colsample_bynode=1) 
• Colsample_bytree is the subsample ratio of columns when constructing each tree. 
Subsampling occurs once for every tree constructed. (colsample_bytree=0.9) 
• Minimum loss reduction required to make a further partition on a leaf node of the tree. If 
the gamma value increases the algorithm becomes more conservative (gamma=0.1) 
• To know the contribution of each feature for each tree in the model 
(importance_type='gain') 
• The weight update used to prevent overfitting: range [0,1] (learning_rate=0.05) 
• Maximum delta step we allow each leaf output (max_delta_step=0) 
• Maximum depth of a tree (max_depth=12) 
• Minimum sum of instance weight needed in a child (min_child_weight=5) 
• The number of trees build (n_estimators=100) 
• Number of parallel trees constructed during each iteration. This option is used to support 
boosted random forest. (num_parallel_tree=1) 
• The learning task and corresponding learning objective (objective='binary: logistic') 
• Control the balance of positive and negative weights, useful for unbalanced classes 
(scale_pos_weight=1) 
3.3.5. Training, Testing, and Validation 
The dataset was randomly divided into a training and testing set and a validation set. The training 
and testing set together contains 70% (15,394 records) of data and validation set contains 30% 
(6,598 records) of data. Using SPSS->Data->Select Cases->Random Sample of Cases we have 
randomly selected 30% of total unique ED High Utilizers (10,996) and selected output as “Filter 
out unselected cases”. In SPSS with the help of filter column we separated the filtered data as 
validation dataset (30%) and remaining data as a training and testing dataset (70%). Likewise, 
from the 408,432 Not-ED High Utilizers we have randomly selected 10,996 Not-ED High Utilizers 
and separated the validation and a training and testing dataset. Finally, the corresponding ED High 
Utilizers validation and a training and testing data is merged with Not ED High Utilizers validation 
and a training and testing data. Hence, the training and testing dataset and the validation dataset 
have equal number of ED High Utilizers (1) and Not-ED High Utilizers (0). The validation dataset 
is used to validate the machine learning techniques utilized; the same data should not be used in 
both training and validation of the model. During training, KFold (from sklearn.model_selection; 
the value of K is 10) is used to break the training and testing dataset randomly and repeatedly into 
training and testing datasets, a technique that help improve generalization and reduce overfitting. 
The developed models are trained on the training dataset and the evaluation metrics Area Under 
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Curve (AUC) score, Accuracy, Precision, Recall, Specificity and F1 score are used to evaluate the 
models. The models which have high AUC and F1 score are the best fit models. Additionally, the 
models should have higher Accuracy, Recall, Specificity, Precision scores as they are used to 
examine the percentage of number of correctly classified ED high utilizers, Not-ED high utilizers 
with respect to actual count of ED high utilizers, Not-ED high utilizers in the dataset. Table 2.1 in 
Chapter 2 shows the calculation details for each evaluation metric. 
3.4. ED High Utilizers Spatial Analysis 
 After the predictive classification model development, the ED high utilizers data was used to 
perform spatial analysis. Spatial Autocorrelation, Hot Spot Analysis as discussed in Section 3.1.8 
was performed to identify the clusters of ED High Utilizers based on unique FMOLHS ED patient 
data between 2015-2019. 
3.5. Retrospective Study of COVID Tested Patients 
Due to the COVID outbreak in the United States and increase in the COVID cases in LA, 
FMOLHS asked for a retrospective study to identify factors which may be responsible for 
increased risk of FMOLHS patients acquiring COVID-19 disease. The research question addressed 
here is: 
• Perform a retrospective study and spatial analysis to identify which patient demographics, 
clinical characteristics and SDOH factors are responsible for increasing the risk of 
general population acquiring or dying due to COVID-19. 
 In this research study, to perform of the retrospective study of COVID tested patients is 
separated into four datasets. The first filter applied is based on the on the test result 
(‘Positive/Negative’) for SARS-CoV-2. The First dataset contains all positive tested patient’s data, 
and the other dataset contains all negative tested patients. As discussed in Section 3.1.7.3, the 
positive tested patient’s data is separated into another two datasets based on Institutionalized field 
(‘Yes’/’No’). The third data set contains all positive institutionalized patient’s data and the fourth 
one contains all positive non-institutionalized patients. All dataset records were geocoded into 
latitude and longitude coordinates based on the institution's address for institutionalized patients 
and patient’s physical address for non-institutionalized patient’s. The geocoded datasets are 
imported into ArcGIS software as point layer. The SVI and ACS data are imported into the ArcGIS 
software as shapefile. The geocoded patient data was then related to the Census data (SVI and 
ACS) discussed in Section 3.1.3 with the help of spatial joining technique available in the ArcGIS 
tool. The research question is addressed by comparing the datasets as shown below: 
• Correlation analysis was performed between positive and negative tested patients using 
Spearman Correlation and Eta Coefficient test statistical techniques and the features that 
have high influence on the COVID test result, Living Status are identified based on the 
feature selection process discussed in Section 3.3. 
• To study the differences and similarities between positive and negative tested patients for 
SARS-CoV-2, the variables in the dataset are summarized (averages, counts) by 
Age_Category, Race_Ethnicity, Sex, Living_Status, Smoking_Status, Type, 
Institutionalized, Institution_Group. Also, Hot Spot Analysis as discussed in Section 
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3.1.8 was performed to identify the clusters of positive and negative FMOLHS COVID 
tested patients in LA. 
• To study the differences and similarities between positive institutionalized and non-
institutionalized patients, the variables in the dataset are summarized (averages, counts) 
by Age_Category, Race_Ethnicity, Sex, Living_Status, Smoking_Status, Type, 
Institutionalized, Institution_Group. Also, Spatial Autocorrelation, Hot Spot Analysis as 
discussed in Section 3.1.8 was performed to identify the clusters of positive 






































Chapter 4. ED Prediction Model Results and Analysis 
4.1. Correlation Analysis and Feature Selection 
To study the association between the independent and dependent variables discussed in Section 
3.1.6, the Spearman correlation and Eta Coefficient test statistical techniques are used. For this we 
considered all the unique ED High Utilizers patient data (10,996 records) between 2015-2019 
years along with another randomly selected ED visit patient data that are not high utilizers. This 
data has been selected randomly with the help of SPSS Data->Select Cases->Random sample of 
cases. The Spearman correlation is performed between numeric(continuous/binary/Ordinal) 
dependent and independent variables as the dataset satisfied the test assumptions. The 𝐻0 (null 
hypothesis) is defined as “There is no[monotonic] association between the variables”.  
The following SPSS code is used to run the Spearman correlation analysis. 
NONPAR CORR 
  /VARIABLES=Year LOS_Yr Age Admit Gender UC_Visits PC_Visits 
ED_Unneces_Yr ED_HighUti E_TOTPOP 
    EP_POV EP_UNEMP EP_PCI EP_NOHSDP EP_AGE65 EP_AGE17 
EP_DISABL EP_SNGPNT EP_MINRTY EP_LIMENG EP_MUNIT 
    EP_MOBILE EP_CROWD EP_NOVEH EP_GROUPQ RPL_THEME1 
RPL_THEME2 RPL_THEME3 RPL_THEME4 RPL_THEMES 
    EP_UNINSUR 
  /PRINT=SPEARMAN TWOTAIL NOSIG 
  /MISSING=PAIRWISE. 
  The results of the Spearman Correlation analysis are shown in Table 4.1.  
From Table 4.1, there is a strong correlation between the two dependent variables, 
ED_Unnecessary_Yr and ED_High_Utilizers. In this scenario, we have selected the ED High 
Utilizers dependent variable over ED_Unnecessary_Visits because the ED_High Utilizers has 
showed higher correlation scores with respect to the independent variables when compared to ED 
Unnecessary Visits. 
 Considering the correlation scores between dependent (ED_High Utilizers) variable and 
independent variables, the E_TOTPOP, EP_AGE17, EP_LIMENG, EP_MOBILE, 
RPL_THEME3 independent variables showed negligible correlation scores with respect to 
dependent variables. So, removing these variables. 
 From the covariance matrices shown in Appendix I we find that some of the independent 
variables are highly correlated (correlation scores between 0.7-1) with each other: 
• Admit is strongly correlated with LOS_Yr.  
• EP_PCI is strongly correlated with EP_POV, EP_NOHSDP 
• EP_NOVEH is strongly correlated with EP_POV, RPL_THEME1, RPL_THEMES 
• EP_POV, EP_UNEMP, EP_PCI, EP_NOHSDP, EP_NOVEH, RPL_THEMES variables are 
strongly correlated with RPL_THEME1. 
• EP_MINRTY, EP_LIMENG are strongly correlated with RPL_THEME3   
• EP_SNGPT, EP_DISABL is strongly correlated with RPL_THEME2 
• RPL_THEME4, EP_UNINSUR is strongly correlated with RPL_THEMES 
We removed all RPL_THEME* variables because they are strongly correlated with other 
independent variables. EP_PCI is removed as it is strongly correlated with EP_POV, 
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EP_NOHSDP. EP_POV is selected over EP_NOVEH and Admit is considered over LOS_Yr 
because the EP_POV, Admit has desirable high correlation scores with the dependent variables 
when compared to EP_NOVEH, LOS_Yr respectively. 




𝒓𝒔 p-value 𝒓𝒔 p-value 
Year -0.38 0.000 -0.40 0.000 
LOS_Yr -0.68 0.000 -0.47 0.000 
Age -0.34 0.000 -0.34 0.000 
Admit -0.68 0.000 -0.47 0.000 
Gender -0.01 0.305 -0.01 0.225 
UC_Visits 0.15 0.000 0.16 0.000 
PC_Visits -0.12 0.000 -0.14 0.000 
ED_Unneces_Yr ***  0.89 0.000 
ED_HighUtilizers 0.89 0.000 ***  
E_TOTPOP -0.07 0.000 -0.09 0.000 
EP_POV 0.23 0.000 0.25 0.000 
EP_UNEMP 0.21 0.000 0.22 0.000 
EP_PCI -0.27 0.000 -0.30 0.000 
EP_NOHSDP 0.21 0.000 0.22 0.000 
EP_AGE65 -0.17 0.000 -0.17 0.000 
EP_AGE17 0.06 0.000 0.05 0.000 
EP_DISABL 0.12 0.000 0.13 0.000 
EP_SNGPNT 0.16 0.000 0.18 0.000 
EP_MINRTY 0.10 0.000 0.12 0.000 
EP_LIMENG -0.05 0.000 -0.05 0.000 
EP_MUNIT 0.10 0.000 0.12 0.000 
EP_MOBILE -0.03 0.000 -0.06 0.000 
EP_CROWD 0.16 0.000 0.18 0.000 
EP_NOVEH 0.17 0.000 0.18 0.000 
EP_GROUPQ 0.12 0.000 0.13 0.000 
RPL_THEME1 0.25 0.000 0.26 0.000 
RPL_THEME2 0.10 0.000 0.11 0.000 
RPL_THEME3 0.03 0.000 0.04 0.000 
RPL_THEME4 0.22 0.000 0.23 0.000 
RPL_THEMES 0.23 0.000 0.25 0.000 
EP_UNINSUR 0.27 0.000 0.29 0.000 
 
 To find the correlation scores between numeric (continuous/binary) dependent and categorical 
independent variables, an Eta Coefficient test is run. The null hypothesis is defined as 𝐻0 : There 
is no correlation between two variables. The results are shown in Table 4.2. 
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The following SPSS Code is used to find the association between the dependent and 
independent variables using Eta Coefficient test. 
 
CROSSTABS 
  /TABLES=Race Prim_RUCA Fin_class BY ED_Unneces_Yr ED_HighUti 
  /FORMAT=AVALUE TABLES 
  /STATISTICS=ETA 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /BARCHART. 
Table 4.2. Results of the Eta Coefficient Test 
Eta (ἠ)- Nominal by Interval Measure 
Independent/Dependent ED_Unnecessary_Visits ED_High_Utilizers 
Fin_class 0.38 0.51 
Race 0.11 0.13 
Prim_RUCA 0.05 0.07 
 
From Table 4.2, ED High Utilizers shows higher association scores with respect to the categorical 
independent variables when compared to ED_Unnecessary_Visits.  
• There is a strong association between ED_High_Utilizers and Fin_Class, the Eta 
coefficient ἠ = 0.51, ἠ2 = 0.26, implies that we can reject the null hypothesis as there an 
association between Fin_Class and ED_High_Utilizers; Financial Class has 26% effect 
on the ED_High_Utilizers. 
• There is a weak association between Race and ED_High_Utilizers, the Eta coefficient ἠ = 
0.11, ἠ2 = 0.0121, this implies that we can reject null hypothesis as there an association 
between Race and ED_High_Utilizers; Race has 1.21% effect on the ED_High_Utilizers. 
• There is a weak association between Prim_RUCA and ED_High_Utilizers, the Eta 
coefficient ἠ = 0.07, ἠ2 = 0.0049, this implies that we can reject null hypothesis as there 
an association between Prim_RUCA and ED_High_Utilizers; Prim_RUCA has 0.49% 
effect on the ED_High_Utilizers. 
 Based on the Spearman and Eta Coefficient test association scores, feature selection of the 
independent variables is performed. Rank 1 is assigned to the variable that has highest correlation 
score among the independent variables and the rank increases if the correlation score decreases. 
As discussed earlier, we are removing the strongly correlated variables RPL_THEME1, 
RPL_THEME2, RPL_THEME3, RPL_THEME4, RPL_THEMES EP_PCI, EP_NOVEH, 
LOS_Yr. In this research study, due to consolidation of multiple visits of a specific patient to a 
single record and variability in the dataset we obtained lower correlation scores for statically 
significant variables and decided to accept the variables that showed correlation score greater than 
0.1 (irrespective of +/-). We removed independent variables that had correlation scores of less than 
0.1 (irrespective of + or – sign, because it only indicates direction); these were E_TOTPOP, 
EP_AGE17, EP_LIMENG, and EP_MOBILE. The feature ranking of the remaining independent 




Table 4.3. Feature Ranking of Independent Variables 
Independent/Dependent ED_High_Utilizers Rank 
Fin_Class 0.513 1 
Admit -0.472 2 
Year -0.400 3 
Age -0.335 4 
EP_UNINSUR 0.293 5 
EP_POV 0.254 6 
EP_UNEMP 0.223 7 
EP_NOHSDP 0.216 8 
EP_CROWD 0.176 9 
EP_SNGPNT 0.175 10 
EP_AGE65 -0.173 11 
UC_Visits 0.159 12 
PC_Visits -0.144 13 
Race 0.134 14 
EP_GROUPQ 0.131 15 
EP_DISABL 0.125 16 
EP_MINRTY 0.118 17 
EP_MUNIT 0.115 18 
Prim_RUCA 0.066 19 
Gender -0.008 20 
Prim_RUCA and Gender fields had negligible correlation scores and were removed. 
4.2. ED Prediction Model Development and validation 
As discussed in Section 3.3, by using Python 3.7 software the predictive classification models are 
developed by applying Neural Networks, Random Forest and XGBoost machine learning 
techniques. The dependent variable/predictor variable is ED_High Utilizers (‘Yes (1)/No (0)’) and 
categorical (or binary). The machine learning task is a classification task. Initially the dataset is 
divided into a training and testing (70%) and a validation (30%) sets. The training and testing 
(70%) dataset is then divided randomly and repeatedly into training and testing datasets by using 
K-fold cross validation technique and the value of K is 10. The dependent variable is predicted by 
including all the independent variables selected as part of feature selection process. The codes for 
each machine learning methodology are shown in Appendix J, Appendix K, and Appendix L.  The 
average accuracy score, F1-Score, and ROC_AUC for the 10 folds was calculated for each of the 
different machine learning models and is shown in Table 4.4. The validation dataset is used and 
the evaluation metrics Accuracy, Sensitivity (Recall), Specificity, Precision, F1-Score and 
ROC_AUC Score are calculated for the developed models. With the help of these evaluation 
metrics the models are evaluated. The evaluation metrics are shown in Table 4.5. 
 In Table 4.5, we can see that the prediction model developed using XGBoost machine learning 




 The FMOLHS ED Visit population has large amount of Not ED High Utilizers when compared 
to ED High Utilizers. We also validated the developed machine learning models on the unbalanced 
general FMOLHS ED population, and the results are shown in  Table 4.6. In the general population 
validation data set the Neural Network machine learning technique showed slightly higher scores 
in all the evaluation metrics when compared to other models.  
Table 4.4. Average of Accuracy Scores for 10-Folds on Testing Dataset 
Classification Technique Accuracy (%) F1-Score (%) ROC_AUC (%) 
Neural Network 87.75 87.66 95.13 
XGBoost 88.01 87.93 95.29 
Random Forest 86.33 86.30 93.96 
































































50.78 0.86 0.01 0.50 2.79 73.89 [202305 198400
446    2853
] 
XGBoost 50.25 0.87 0.01 0.50 2.77 72.02 [200191 200514




49.70 0.86 0.01 0.49 2.71 72.65 [197980 202725
471    2828
] 
4.3. Spatial AutoCorrelation 
As discussed in Section 3.1.8, to understand the patterns of unique ED High Utilizers (10996) 
between 2015-2019 in LA we used Spatial Statistics Tools->Analyzing Patterns-> Spatial 
Autocorrelation (Moran’s I) in ArcGIS. To run this analysis, we have included the census tracts 
that have positive patients count greater than 0.  
• We chose EUCLIDEAN distance method as the study area is small (Example: Census 
Tracts) and it calculates the distance between two points connected by a straight-line. 
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• We chose conceptualization of spatial relationships as INVERSE DISTANCE because 
the nearby features have a larger influence on the computations of a target feature than 
features that are far away. 
The metric reported are shown in Figure 4.1, the values are shown in Table 4.7 
Table 4.7. Global Moran's I Results 
Global Moran's I Summary ED High Utilizers 
Moran's Index: 0.409541 




From Table 4.7 we can see that 
• The null hypothesis in this analysis is defined as “the values associated with features are 
randomly distributed”. Here P-value is near 0 (<0.01) and statistically significant for ED 
High Utilizers. So, null hypothesis can be rejected. 
• Moran’s Index varies between −1 and +1. A value near +1 indicates that similar attributes 
are clustered (either high values near high values or low values near low values); and a 
value near −1 indicates that dissimilar attributes are clustered (either high values near low 
values or low values near high values). If a Moran’s I is close to 0, it indicates a random 
pattern or absence of spatial autocorrelation. 
o ED High Utilizers: The Z-score for Moran's I is 36.231788 and p-value is 0.00, 
these values indicate that the detected spatial autocorrelation (ED High Utilizers) 
was statistically significant. In this scenario, Moran’s I (0.409541) is close to +1, 
it indicates that the ED High Utilizers census tracts in the study area are clustered.  
 
LA ED High Utilizers 
Figure 4.1. Spatial Autocorrelation Report (Moran’s I) for ED High Utilizers 
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4.4. Hot Spot Analysis 
As discussed in Section 3.1.8, we used Spatial Statistics Tools->Mapping Clusters-> Hot Spots 
Analysis (Getis-Ord Gi). When the Hot Spots Analysis (Getis-Ord Gi) is run, the number of ED 
High Utilizers in a census tract (input feature) are analyzed within the context of neighboring input 
features. The clustering of high values (high number of ED High Utilizers) is considered as hot 
spot and the clustering of low values (low number of ED High Utilizers) is considered as cold spot. 
In this analysis we used unique ED High Utilizers (10,996) between 2015-2019 in LA. 
 
 LA ED High Utilizers 
Figure 4.2. FMOLHS LA ED High Utilizers Hot Spot Analysis 
To identify the Hot Spots of FMOLHS ED High Utilizers, the Hot Spot Analysis is run with the 
help of ArcGIS software on the count (number of ED High Utilizers) variable. We have considered 
the census tracts that have count value greater than 0 in the analysis. Also, the census tracts number, 
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parish and total ED High Utilizers count with the associated hot spot/ cold spot are shown in 
Appendix M. From Appendix M  count values and Figure 4.2 we can observe that majority (more 
than 50%) of ED High Utilizer clusters of Hot Spots are in East Baton Rouge Parish. The other 
clusters of hot spots are in Iberville, East Feliciana, Livingston, Point Coupee, St. Helena, St. 
James, Tangipahoa, West Baton Rouge, West Feliciana Parishes. The Hot Spot map summary 
tables for ED High Utilizers are shown in Table 4.8.  We also performed Cluster and Outlier 
analysis but we preferred Hot Spot analysis because as per the Cluster and Outlier analysis results 
shown in Appendix O, the number of ED High Utilizers under” Not Significant” category are 11% 
higher when compared to Hot Spot analysis results shown in Table 4.8. The maps generated as 
part of Cluster and Outlier analysis are shown in Appendix N, , average values of SVI and ACS 
Data in Appendix P and, the census tracts number, Parish and total ED High Utilizers count with 
the associated Cluster and Outlier’s are shown in Appendix Q. 












# ED High 
Utilizers/total 
pop x 1000 
Hot Spot 99% 
Confidence 
8557.3698 155 10648 878,553 12.12 
Hot Spot 95% 
Confidence 
451.8844 2 30 6,449 4.65 
Hot Spot 90% 
Confidence 
137.8266 1 1 5,342 0.19 
Not Significant 19799.1608 74 193 375,097 0.51 
Cold Spot 90% 
Confidence 
2103.1884 9 13 42,480 0.31 
Cold Spot 95% 
Confidence 
1509.4957 33 41 200,727 0.20 
Cold Spot 99% 
Confidence 
592.7914 53 69 211,838 0.33 
Table 4.9 shows the percentage averages of SVI and ACS data based on Hot spot Analysis results. 
In this analysis, we are not considering the “Not Significant “results because it is such a large area, 
and there is large amount of variability in the area (kilometer square) of Louisiana state.  In 
comparison to the cold spots the hots spot have higher averages of % Age17, % Disability, % 
Single Parent, % Mobile Homes, % Crowded Housing, % Institutionalized Group Quarters, % 
Household Composition Rank, % Overall Rank SVI variable averages are higher in hot spot 
results. Additionally, the Per Capita Income average value is low in Hot Spots when compared to 
Cold Spots. 
 From Appendix M  count values and Figure 4.2 we noticed that more than 50% of ED High 
Utilizer clusters of Hot Spots are in EBRP. So, we are performing Hot Spot Analysis with the help 
of ArcGIS software on the count (number of ED High Utilizers) variable for East Baton Rouge, 
Parish. From Figure 4.3 we can see the hot spots among the EBRP in the years 2015-2016, 2017, 
2018 and, 2019. 
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In Figure 4.3 map (a) is shown for 2015-2016. After 2016 flood in LA many low-income 
people moved to student areas Burbank and Bluebonnet. Moreover, due to the Medicaid expansion 
in 2016 calendar year we have large number of ED high utilizers from low income neighborhoods 
when compared to other areas. From map (b) we can see that fair number of hot spots went away 
in 2017 due to the inauguration of the OLOL NBR ED. In the 2018 calendar year, there is 8.4% 
increase in the Medicaid enrollment for the LA population when compared to the Medicaid 
enrollment in 2017 [87] and from map (c) we can notice that there is an increase in the number of 
hot spots.  In contrast, in 2019 there is 6.1% decrease in the Medicaid enrollment of LA population 
when compared to the 2018 calendar year [87]. Also, in 2019 the St. Elizabeth ED in Ascension 
parish was acquired by FMOLHS. Per map (d) notice that the hot spot confidence percentage is 
decreased when compared to 2018 because the census blocks have fewer number of ED High 
utilizers visiting the FMOLHS ED in 2019. 
Table 4.9. Hot Spot Analysis Percentage Average Values of SVI and ACS Data Based on 
FMOLHS LA ED High Utilizers 
 
Results Confidence Spots/ 











LA Census Tract Data 
Poverty 19.35 20.95 19.30 18.73 20.35 22.85 
Unemployment 7.41 5.60 7.10 6.48 6.71 8.81 
Per Capita Income 28359.80 24826.0
0 
25085.00 26501.56 26896.94 26415.79 
No High School Dip 13.40 23.35 10.50 19.28 17.98 16.69 
Age 65 13.67 15.10 14.00 16.89 13.25 14.44 
Age 17 23.25 27.75 26.30 22.50 25.97 21.50 
Disability 15.77 23.30 17.70 16.67 14.11 14.70 
Single Parent 11.17 9.60 16.20 7.63 12.63 12.11 
Minority 48.96 40.80 29.40 23.36 37.69 63.39 
Limited English Proficiency 1.37 0.10 0.60 0.83 1.58 2.41 
Housing 10 or More 10.73 0.00 0.50 2.36 5.63 12.22 
Mobile Homes 11.00 24.30 8.50 19.41 15.80 2.58 
Crowded Housing 2.81 3.55 2.90 1.92 2.77 1.82 
No Vehicle 8.05 6.95 1.80 7.37 7.55 16.01 
Institutionalized Group 
Quarters 
2.96 1.85 0.10 0.97 1.28 2.55 
Socioeconomic Rank 0.43 0.57 0.43 0.46 0.49 0.56 
Household Composition 
Rank 
0.47 0.79 0.85 0.49 0.51 0.45 
Minority/Language Rank 0.51 0.35 0.47 0.34 0.54 0.69 
Housing/Transportation 
Rank 
0.52 0.51 0.40 0.43 0.60 0.40 
Overall Rank 0.47 0.57 0.53 0.42 0.55 0.52 











Figure 4.3. FMOLHS EBRP ED High Utilizers Hot Spot Analysis in the year a)2015-2016, 




The primary outcomes of ED predictive classification model developments and spatial analysis 
are discussed in this section.  
 In the FMOLHS ED population visit information dataset, we had high number of Not-ED high 
utilizers and a smaller number of ED high utilizers. Because of the unbalanced data, the ED 
Predictive classification model development focused on identifying the ED high utilizers rather 
than Not-ED high utilizers. As we concentrated on the ED high utilizers(positives), the model 
development focused on the higher score of Accuracy, F1-Score, Recall, and Precision. The 
XGBoost classification model had the best Accuracy score of approximately 87.87% and is 0.42%, 
1.05% higher when compared to Neural Network and Random Forest classification models 
respectively. Moreover, the evaluation metric scores for XGBoost model are: F1-Score is 87.36%, 
ROC_AUC is 95.11%, Recall, Precision, and Specificity are 0.87, 0.88, 0.88 respectively. The 
second-best model is Neural Network predictive classification model. This model evaluation 
metrics are Accuracy 87.45%, F1-Score is 87.34%, ROC_AUC is 95.01%, Recall, Precision, and 
Specificity are 0.87, 0.88, 0.88 respectively. These models will be useful for the FMOLHS to 
assess how changes in the ED patient visit data alter the FMOLHS ED high utilizers prediction 
based on previous patient data. The evaluation metrics on the validation showed that the on an 
average the developed predictive classification models had got only 12% of false positives and 
13% of false negatives. 
 The ED predictive classification model has been validated on the unbalanced general 
FMOLHS ED visit data. The Neural Network classification model showed an Accuracy score of 
approximately 50.78% and is 0.53%,1.08% higher when compared to XGBoost and Random 
Forest classification models respectively. Moreover, the evaluation metrics of Neural Network 
model are: F1-Score is 2.79%, ROC_AUC is 73.89%, Recall, Precision, and Specificity are 0.86, 
0.01, 0.50 respectively. Though the Neural network model had showed higher accuracy score, the 
evaluation metric Recall (0.87) has showed slightly higher scores in the XGBoost classification 
model.  The evaluation metrics on the general population showed that the on an average the 
developed predictive classification models had identified large number (49%) of false positives 
and smaller number (14%) of false negatives. 
  Good results were achieved for the true positive rate and the model was able to classify 87 
actual ED High utilizers out of 100 but overall the accuracy (50.25%) was poor due to many false 
positives, indicating additional work will be needed before the model is useful in practice.  
 To examine possible causes for the false positives, the “Admit” variable that differentiates the 
“ED Discharge and Admitted” patients was removed from the dataset and reran the model to 
identify if the classification model was relying too heavily on that one variable.  Results from the 
classification model showed a 14% reduction in accuracy, true negative rate, and 3% reduction in 
true positive rate by removing the “Admit” variable. This implies that the SDOH and demographic 
factors account for only a small proportion of classification and “Admit” variable accounts for 
majority of the classification.  With this change in the accuracy we noticed that the “Admit” 
variable should be included in the model and also that we are missing key information about the 
patients that would be needed to be able to accurately predict. The existing Epic readmission 
predictive model in OLOL has some overlap with the features used in our classification model but 
55 
  
then includes features concentrating on diagnosis and lab result codes. Moreover, the Epic model 
results are fairly close to the results we achieved in our study. In future research, by collecting 
more SDOH information at the patient level (rather than census level) and combining the diagnosis 
information, lab results, medications (used by the Epic model) to the ED visit patient data then the 
performance of the model likely can be significantly improved.  
 The hot spot analysis results will be useful for the healthcare organization/ healthcare 
advocates to guide the people to get connected with right resources in order to improve their health 
based on the features associated with the census blocks that have high number of ED high utilizers. 
For example, the ED high utilizers hot spots showed limited English proficiency and the patient 
advocates can use this result to guide the ED high utilizers to various health promotion programs 
across EBRP that can benefit the individual to improve their health and at the same time educating 
the people to visit other alternatives such as primary care, urgent care in order to reduce the ED 
visits for non-emergency conditions.  
 The hotspot analysis can be improved by including more patients and more hospitals. For 
example, not just the people going to OLOL facilities but including all the people who visit 
regional hospitals not affiliated to FMOLHS. In future research, we can also perform the hotspot 
analysis based on SDOH factors such as per capita rate or population density by breaking down to 
the smaller geographical areas. This can help us to know if the less densely populated areas are 
having larger number of ED high utilizers due to the impact of SDOH factors. 
The key points of hot spot analysis are: 
• The census tracts that have higher percentages of SVI variables such as poverty, 
unemployment, no high school diploma, crowded housing, single parent, elderly 
population, institutionalized group quarters, disability, minority, multiunit housing are 
highly correlated for the increase in ED High Utilizers among the FMOLHS patient 
population. 
• East Baton Rouge parish is considered as socially vulnerable area and people living in 
these areas utilize ED more for non-emergency reasons.  
o The Medicaid expansion in 2016 and inauguration of OLOL NBR ED in 2017 led 
to the FMOLHS ED High Utilizers in EBRP between 2015-2017.  
o In 2018, for the first time we noticed the hot spots in the West Baton Rouge 
parish due to increase in Medicaid enrollment across LA state. 
o In the 2019 calendar year there is a decrease in the Medicaid enrollment in the LA 
population and parallelly St. Elizabeth ED in Ascension parish was acquired by 
FMOLHS and went live in EPIC. So, the majority of hot spots are from 
Ascension, Livingston parishes but, the EBRP showed cold spots. 
o In comparison to the cold spots, the hot spots have higher averages of single 
parent population; limited English proficiency; people living in multiunit houses; 
minority status population; people living in crowded housing; are higher in hot 
spot results. Additionally, the Per Capita Income average value is low in hot spots 
when compared to cold spots. These factors in East Baton Rouge parish might 
drive the people to use the ED for non-emergency reasons. 
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• The FMOLHS ED management might work on developing a screening tool that will 
improve the existing process of integrating the SODH information to the patient 
information during/after their visit. 
• The FMOLHS management have patients coming from census tracts that have higher 
percentages of poverty rates, unemployment rates, single parent, disability, minority.  An 
interactive web application can be developed to provide necessary social prescriptions 
such as healthy nutrient food outlets, access to exercise, and guidance on financial 






































Chapter 5. COVID Retrospective Study Results and Analysis 
5.1. Retrospective Study of FMOLHS COVID Tested Patients 
The purpose of this study is to identify the characteristics of COVID Positive tested patients and 
identify factors that may have contributed to the outbreak of the diseases across LA based on 
FMOLHS COVID patient data. In this study, COVID tested patient’s information (18 and above 
age) between March 13th 2020 to July 15th 2020 are used for the analysis. To identify the patient 
demographics, clinical characteristics, SVI data and ACS occupational census data that are highly 
responsible for the COVID-19 disease the following retrospective studies have been conducted. 
5.1.1. Correlation Analysis on COVID Tested Patients 
As discussed in Section 3.1.7.2, the institutionalized patient population are treated as a separate 
population because they do not reflect the social and demographic characteristics of the 
neighborhoods their institution is located in. To understand the influence of SVI data, patient data 
discussed in Table 3.8 with respect to the COVID result (‘Positive/Negative’) we are considering 
the 2204 records of non-institutionalized positive patients. These records are added to the 
randomly selected 2204 negative non-institutionalized patients using SPSS Data->Select Cases-
>Random sample of cases. This dataset has satisfied the Spearman correlation test assumptions. 
The Spearman correlation is done between the numeric(continuous/binary) dependent and 
independent variables. The 𝐻0 (null hypothesis) is defined as “There is no[monotonic] association 
between the variables” 
The following SPSS code is used to run the Spearman correlation analysis. 
NONPAR CORR 
  /VARIABLES=BMI Age LOS Living_Status Sex COVID_results 
Charlson_predictive_mortality E_TOTPOP 
    EP_POV EP_UNEMP EP_PCI EP_NOHSDP EP_AGE65 EP_AGE17 
EP_DISABL EP_SNGPNT EP_MINRTY EP_LIMENG EP_MUNIT 
    EP_MOBILE EP_CROWD EP_NOVEH EP_GROUPQ RPL_THEME1 
RPL_THEME2 RPL_THEME3 RPL_THEME4 RPL_THEMES 
    EP_UNINSUR EP_OCC_MBSA EP_OCC_SER EP_OCC_SAL_OFF 
EP_OCC_NRCM EP_OCC_PTMM Auto_immun CEVD CKD CLD 
    CVD Diabetes ESRD Hep_B Hep_C HIV HTN Immunocompromised 
Obesity overweight PVD Respiratory 
  /PRINT=SPEARMAN TWOTAIL NOSIG 
  /MISSING=PAIRWISE. 
The results of the Spearman Correlation analysis are shown in Table 5.1. The correlation scores 
among other variables are shown in Appendix R. 
 From Table 5.1 we can see that BMI, Age, LOS, Living Status, EP_UNEMP, EP_SNGPNT, 
EP_MINRTY, RPL_THEME3, RPL_THEMES, EP_OCC_SER, Obesity have weak correlation 
scores and the rest of the factors have correlation scores less than 0.1(irrespective of + or -) with 
respect to COVID_Results. Additionally, Age, LOS, COVID_results, CPMI, CEVD, CKD, CVD, 
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Diabetes, ESRD, HTN have weak correlation scores and the rest of the factors have correlation 
scores less than 0.1 with respect to Living Status. 
Table 5.1. Spearman Correlation Scores Between Numeric Variables 
 
Spearman (𝒓𝒔) Living Status Covid Result 
 (𝒓𝒔) p-value (𝒓𝒔) p-value 
BMI -0.01 0.711 0.14 0.000 
Age 0.19 0.000 -0.10 0.000 
LOS 0.18 0.000 0.19 0.000 
Living_Status ***  0.12 0.000 
Sex 0.07 0.000 -0.02 0.200 
COVID_results 0.12 0.000 ***  
CPMI -0.24 0.000 0.08 0.000 
E_TOTPOP -0.04 0.024 -0.01 0.392 
EP_POV 0.04 0.004 0.08 0.000 
EP_UNEMP 0.03 0.068 0.10 0.000 
EP_PCI -0.05 0.002 -0.08 0.000 
EP_NOHSDP 0.04 0.008 0.06 0.000 
EP_AGE65 0.01 0.714 -0.05 0.002 
EP_AGE17 0.00 0.885 0.05 0.001 
EP_DISABL 0.03 0.102 0.03 0.037 
EP_SNGPNT 0.03 0.061 0.10 0.000 
EP_MINRTY 0.06 0.000 0.19 0.000 
EP_LIMENG 0.02 0.123 0.05 0.001 
EP_MUNIT -0.01 0.545 0.03 0.098 
EP_MOBILE -0.02 0.268 -0.08 0.000 
EP_CROWD 0.03 0.056 0.03 0.033 
EP_NOVEH 0.04 0.014 0.09 0.000 
EP_GROUPQ -0.01 0.609 0.00 0.796 
RPL_THEME1 0.05 0.003 0.09 0.000 
RPL_THEME2 0.03 0.061 0.07 0.000 
RPL_THEME3 0.06 0.000 0.17 0.000 
RPL_THEME4 0.01 0.459 0.03 0.042 
RPL_THEMES 0.05 0.003 0.11 0.000 
EP_UNINSUR 0.03 0.093 0.07 0.000 
EP_OCC_MBSA -0.06 0.000 -0.08 0.000 
EP_OCC_SER 0.05 0.003 0.10 0.000 
EP_OCC_SAL_OFF -0.02 0.159 -0.02 0.290 
EP_OCC_NRCM 0.02 0.266 -0.03 0.033 





Spearman (𝒓𝒔) Living Status Covid Result 
 𝒓𝒔 p-value 𝒓𝒔 p-value 
Auto_immun 0.01 0.589 -0.05 0.001 
CEVD 0.11 0.000 0.02 0.296 
CKD 0.16 0.000 0.01 0.658 
CLD 0.02 0.240 -0.01 0.493 
CVD 0.13 0.000 -0.01 0.754 
Diabetes 0.14 0.000 0.07 0.000 
ESRD 0.11 0.000 0.04 0.020 
Hep_B 0.02 0.280 0.00 1.000 
Hep_C 0.02 0.125 -0.04 0.007 
HIV 0.03 0.024 0.00 0.780 
HTN 0.12 0.000 -0.02 0.140 
Immunocompromised 0.01 0.690 -0.01 0.592 
Obesity 0.09 0.000 0.19 0.000 
overweight 0.01 0.713 0.03 0.033 
PVD 0.05 0.002 0.00 0.921 
Respiratory 0.06 0.000 -0.07 0.000 
 To find the correlation scores between numeric (continuous/binary) dependent and categorical 
independent variables an Eta Coefficient test was run. In this scenario the null hypothesis is defined 
as 𝐻0 : There will not be any association between two variables. The results are shown in Table 
5.2. 
The following SPSS Code is used to find the association between the Living Status, 
COVID_results and other factors using Eta Coefficient test. 
CROSSTABS 
  /TABLES=Type Smoking_status Race_Ethnicity Prim_RUCA_ BY 
Living_Status COVID_results 
  /FORMAT=AVALUE TABLES 
  /STATISTICS=ETA 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
 Table 5.2. Results of the Eta Coefficient Test 
Eta (ἠ)- Nominal by Interval Measure 
Independent/Dependent COVID_Results Living_Status 
Type 0.138 0.299 
Smoking Status 0.220 0.093 
Race_Ethnicity 0.296 0.060 





Table 5.2 shows: 
• There is a weak association between Type and COVID_Results; the Eta coefficient ἠ = 
0.138 and ἠ2 = 0.019 implies that we can reject null hypothesis and there is an 
association between Type and COVID_Results; the Type variable contributes to 1.9% of 
variance in COVID_Results 
• There is a weak association between Smoking Status and COVID_Results; the Eta 
coefficient ἠ = 0.220 and ἠ2 = 0.048 implies that we can reject null hypothesis and there 
is an association between Smoking Status and COVID_Results; the Smoking Status 
variable contributes to 4.8% of variance in COVID_Results 
• There is a weak association between Race_Ethnicity and COVID_Results; the Eta 
coefficient ἠ = 0.296 and ἠ2 = 0.087 implies that we can reject null hypothesis and there 
is an association between Race_Ethnicity and COVID_Results; the Race_Ethnicity 
variable contributes to 8.8% of variance in COVID_Results  
• There is a weak association between Prim_RUCA and COVID_Results; the Eta 
coefficient ἠ = 0.119 and ἠ2 = 0.014 implies that we can reject null hypothesis and there 
is an association between Prim_RUCA and COVID_Results; the Prim_RUCA variable 
contributes to 1.4% of variance in COVID_Results 
Likewise, there is a weak association between Living Status and Type, and negligible 
association between Living Status and Smoking Status, Living Status and Race_Ethnicity, Living 
Status and Prim_RUCA. The variables Type, Smoking Status, Race_Ethnicity, and Prim_RUCA 
contribute 8.9%, 0.9%, 0.4%, and 0.1% of variance in Living Status respectively. 
  From Table 5.1 and Table 5.2 can observe that the COVID test result (‘Positive/Negative’) 
for the general patients (non-institutionalized FMOLHS patients) are correlated with patient 
demographics: Age, BMI, Race_Ethnicity, Smoking Status,  clinical data such as LOS,  Type, 
underlying conditions: Obesity, SVI data: EP_UMEMP, EP_SNGPNT, EP_MINRTY, 
RPL_THEME3, RPL_THEMES and, ACS data: EP_OCC_SER. This implies that FMOLHS 
patients who belongs to minority race/ethnicity, single parent, having occupations related to 
service such as plumber services, restaurants, computer services, high socioeconomic rank 
(RPL_THEME1) and overall rank (if RPL_THEME is high then that area have high social 
vulnerability) might have higher chance of acquiring COVID-19 disease. 
 By considering Living Status (‘Alive/Deceased’) for the general patients (non-institutionalized 
FMOLHS patients), it is influenced by the by the patient demographics: Age, clinical data: LOS, 
CPMI, underlying conditions: CEVD, CKD, CVD, Diabetes, ESRD, HTN. 
5.1.2. Comparison of FMOLHS COVID Positive and Negative Tested Patients 
Based on the data in the tables shown in  Appendix S, Appendix T, Appendix U, Appendix V, 
Appendix W, and Appendix X we can interpret the differences and similarities between positive 
and negative tested COVID FMOLHS patients. 




• Out of the total COVID tested patients, 3.65% died. Of this,1.98% died due to underlying 
health conditions: HTN, Diabetes, CVD, CKD, CEVD, Obesity, Respiratory, other 
problems and 1.67% died due to COVID-19 disease. 
• The mortality rate is higher in males when compared to females in both COVID positive 
and negative tested patients (Appendix S, Appendix V).  
• The average age and CPMI of FMOLHS patients who tested positive for COVID-19 and 
died is approximately 72 and 36.26% respectively, and for positive patients who are alive 
is approximately 54 and 57.94% (Appendix S).  However, for the patients who tested 
negative for COVID-19 and died is approximately around 70, 32.17% and negative 
patients who are alive is around 56, 50.47% (Appendix V). 
• We could notice higher percentage (47.65%) of negative tested FMOLHS patients with 
Smoking Status as “Current” and “Former” when compared to positive tested patients 
(28.21%) (Appendix S, Appendix V). 
• There is higher rate (8.23%) of death rates among FMOLHS COVID positive patients 
admitted in the hospital when compared to the negative tested patients (1.95%) admitted 
in the hospital (Appendix S, Appendix V). 
• 20.09% of all positive tested patients are institutionalized patients with average age around 
74 and 4.06% of them are deceased. 8.42% of all negative tested patients are 
institutionalized patients with average age around 73 and 0.36% of them are deceased. 
Also, most of the institutionalized patients are coming from Nursing Homes (Appendix S, 
Appendix V). 
• In both positive and negative cases, the underlying health conditions are similar and they 
have high percentages of HTN, Diabetes, CVD, Respiratory, Obesity, CKD, CEVD and, 
the rest of the problem categories such as PVD, Overweight, Immunocomp, ESRD, Hep 
B, Hep C, HIV, CLD, Auto immune are having negligible percentages among COVID 
tested patients. Moreover, HTN, Diabetes and CVD are the top 3 underlying conditions 
for both positive and negative tested patients (Appendix T, Appendix W). 
• The Average_BMI is higher in positive patients when compared to negative tested 
patients (Appendix S, Appendix V). 
• The negative tested patients have lower average percentage values of SVI data when 
compared to positive tested patients. For example, EP_PCI is low for positive patient, 
EP_SNGPNT (11.53%), EP_MINRTY (46.54%), EP_LIMENG (1.25%), EP_MUNIT 
(7.87%), EP_GROUPQ (3.46%), RPLTHEME (0.46) (Overall ranking based on SVI 
data) are high in positive patients. The overall ranking indicates that the population who 
have high social vulnerability are at high risk of getting COVID-19 when compared to 
the counterparts (Appendix U, Appendix X). 
• FMOLHS patients who have occupations related to service (18.99%) are at higher risk of 
acquiring COVID-19 disease when compared to counterparts. For example, jobs such as 
plumber services, restaurants, computer services etc... (Appendix U, Appendix X). 
• In total 16472 tested patients, 6141 (37.28%) are black, 8849 (53.72%) are white but, 
1553 (9.43%) of all tested are positive and black. This implies that approximately 77.71% 
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of positive tested (2758) people are blacks. Moreover, 7632 (46.33%) of all tested 
patients are white and negative (Appendix S, Appendix V). 
Based on the above discussion, we noticed that the positive tested population groups are different 
from negative tested population. This is because the positive tested group has elderly population 
staying in socially vulnerable areas with underlying health conditions and employed at service 
occupations (e.g., grocery stores, restaurants etc.)  
 5.1.2.1. Hot Spot Analysis 
As discussed in Section 3.1.8, we used Spatial Statistics Tools->Mapping Clusters-> Hot Spots 
Analysis (Getis-Ord Gi) in ArcGIS. When the Hot Spots Analysis (Getis-Ord Gi) is run, the 
number of COVID positive cases in a census tract (input feature) are analyzed within the context 
of neighboring input features. The clustering of high values (high number of COVID Positive 
patients or high number of COVID Negative patients) is considered as hot spot and the clustering 
of low values (small number of COVID Positive patients or small number of COVID Negative 




                                   b) Negative 
Figure 5.1. FMOLHS COVID a) Positive and b) Negative Tested Patients Hot Spot Analysis 
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To identify the Hot Spots of FMOLHS COVID Positive and Negative tested patients the Hot Spot 
Analysis is run with the help of ArcGIS software on the count greater than 0 (number of 
positive/number of negative patients) variable. From Figure 5.1 map (a) we can observe that census 
tracts with less/ no COVID positive patients shown in map has more hot spots/ clusters of negative 
tested patients in map (b). Figure 5.1 shows that the black ethnicity patients are more in Positive 
tested patients. In contrary, the White ethnicity patients are more in Negative tested patients. 
5.1.3. Comparison of FMOLHS COVID Positive Institutionalized and Non-Institutionalized 
Patients 
Based on the tables shown in  Appendix S, Appendix Y, Appendix Z, Appendix AA, Appendix 
AB, and Appendix AC we can identify the differences and similarities between positive 
institutionalized and non-institutionalized COVID FMOLHS patients. 
• Out of 2758 positive tested patients, 2204 (79.91%) are non-institutionalized and 554 
(20.09%) are institutionalized (Appendix S). 
• Out of total COVID positive tested patients, 9.97% are dead. In this 5.91% are non-
institutionalized and 4.06% are institutionalized (Appendix S). 
• Though the females are tested positive at higher rate than males among institutionalized 
and non-institutionalized patients, the mortality rate is high in males (Appendix Y, 
Appendix AA). 
• The average age, CPMI of FMOLHS positive institutionalized patients who die due to 
COVID-19 is approximately around 75, 25.32 and positive institutionalized patients who 
are alive is around 73, 31.58. However, for positive non-institutionalized patients who die 
due to COVID-19 is approximately around 69, 43.78 and positive non-institutionalized 
patients who are alive is around 50, 63.65 (Appendix Y, Appendix AA). 
• We could notice higher percentage (44.40%) of institutionalized FMOLHS patients with 
Smoking Status as “Current” and “Former” when compared to non-institutionalized 
patients (24.13%) (Appendix Y, Appendix AA). 
• There is higher rate (14.80%) of death rates among institutionalized patients admitted in 
the hospital when compared to the non-institutionalized patients (6.40%) admitted in the 
hospital (Appendix Y, Appendix AA). 
• In both institutionalized and non-institutionalized positive tested cases, the underlying 
problem are similar and they have high percentages of HTN, Diabetes, CVD, 
Respiratory, Obesity, CKD, CEVD and, the rest of the problem categories such as PVD, 
Overweight, Immunocomp, ESRD, Hep B, Hep C, HIV, CLD, Auto immune are having 
negligible percentages among COVID positive tested patients (Appendix Z, Appendix 
AB). 
• HTN, Diabetes, CVD are the top 3 underlying health conditions for institutionalized 
patients (Appendix Z). 
• HTN, Diabetes, Obesity are the top 3 underlying conditions for non-institutionalized 
patients (Appendix AB). 
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• The minority ethnicity population showed higher percentage of positive cases among 
non-institutionalized patients when compared to institutionalized patients (Appendix Y, 
Appendix AA). 
• There were no deaths among Asian and Hispanic FMOLHS non-institutionalized patients 
(Appendix AA). 
• The Average age is high in positive institutionalized patients when compared to positive 
non-institutionalized patients. Moreover, majority of the positive tested institutionalized 
people are of age above 60 (Appendix Y, Appendix AA). 
Based on the above discussion, we noticed that the institutionalized positive patient population 
groups are different from non-institutionalized positive patient population. This is because the 
institutionalized positive patient group has elderly population with many underlying health 
conditions. Moreover, these group of people have experienced higher death rates when compared 
to non-institutionalized positive patient population. 
  5.1.3.1. Spatial Autocorrelation 
As discussed in Section 3.1.8, to understand the patterns of institutionalized and non-
institutionalized positive patients we used Spatial Statistics Tools->Analyzing Patterns-> Spatial 
Autocorrelation (Moran’s I). To run this analysis, we have included the census tracts that have 
positive patients count greater than 0.  
• We choose EUCLIDEAN distance method as the study area is small (Example: Census 
Tracts) and it calculates the distance between two points connected by a straight-line. 
• We choose conceptualization of spatial relationships as INVERSE DISTANCE because 
the nearby features have a larger influence on the computations of a target feature than 
features that are far away. 
The reports that are generated are shown in the Figure 5.2, the values are shown in Table 5.3 
Table 5.3. Global Moran's I Results 
Global Moran's I Summary Institutionalized Non-Institutionalized 
Moran's Index: 0.014828 0.139548 
Expected Index: -0.014286 -0.002755 
Variance: 0.001071 0.000097 
Z-score: 0.889800 14.433133 
p-value 0.373573 0.000000 
From Table 5.3 and Figure 5.2  we can see that 
• The Variance is 0.001071 for institutionalized and 0.000097 for non-institutionalized 
positive patients 
• P-value is a probability, it is used to check whether the observed spatial pattern is the 
result of random process and based on that we decided whether to reject or not to reject 
the null hypothesis.  The null hypothesis in these scenarios is defined as “the values 
associated with features are randomly distributed”. 
o Here P-value is 0.373573 (>0.05) and not statistically significant for 
institutionalized positive patients. So, null hypothesis cannot be rejected. 
o Here P-value is near 0 (<0.01) and statistically significant for non-
institutionalized positive patients. So, null hypothesis can be rejected. 
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• Moran’s Index varies between −1 and +1. A value near +1 indicates that the census tracts 
in the study are area clustered; and a value near −1 indicates that the census tracts in the 
study area are dispersed. If a Moran’s I is close to 0, it indicates a random pattern or 
absence of spatial autocorrelation. 
o Non-Institutionalized patients: The Z-score for Moran's I is 14.433133 and p-
value is 0.00, these values indicate that the detected spatial autocorrelation 
(positive non-institutionalized patients) was statistically significant. In this 
scenario, Moran’s I is 0.139548, it indicates that the positive non-institutionalized 
patient census tracts in the study area are clustered.  
o Institutionalized patients: Z-score for Moran's I is 0.889800 and p-value is 
0.373573, these values indicate that the detected spatial autocorrelation (positive 
institutionalized patients) was not statistically significant. In this analysis, the 
Moran’s I’s is 0.014828 and close to zero. This indicates the absence of spatial 
autocorrelation 
As discussed in earlier Section 3.1.7.2, the institutionalized patients should be treated as separate 
population and it is seen in the spatial autocorrelation analysis that the FMOLHS institutionalized 
positive patients are not clustered but randomly distributed. So, the institutionalized population do 




a) Institutionalized Patients b) Non-Institutionalized 
Figure 5.2 Spatial Autocorrelation Report (Moran’s I) for a) Institutionalized Patients b) Non-
Institutionalized Patients 
  5.1.3.2 Hot Spot Analysis 
As discussed in Section 3.1.8, we used Spatial Statistics Tools->Mapping Clusters-> Hot Spots 
Analysis (Getis-Ord Gi). When the Hot Spots Analysis (Getis-Ord Gi) is run for EBRP, the number 
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of COVID positive cases in a census tract (input feature) are analyzed within the context of 
neighboring input features. The clustering of high values (high number of COVID Positive 
institutionalized patients or high number of COVID Positive non-institutionalized patients) is 
considered as hot spot and the clustering of low values (small number of COVID Positive 
institutionalized patients or small number of COVID Positive non-institutionalized patients) is 
considered as cold spot. 
a) Institutionalized 
 
                      b) Non-Institutionalized 
Figure 5.3. FMOLHS EBRP COVID a) Institutionalized and b) Non-Institutionalized Positive 
Tested Patients Hot Spot Analysis 
To identify the Hot Spots of FMOLHS COVID Positive institutionalized and non-institutionalized 
patients, the Hot Spot Analysis is run with the help of ArcGIS software on the count (number of 
positive institutionalized/number of negative institutionalized) variable. We have considered the 
census tracts that have count value greater than 0 in the analysis. From Figure 5.3 map a we can 
observe that there are only few census tracts with COVID positive institutionalized patients 
identified as hot spots. In contrary, we have more hot spots/ clusters of non-institutionalized 
positive tested patients in map b. By looking and comparing both the maps we can notice that most 
of the cold spots and hot spots in the non-institutionalized patients map are in the census tract that 
does not have the institutionalized patients hot or cold spots. This indicates that institutionalized 
population are different from the non-institutionalized (general) patients of FMOLHS.   
 The Hot Spot map summary tables for Institutionalized and Non-Institutionalized positive 
patients are shown in Table 5.4 and Table 5.5. In the Table 5.5 and Figure 5.3 map b we could see 
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clusters of non-institutionalized COVID-19 positive cases in Northwest and South-Central 
Louisiana, and compromised of 196 census tracts that are identified as Hot Spots. Also, the census 
tracts number, parish and total positive patients count with the associated hot spot/ cold spot are 
shown in Appendix AD and Appendix AE.  We also performed Cluster and Outlier analysis but 
we preferred Hot Spot analysis because the Cluster and Outlier analysis has considered most of 
the positive patients as” Not Significant” when compared to Hot Spot analysis. The maps generated 
as part of Cluster and Outlier analysis are shown in Appendix AF, map summary tables in 
Appendix AG , average values of SVI and ACS Data in Appendix AH and, the census tracts 
number, Parish and total positive patients count with the associated Cluster and Outlier’s are shown 
in Appendix AI and Appendix AJ. 
 Table 5.6 shows the percentage averages of SVI and ACS data based on Hot spot Analysis 
results. In this analysis, we are not considering the “Not Significant “results because it is such a 
large area, and there is large amount of variability in the area (kilometer square) of Louisiana state. 
In Table 5.6 we can see that the % Housing with 10 or More Units, % Mobile Homes, % of 
Management, Business, Science & Art Occupations averages are high in hot spot results when 
compared to cold spots. 














Hot Spot 99% 
Confidence 
40.77 1 15 6,742 
2.22 
Hot Spot 95% 
Confidence 
1053.24 23 277 141,894 
1.95 
Hot Spot 90% 
Confidence 
185.44 7 100 53,793 
1.86 
Not Significant 4035.73 40 162 171,823 0.94 














Hot Spot 99% 
Confidence 
9841.38 161 1308 884,022 1.48 
Hot Spot 95% 
Confidence 
5277.40 19 69 73,665 0.94 
Hot Spot 90% 
Confidence 
4294.21 16 89 80,401 1.11 
Not Significant 9080.78 65 432 244,422 1.77 
Cold Spot 90% 
Confidence 
2547.83 4 5 16,054 0.31 
Cold Spot 95% 
Confidence 
310.94 9 10 39,216 0.25 
Cold Spot 99% 
Confidence 
6193.16 90 290 486,767 0.60 
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Poverty 18.68 26.48 21.31 27.23 24.71 22.17 
Unemployment 7.20 6.58 6.18 6.88 9.44 7.34 
Per Capita Income 28287 21214 22739 18058 22183 24328 
No High School Dip 13.87 19.54 17.51 21.75 17.03 19.46 
Age 65 14.00 16.47 16.76 17.85 13.53 13.70 
Age 17 23.29 23.37 23.48 21.95 26.86 25.12 
Disability 15.54 16.34 14.97 19.27 13.83 15.25 
Single Parent 11.47 10.71 8.97 9.00 15.40 12.03 
Minority 49.62 44.17 31.63 26.27 62.53 39.83 
Limited English 
Proficiency 
1.36 0.87 0.47 0.63 3.36 1.64 
Housing 10 or More 9.78 2.29 0.68 0.80 4.73 5.93 
Mobile Homes 11.64 22.33 28.24 24.25 6.67 16.03 
Crowded Housing 2.82 1.92 2.45 2.95 3.08 3.05 
No Vehicle 7.95 11.34 6.91 8.98 13.33 9.63 
Institutionalized Group 
Quarters 
2.43 2.95 4.97 6.77 0.18 2.12 
Socioeconomic Rank 0.43 0.60 0.52 0.67 0.57 0.55 
Household Composition 
Rank 
0.48 0.57 0.45 0.54 0.64 0.53 
Minority/Language 
Rank 
0.51 0.46 0.29 0.31 0.61 0.53 
Housing/Transportation 
Rank 
0.51 0.60 0.58 0.69 0.39 0.61 
Overall Rank 0.47 0.59 0.47 0.61 0.56 0.58 
Uninsured 10.34 12.63 13.16 15.23 14.01 12.02 
Management, Business, 
Science & Art 
Occupations 
32.81 26.06 28.62 22.28 27.76 28.75 
Service Occupations 19.60 21.28 19.61 19.55 27.74 20.57 
Sales & Office 
Occupations 















In this section, the primary outcomes of the analysis conducted on the FMOLHS COVID-19 tested 
patients are discussed.  
 
 
Weekly Mortality Rate 
Figure 5.4 Weekly Mortality Rate of COVID Positive Patients 
From Figure 5.4, we can see that there is an increase in the number of COVID positive patients 
and deaths from March 13th to April 2nd. Moreover, from April 3rd to May 14th there is a gradual 
decrease in the number of COVID positive cases and deaths. From May 15th to June 11th there is 
an increase in the number of COVID positive cases but, the number of deaths are decreased. Over 
all, the death rate decreased. 
 As part of the analysis and results discussed in Section 5.1, From Table 5.1, we can see that 
the CEVD, CKD, CVD, Diabetes, ESRD, and HTN underlying conditions, age and CPMI are 
weakly correlated with the mortality rate of COVID non-institutionalized positive patients. 
Moreover, the COVID test result (‘Positive/Negative’) is weakly correlated by the socioeconomic 
factors such as unemployment (EP_UNEMP), household composition factors single parent 
(EP_SNGPNT), minority status, and population who are doing service occupations. This implies 
population who work in jobs such as restaurants, plumber services etc. have more interaction with 




 Based on Louisiana ACS data [88], 48.9% of LA population are male and 51.1% are females.  
Though the female population is more in LA, the death rates are high in FMOLHS COVID male 
patients. In general, the LA demographics based on race and ethnicity contributes 58.8% White, 
32.0% Black or African American, 1.7% Asian, 0.7% Other, 5.0% Hispanic. In contrary, the 
FMOLHS majority of COVID positive percentage tested patients are higher in minority ethnicity 
population.  
 
a) LA Population 
 
                b) FMOLHS COVID Minority Positive 
Figure 5.5. Minority Comparison between a) LA Population b) FMOLHS COVID Minority 
Positive Cases Population Hot Spot Analysis 
 
From Figure 5.5 a and b maps, we can see that few of the hot spots in census tracts of EBRP, West 
Baton Rouge, Livingston, Iberville of LA minority map are consistent with the FMOLHS minority 
population COVID positive tested patients. Also, from map b) we can see that there are other 
census tracts in Assumption, Ascension, St. Helen, St. James, Iberia parishes that shows the hot 
spots of minority FMOLHS populations who got COVID-19 disease. 
 From the statistics shown in Appendix Y and Appendix Z we can understand that the White 
ethnicity institutionalized population got COVID-19 more than other ethnicity (Asians, Other, 
Unknown, Hispanic). HTN, Diabetes, and CVD are the top 3 underlying conditions for 
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institutionalized patients. The institutionalized deceased positive patients average age is 76. Also, 
the Asians and Hispanics have 0% of death rates in non-institutionalized FMOLHS COVID 
positive patient population. From Appendix AA and Appendix AB  we can see that the minority 
ethnicity non- institutionalized patients acquired COVID-19 more. The non-institutionalized 
deceased positive patients average age is 68. HTN, Diabetes, and Obesity are the top 3 underlying 
conditions for non-institutionalized patients. 
 Weak correlations are noticed for patient demographics Age, BMI, Race_Ethnicity, Smoking 
Status; Clinical data: LOS, Type; Underlying conditions: Obesity with respect to Covid test result. 
Due to small number of Covid positive tested records we did not observe strong correlations of 
features with respect to the Covid test result. The hot spot clusters of positive non-institutionalized 
Covid-19 patients are associated with high percentages of low per capita income; single parent 
population; minority status population; people living in mobile homes and crowded housing. 
Moreover, the positive patients spatial clusters showed higher occupation rate in service, sales, 
production, transportation and, material moving jobs. In the future research with the availability 
of more SDOH and clinical data the correlation results can change and these factors will be useful 
to the healthcare organization in developing a model that can predict the likelihood of testing 
positive for the Covid-19 virus and the outcomes of the disease(severity/mortality/hospitalization). 
Moreover, the good performance of the model can be useful for the organization to keep informed 
on the bad outcomes (severity/mortality/hospitalization) of the Covid-19 disease and improve the 
management of health/hospital scarce resources and disease in the event of contagious pandemic. 
 The hotspot analysis can be improved by including more patients and more hospitals. For 
example, not just the people going to OLOL facilities but including all the people who visit 
multiple hospitals not affiliated to FMOLHS. We can also perform the hotspot analysis based on 
underlying health conditions, social vulnerability index of people living in small geographical area. 
This can help us to know if the clusters of sick people living in same are being the major reason 
for the spread of the Covid-19 disease. 
The key points of results discussed in Section 5.1 and Section 5.2 are: 
• The institutionalized COVID positive tested patients are having high average age 
approximately around 70 when compared to non-institutionalized COVID positive tested. 
• The male gender has higher mortality rate when compared to female gender. 
• The minority FMOLHS COVID positive patient percentage is more when compared to 
LA demographics. 
• The FMOLHS patients living in regions that has high percentages of socioeconomic 
factors such as poverty rate, unemployment rate, no high school diploma, and low per 
capita income; higher percentages of household composition factors such as elderly 
population, disability; higher percentages of minority status population and people living 
in crowded housing showed higher COVID death rates when compared to the 
counterparts. 
• There were no deaths among Asian and Hispanic non-institutionalized positive patients. 
• The patients who have occupations related to service, sales, production, transportation 





Chapter 6. Conclusions and Future Research 
GIS can play a major role in informing health care industry policy and decision making. By using 
ArcGIS and geocoding, FMOLHS patient data and spatial non-clinical data such as Social 
Determinants of Health (SDOH) factors may be integrated to enhance analysis and broaden the 
questions that may be investigated by the hospital system. Further, incorporating machine 
learning-based predictive analytics for the FMOLHS patient data can lead to the development of 
real-time decision-making tools for improving health-related outcomes. This predictive 
classification model developed in this research study can be used as an alternative to the existing 
prediction model in the FMOLHS Epic. This model can be used to predict the likelihood of the 
patient being an ED High Utilizer in the future. 
 In this research study, as part of ED High Utilizers predictive classification model development 
the ED high utilizers patient visits data is studied based on age, gender, year, financial class, and 
ethnicity to identify the visit pattern between 2015-2019. The correlation analysis is performed to 
identify the patient and census tract non-clinical (SDOH factors) data that are influencing the 
FMOLHS patients for the overutilization of ED for unnecessary/non-urgent reasons. In the next 
step of this research study, the FMOLHS COVID-19 tested patient data set is studied based on 
age, gender, institutionalized(‘Yes/No’), ethnicity, clinical, and non-clinical factors. Correlation 
analysis is performed to identify the factors that are responsible for the acquiring COVID-19 
disease and mortality. 
 As part of this research study, ED high utilizer predictive classification model is developed. 
This model will be useful to the healthcare organization/social workers/patient advocates to follow 
up on the high-risk patients in order to keep them being an ED High utilizer. For example, these 
results can be used to make a phone call to the high-risk patients a week following ED visit and 
make sure that they are taking medicine, eating right food, doing exercise, and properly monitoring 
their health. More than 70% of OLOL ED high utilizers are covered by Medicaid and Medicare. 
In general, if the ED high utilizers covered by Medicaid, Medicare, and other payers are readmitted 
to ED within 30 days then the hospital organization have to pay penalties charged by Center for 
Medicare & Medicaid Services (CMS) and other payers. Hence these results can be used by 
community paramedics to educate people on healthier lifestyles that can reduce the risk of 
developing severe illness and provide primary care services in order to reduce non-urgent ED visits 
when the patient health problem is not critical. Having good predictor results will help the 
healthcare organization to reduce financial penalties by reducing the number of ED high utilizers 
and associated over utilization of hospital scarce resources. 
 As part of COVID study, correlation analysis and spatial analysis is done to identify the 
features associated with the risk of acquiring/spreading Covid-19. This analysis results will be 
useful for the hospital organization to know how different neighborhood characteristics impact the 
spread of Covid-19 and can develop a strategic response throughout the different stages of 
pandemic. For example, managing the patient flow, staffing, and hospital resources (PPE (Personal 
Protective Equipment), supplies, ventilators) during the pandemic. 
 The techniques/methodologies used in the above summarized analysis can be used by 
healthcare providers and research institutions to study, analyze, predict, and uncover the hidden 
patterns in different types of healthcare data available with simple tweaks. Implementing of the 
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latest artificial intelligence tools and statistical techniques like in this study opens up new ways to 
understand and investigate huge data which otherwise cannot be anticipated by human intelligence.  
 The scope of this research study is LA but we have included only FMOLHS affiliated patient 
data across LA. For the machine learning model, we have not validated the model on “Live” patient 
data in the operational environment. Moreover, the underlying health conditions are not included 
in the model. Due to unavailability of latest spatial non-clinical data the COVID-19 retrospective 
study had integrated the 2018 non-clinical data to the clinical data. Though there are these 
limitations, this research study has successfully generated outcomes that would be useful for 
developing the predictive model of COVID-19 disease. By using ED overutilization data analysis 
results, we could compare the performance of existing prediction model in the FMOLHS Epic with 
the predictive classification model developed in this research study. Additionally, we could 
explore on developing an interactive web application that will generate social prescriptions based 
on the patient’s physical address. Moreover, with the help of ED High Utilizers data analysis 
results, we could perform a research study on identifying patterns or uncover the hidden facts in 
the FMOLHS ED revisits within 30 days. 
 In this research study, with the help of latest technology I was able to learn how to discover 
the hidden facts in different types of healthcare data. Additionally, I was able to learn the 
importance of data-driven analytical solutions in improving the existing process efficiency of a 
healthcare organization. By doing thesis as part of my master’s degree I was able to improve my 
writing and presentation skills. Moreover, I was able to collaborate with new people and 
communicate with them. This helped me to learn/improve my project management, team work, 


































































































Label Frequency Percent 



















Private Insurance (1) 


























































Other or Unknown (5) 


























Metropolitan area core (1) 
Metropolitan area high commuting (2) 
Micropolitan area core (4) 
Rural areas (10) 
Small town core (7) 
Metropolitan area low commuting (3) 
Micropolitan area high commuting (2) 
Small town high commuting (8) 
Small town low commuting (9) 
Micropolitan area low commuting (6) 

























Appendix G. Categorical Variables and Frequencies of COVID Positive 






























































Institution_group Nursing Home 
Prison 



















Race_Ethnicity White or Causian 






















Another acute care facility 
Hospice 






















Categorical Variable Label Frequency Percent 


































































































Metropolitan area core 
Metropolitan area high commuting 
Rural areas 
Micropolitan area core 
Micropolitan area high commuting 
Small town core 
Metropolitan area low commuting 
Micropolitan area low commuting 
Small town high commuting 






























Appendix H. Categorical Variables and Frequencies of COVID Positive 










































































Race_Ethnicity Black or African American 





















Another acute care facility 
Nursing Home 
Hospice 









































































































































Metropolitan area core 
Metropolitan area high commuting 
Micropolitan area core 
Rural areas 
Small town core 
Micropolitan area high commuting 
Micropolitan area low commuting 
Small town high commuting 
Metropolitan area low commuting 






























Appendix I. Spearman Correlation Scores between independent variables of 
ED High Utilizers Data 
 
Spearman (𝒓𝒔) Year LOS_Yr Age Admit Gender 
Year *** 0.15 0.15 0.15 0.01 
LOS_Yr 0.15 *** 0.35 0.99 0.01 
Age 0.15 0.35 *** 0.33 0.07 
Admit 0.15 0.99 0.33 *** 0.01 
Gender 0.01 0.01 0.07 0.01 *** 
UC_Visits 0.08 -0.09 -0.05 -0.09 0.02 
PC_Visits 0.15 0.04 -0.14 0.04 0.00 
ED_Unneces_Yr -0.34 -0.68 -0.34 -0.68 -0.01 
ED_HighUtilizers -0.40 -0.47 -0.34 -0.47 -0.01 
E_TOTPOP 0.08 -0.01 -0.04 -0.01 0.02 
EP_POV -0.16 -0.13 -0.09 -0.13 0.00 
EP_UNEMP -0.16 -0.12 -0.08 -0.12 -0.01 
EP_PCI 0.21 0.16 0.13 0.16 0.00 
EP_NOHSDP -0.10 -0.14 -0.07 -0.15 0.00 
EP_AGE65 0.12 0.14 0.16 0.13 0.00 
EP_AGE17 -0.01 -0.07 -0.09 -0.07 0.02 
EP_DISABL -0.06 -0.06 0.01 -0.06 -0.01 
EP_SNGPNT -0.12 -0.11 -0.10 -0.11 0.00 
EP_MINRTY -0.01 -0.03 -0.03 -0.03 -0.02 
EP_LIMENG 0.11 0.02 0.01 0.02 0.00 
EP_MUNIT -0.10 -0.03 -0.03 -0.03 0.00 
EP_MOBILE 0.07 -0.03 -0.01 -0.03 0.02 
EP_CROWD -0.10 -0.11 -0.11 -0.11 0.01 
EP_NOVEH -0.05 -0.09 -0.02 -0.09 0.00 
EP_GROUPQ -0.07 -0.06 -0.01 -0.06 -0.02 
RPL_THEME1 -0.12 -0.15 -0.10 -0.15 0.00 
RPL_THEME2 -0.07 -0.05 -0.03 -0.06 0.00 
RPL_THEME3 0.07 0.00 -0.01 -0.01 -0.01 
RPL_THEME4 -0.10 -0.13 -0.08 -0.14 0.00 
RPL_THEMES -0.11 -0.13 -0.08 -0.14 0.00 








Spearman (𝒓𝒔) UC_Visits PC_Visits E_TOTPOP EP_POV 
Year 0.08 0.15 0.08 -0.16 
LOS_Yr -0.09 0.04 -0.01 -0.13 
Age -0.05 -0.14 -0.04 -0.09 
Admit -0.09 0.04 -0.01 -0.13 
Gender 0.02 0.00 0.02 0.00 
UC_Visits *** 0.01 -0.17 0.22 
PC_Visits 0.01 *** -0.02 -0.03 
ED_Unneces_Yr 0.15 -0.12 -0.07 0.23 
ED_HighUtilizers 0.16 -0.14 -0.09 0.25 
E_TOTPOP -0.17 -0.02 *** -0.49 
EP_POV 0.22 -0.03 -0.49 *** 
EP_UNEMP 0.19 -0.04 -0.33 0.63 
EP_PCI -0.22 0.02 0.40 -0.78 
EP_NOHSDP 0.13 -0.02 -0.34 0.65 
EP_AGE65 -0.02 0.05 -0.37 -0.13 
EP_AGE17 0.04 -0.02 0.41 -0.08 
EP_DISABL 0.20 0.00 -0.54 0.54 
EP_SNGPNT 0.17 -0.02 -0.07 0.47 
EP_MINRTY 0.28 -0.01 -0.47 0.56 
EP_LIMENG -0.01 0.00 0.02 -0.05 
EP_MUNIT 0.11 0.00 -0.20 0.18 
EP_MOBILE -0.17 0.00 0.32 -0.17 
EP_CROWD 0.11 0.00 -0.04 0.41 
EP_NOVEH 0.21 -0.02 -0.56 0.73 
EP_GROUPQ 0.08 -0.05 -0.19 0.28 
RPL_THEME1 0.22 -0.02 -0.46 0.88 
RPL_THEME2 0.18 0.01 -0.32 0.46 
RPL_THEME3 0.17 -0.01 -0.29 0.32 
RPL_THEME4 0.12 -0.03 -0.22 0.54 
RPL_THEMES 0.23 -0.02 -0.47 0.79 











Spearman (𝒓𝒔) EP_UNEMP EP_PCI EP_NOHSDP EP_AGE65 
Year -0.16 0.21 -0.10 0.12 
LOS_Yr -0.12 0.16 -0.14 0.14 
Age -0.08 0.13 -0.07 0.16 
Admit -0.12 0.16 -0.15 0.13 
Gender -0.01 0.00 0.00 0.00 
UC_Visits 0.19 -0.22 0.13 -0.02 
PC_Visits -0.04 0.02 -0.02 0.05 
ED_Unneces_Yr 0.21 -0.27 0.21 -0.17 
ED_HighUtilizers 0.22 -0.30 0.22 -0.17 
E_TOTPOP -0.33 0.40 -0.34 -0.37 
EP_POV 0.63 -0.78 0.65 -0.13 
EP_UNEMP *** -0.63 0.54 -0.13 
EP_PCI -0.63 *** -0.75 0.20 
EP_NOHSDP 0.54 -0.75 *** -0.05 
EP_AGE65 -0.13 0.20 -0.05 *** 
EP_AGE17 0.06 -0.13 0.06 -0.56 
EP_DISABL 0.48 -0.56 0.61 0.29 
EP_SNGPNT 0.35 -0.55 0.39 -0.32 
EP_MINRTY 0.51 -0.54 0.26 0.00 
EP_LIMENG -0.15 0.08 -0.12 0.00 
EP_MUNIT 0.04 -0.06 -0.14 0.02 
EP_MOBILE -0.13 0.02 0.29 -0.11 
EP_CROWD 0.30 -0.46 0.45 -0.31 
EP_NOVEH 0.53 -0.60 0.63 0.09 
EP_GROUPQ 0.19 -0.30 0.22 0.05 
RPL_THEME1 0.80 -0.90 0.84 -0.13 
RPL_THEME2 0.40 -0.56 0.53 0.19 
RPL_THEME3 0.22 -0.30 0.09 0.02 
RPL_THEME4 0.35 -0.55 0.55 -0.12 
RPL_THEMES 0.64 -0.84 0.75 -0.02 











Spearman (𝒓𝒔) EP_AGE17 EP_DISABL EP_SNGPNT EP_MINRTY 
Year -0.01 -0.06 -0.12 -0.01 
LOS_Yr -0.07 -0.06 -0.11 -0.03 
Age -0.09 0.01 -0.10 -0.03 
Admit -0.07 -0.06 -0.11 -0.03 
Gender 0.02 -0.01 0.00 -0.02 
UC_Visits 0.04 0.20 0.17 0.28 
PC_Visits -0.02 0.00 -0.02 -0.01 
ED_Unneces_Yr 0.06 0.12 0.16 0.10 
ED_HighUtilizers 0.05 0.13 0.18 0.12 
E_TOTPOP 0.41 -0.54 -0.07 -0.47 
EP_POV -0.08 0.54 0.47 0.56 
EP_UNEMP 0.06 0.48 0.35 0.51 
EP_PCI -0.13 -0.56 -0.55 -0.54 
EP_NOHSDP 0.06 0.61 0.39 0.26 
EP_AGE65 -0.56 0.29 -0.32 0.00 
EP_AGE17 *** -0.12 0.46 -0.06 
EP_DISABL -0.12 *** 0.26 0.42 
EP_SNGPNT 0.46 0.26 *** 0.43 
EP_MINRTY -0.06 0.42 0.43 *** 
EP_LIMENG -0.07 -0.10 0.00 0.22 
EP_MUNIT -0.25 -0.01 0.05 0.34 
EP_MOBILE 0.29 -0.01 0.01 -0.56 
EP_CROWD 0.33 0.22 0.44 0.22 
EP_NOVEH -0.15 0.59 0.29 0.52 
EP_GROUPQ -0.25 0.16 0.12 0.24 
RPL_THEME1 0.02 0.63 0.48 0.54 
RPL_THEME2 0.30 0.72 0.71 0.39 
RPL_THEME3 -0.10 0.21 0.25 0.76 
RPL_THEME4 -0.01 0.34 0.37 0.30 
RPL_THEMES 0.04 0.65 0.60 0.64 











Spearman (𝒓𝒔) EP_LIMENG EP_MUNIT EP_MOBILE EP_CROWD 
Year 0.11 -0.10 0.07 -0.10 
LOS_Yr 0.02 -0.03 -0.03 -0.11 
Age 0.01 -0.03 -0.01 -0.11 
Admit 0.02 -0.03 -0.03 -0.11 
Gender 0.00 0.00 0.02 0.01 
UC_Visits -0.01 0.11 -0.17 0.11 
PC_Visits 0.00 0.00 0.00 0.00 
ED_Unneces_Yr -0.05 0.10 -0.03 0.16 
ED_HighUtilizers -0.05 0.12 -0.06 0.18 
E_TOTPOP 0.02 -0.20 0.32 -0.04 
EP_POV -0.05 0.18 -0.17 0.41 
EP_UNEMP -0.15 0.04 -0.13 0.30 
EP_PCI 0.08 -0.06 0.02 -0.46 
EP_NOHSDP -0.12 -0.14 0.29 0.45 
EP_AGE65 0.00 0.02 -0.11 -0.31 
EP_AGE17 -0.07 -0.25 0.29 0.33 
EP_DISABL -0.10 -0.01 -0.01 0.22 
EP_SNGPNT 0.00 0.05 0.01 0.44 
EP_MINRTY 0.22 0.34 -0.56 0.22 
EP_LIMENG *** 0.36 -0.20 0.01 
EP_MUNIT 0.36 *** -0.61 0.02 
EP_MOBILE -0.20 -0.61 *** 0.11 
EP_CROWD 0.01 0.02 0.11 *** 
EP_NOVEH -0.03 0.23 -0.14 0.28 
EP_GROUPQ 0.02 0.27 -0.19 0.06 
RPL_THEME1 -0.11 0.03 -0.01 0.45 
RPL_THEME2 -0.05 -0.08 0.08 0.34 
RPL_THEME3 0.78 0.43 -0.47 0.15 
RPL_THEME4 0.07 0.41 0.04 0.61 
RPL_THEMES 0.14 0.24 -0.07 0.55 











Spearman (𝒓𝒔) EP_NOVEH EP_GROUPQ RPL_THEME1 RPL_THEME2 
Year -0.05 -0.07 -0.12 -0.07 
LOS_Yr -0.09 -0.06 -0.15 -0.05 
Age -0.02 -0.01 -0.10 -0.03 
Admit -0.09 -0.06 -0.15 -0.06 
UC_Visits 0.00 -0.02 0.00 0.00 
Gender 0.21 0.08 0.22 0.18 
PC_Visits -0.02 -0.05 -0.02 0.01 
ED_Unneces_Yr 0.17 0.12 0.25 0.10 
ED_HighUtilizers 0.18 0.13 0.26 0.11 
E_TOTPOP -0.56 -0.19 -0.46 -0.32 
EP_POV 0.73 0.28 0.88 0.46 
EP_UNEMP 0.53 0.19 0.80 0.40 
EP_PCI -0.60 -0.30 -0.90 -0.56 
EP_NOHSDP 0.63 0.22 0.84 0.53 
EP_AGE65 0.09 0.05 -0.13 0.19 
EP_AGE17 -0.15 -0.25 0.02 0.30 
EP_DISABL 0.59 0.16 0.63 0.72 
EP_SNGPNT 0.29 0.12 0.48 0.71 
EP_MINRTY 0.52 0.24 0.54 0.39 
EP_LIMENG -0.03 0.02 -0.11 -0.05 
EP_MUNIT 0.23 0.27 0.03 -0.08 
EP_MOBILE -0.14 -0.19 -0.01 0.08 
EP_CROWD 0.28 0.06 0.45 0.34 
EP_NOVEH *** 0.26 0.71 0.42 
EP_GROUPQ 0.26 *** 0.28 0.06 
RPL_THEME1 0.71 0.28 *** 0.54 
RPL_THEME2 0.42 0.06 0.54 *** 
RPL_THEME3 0.31 0.16 0.28 0.20 
RPL_THEME4 0.60 0.64 0.56 0.31 
RPL_THEMES 0.74 0.44 0.87 0.67 











Spearman (𝒓𝒔) RPL_THEME3 RPL_THEME4 RPL_THEMES EP_UNINSUR 
Year 0.07 -0.10 -0.11 -0.32 
LOS_Yr 0.00 -0.13 -0.13 -0.16 
Age -0.01 -0.08 -0.08 -0.11 
Admit -0.01 -0.14 -0.14 -0.16 
Gender -0.01 0.00 0.00 0.01 
UC_Visits 0.17 0.12 0.23 0.11 
PC_Visits -0.01 -0.03 -0.02 -0.04 
ED_Unneces_Yr 0.03 0.22 0.23 0.27 
ED_HighUtilizers 0.04 0.23 0.25 0.29 
E_TOTPOP -0.29 -0.22 -0.47 -0.39 
EP_POV 0.32 0.54 0.79 0.63 
EP_UNEMP 0.22 0.35 0.64 0.43 
EP_PCI -0.30 -0.55 -0.84 -0.69 
EP_NOHSDP 0.09 0.55 0.75 0.62 
EP_AGE65 0.02 -0.12 -0.02 -0.13 
EP_AGE17 -0.10 -0.01 0.04 -0.04 
EP_DISABL 0.21 0.34 0.65 0.41 
EP_SNGPNT 0.25 0.37 0.60 0.42 
EP_MINRTY 0.76 0.30 0.64 0.40 
EP_LIMENG 0.78 0.07 0.14 0.08 
EP_MUNIT 0.43 0.41 0.24 0.22 
EP_MOBILE -0.47 0.04 -0.07 -0.01 
EP_CROWD 0.15 0.61 0.55 0.34 
EP_NOVEH 0.31 0.60 0.74 0.58 
EP_GROUPQ 0.16 0.64 0.44 0.32 
RPL_THEME1 0.28 0.56 0.87 0.66 
RPL_THEME2 0.20 0.31 0.67 0.39 
RPL_THEME3 *** 0.24 0.50 0.30 
RPL_THEME4 0.24 *** 0.78 0.58 
RPL_THEMES 0.50 0.78 *** 0.72 











Appendix J. Python code for Neural Network ED Model 
 
import pandas as pd 
import numpy as np 
import matplotlib.pyplot as plt 
from sklearn.neural_network import MLPClassifier 
from sklearn import metrics 
from sklearn.preprocessing import StandardScaler 
scaler = StandardScaler() 








X = dataset.iloc[:, 0:19].values 
y = dataset.iloc[:, 19].values 





kf = KFold(n_splits=10, random_state=12, shuffle=True) 
print("10-fold Cross Validation") 
for train_index, test_index in kf.split(X,y): 
    print("TRAIN:", train_index, "TEST:", test_index) 
    X_train, X_test = X[train_index], X[test_index] 
    y_train, y_test = y[train_index], y[test_index] 
    scaler.fit(X_train) 
    X_train = scaler.transform(X_train) 
    X_test = scaler.transform(X_test) 
    Clf = MLPClassifier(hidden_layer_sizes=(20,20,20),  
 activation= 'relu', solver='sgd', alpha= 0.3,learning_rate = 
 'adaptive', learning_rate_init = 0.3, momentum=0.4, 
 max_iter=1000) 
    Clf.fit(X_train, y_train) 
    y_predk = Clf.predict(X_test) 
    df = pd.DataFrame({'Actual': y_test, 'Predicted': y_predk}) 
    print(df.head(25)) 
    print("***Evaluation Metrics for testing dataset***") 
    Confusion_Matrix = metrics.confusion_matrix(y_test, y_predk) 
    print("Confusion Matrix:") 
    print(metrics.confusion_matrix(y_test, y_predk)) 




    print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_test, y_predk)) 
    print("Sensitivity:", metrics.recall_score(y_test, y_predk)) 
    print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("Precision:", metrics.precision_score(y_test, 
y_predk)) 
    print("F1 Score:" ,metrics.f1_score(y_test, y_predk)) 
    print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_test, y_predk)) 
    y_pred_probk = Clf.predict_proba(X_test)[:, 1] 
    print("ROC_AUC_SCORE OF Predictied Value Probability:", 
metrics.roc_auc_score(y_test, y_pred_probk)) 
    Accuracy_Score = metrics.accuracy_score(y_test, y_predk) 
    F1_score = metrics.f1_score(y_test, y_predk) 
    ROC_AUC_SCORE=metrics.roc_auc_score(y_test, y_predk) 
    ROC_AUC_SCORE_PVP=metrics.roc_auc_score(y_test, 
y_pred_probk) 
    accuracy.append(Accuracy_Score) 
    F1_Score.append(F1_score) 
    ROC_AUC.append(ROC_AUC_SCORE) 





print("Average Accuracy for 10 Folds:", Accuracy) 
print("Average F1-Score for 10 Folds:", F1_SCORE) 
print("Average ROC_AUC for 10 Folds:", roc_auc) 
print("Average ROC_AUC_PVP for 10 Folds:", roc_auc_pvp) 








X_valid = dataset_Validation.iloc[:, 0:19].values 
y_valid = dataset_Validation.iloc[:, 19].values 
X_valid = scaler.transform(X_valid) 
y_pred = Clf.predict(X_valid) 
df = pd.DataFrame({'Actual': y_valid, 'Predicted': y_pred}) 
print(df.head(25)) 
print("***Evaluation Metrics of Validation dataset***") 
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from sklearn import metrics 
Confusion_Matrix = metrics.confusion_matrix(y_valid, y_pred) 
print("Confusion Matrix:") 
print(metrics.confusion_matrix(y_valid, y_pred)) 
print("Accuracy Score:",metrics.accuracy_score(y_valid, y_pred)) 
print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_valid, y_pred)) 
print("Sensitivity:", metrics.recall_score(y_valid, y_pred)) 
print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("Precision:", metrics.precision_score(y_valid, y_pred)) 
print("F1 Score:" ,metrics.f1_score(y_valid, y_pred)) 
fpr, tpr, thresholds = metrics.roc_curve(y_valid, y_pred) 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 
print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_valid, y_pred)) 
y_pred_prob = Clf.predict_proba(X_valid)[:, 1] 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 




     
 





Appendix K. Python code for Random Forest ED Model 
 
import pandas as pd 
import numpy as np 
import matplotlib.pyplot as plt 
from sklearn.ensemble import RandomForestClassifier 
from sklearn import metrics 
from sklearn.preprocessing import StandardScaler 
scaler = StandardScaler() 








X = dataset.iloc[:, 0:19].values 
y = dataset.iloc[:, 19].values 





kf = KFold(n_splits=10, random_state=12, shuffle=True) 
print("10-fold Cross Validation") 
for train_index, test_index in kf.split(X,y): 
    print("TRAIN:", train_index, "TEST:", test_index) 
    X_train, X_test = X[train_index], X[test_index] 
    y_train, y_test = y[train_index], y[test_index] 
    scaler.fit(X_train) 
    X_train = scaler.transform(X_train) 
    X_test = scaler.transform(X_test) 




    classifier.fit(X_train, y_train) 
    y_predk = classifier.predict(X_test) 
    df = pd.DataFrame({'Actual': y_test, 'Predicted': y_predk}) 
    print(df.head(25)) 
    print("***Evaluation Metrics for testing dataset***") 
    Confusion_Matrix = metrics.confusion_matrix(y_test, y_predk) 
    print("Confusion Matrix:") 
    print(metrics.confusion_matrix(y_test, y_predk)) 




    print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_test, y_predk)) 
    print("Sensitivity:", metrics.recall_score(y_test, y_predk)) 
    print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("Precision:", metrics.precision_score(y_test, 
y_predk)) 
    print("F1 Score:" ,metrics.f1_score(y_test, y_predk)) 
    print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_test, y_predk)) 
    y_pred_probk = classifier.predict_proba(X_test)[:, 1] 
    print("ROC_AUC_SCORE OF Predictied Value Probability:", 
metrics.roc_auc_score(y_test, y_pred_probk)) 
    Accuracy_Score = metrics.accuracy_score(y_test, y_predk) 
    F1_score = metrics.f1_score(y_test, y_predk) 
    ROC_AUC_SCORE=metrics.roc_auc_score(y_test, y_predk) 
    ROC_AUC_SCORE_PVP=metrics.roc_auc_score(y_test, 
y_pred_probk) 
    accuracy.append(Accuracy_Score) 
    F1_Score.append(F1_score) 
    ROC_AUC.append(ROC_AUC_SCORE) 





print("Average Accuracy for 10 Folds:", Accuracy) 
print("Average F1-Score for 10 Folds:", F1_SCORE) 
print("Average ROC_AUC for 10 Folds:", roc_auc) 
print("Average ROC_AUC_PVP for 10 Folds:", roc_auc_pvp) 








X_valid = dataset_Validation.iloc[:, 0:19].values 
y_valid = dataset_Validation.iloc[:, 19].values 
X_valid = scaler.transform(X_valid) 
y_pred = classifier.predict(X_valid) 
df = pd.DataFrame({'Actual': y_valid, 'Predicted': y_pred}) 
print(df.head(25)) 
print("***Evaluation Metrics of Validation dataset***") 
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from sklearn import metrics 
Confusion_Matrix = metrics.confusion_matrix(y_valid, y_pred) 
print("Confusion Matrix:") 
print(metrics.confusion_matrix(y_valid, y_pred)) 
print("Accuracy Score:",metrics.accuracy_score(y_valid, y_pred)) 
print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_valid, y_pred)) 
print("Sensitivity:", metrics.recall_score(y_valid, y_pred)) 
print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("Precision:", metrics.precision_score(y_valid, y_pred)) 
print("F1 Score:" ,metrics.f1_score(y_valid, y_pred)) 
fpr, tpr, thresholds = metrics.roc_curve(y_valid, y_pred) 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 
print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_valid, y_pred)) 
y_pred_prob = classifier.predict_proba(X_valid)[:, 1] 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 











Appendix L. Python code for XGBoost ED Model 
 
import pandas as pd 
import numpy as np 
import matplotlib.pyplot as plt 
from xgboost import XGBClassifier 
from sklearn import metrics 
from sklearn.preprocessing import StandardScaler 
scaler = StandardScaler() 








X = dataset.iloc[:, 0:19].values 
y = dataset.iloc[:, 19].values 





kf = KFold(n_splits=10, random_state=12, shuffle=True) 
print("10-fold Cross Validation") 
for train_index, test_index in kf.split(X,y): 
    print("TRAIN:", train_index, "TEST:", test_index) 
    X_train, X_test = X[train_index], X[test_index] 
    y_train, y_test = y[train_index], y[test_index] 
    scaler.fit(X_train) 
    X_train = scaler.transform(X_train) 
    X_test = scaler.transform(X_test) 
    xgb_clf = XGBClassifier(base_score=0.5, colsample_bylevel=1, 
              colsample_bynode=1, colsample_bytree=0.9, 
gamma=0.1, gpu_id=-1, 
              importance_type='gain',  
              learning_rate=0.05, max_delta_step=0, 
max_depth=12, 
              min_child_weight=5, 
              n_estimators=100, num_parallel_tree=1, 
              objective='binary:logistic', scale_pos_weight=1, 
subsample=1) 
    xgb_clf.fit(X_train, y_train) 
    y_predk = xgb_clf.predict(X_test) 
    df = pd.DataFrame({'Actual': y_test, 'Predicted': y_predk}) 
    print(df.head(25)) 
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    print("***Evaluation Metrics for testing dataset***") 
    Confusion_Matrix = metrics.confusion_matrix(y_test, y_predk) 
    print("Confusion Matrix:") 
    print(metrics.confusion_matrix(y_test, y_predk)) 
    print("Accuracy Score:",metrics.accuracy_score(y_test, 
y_predk)) 
    print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_test, y_predk)) 
    print("Sensitivity:", metrics.recall_score(y_test, y_predk)) 
    print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
    print("Precision:", metrics.precision_score(y_test, 
y_predk)) 
    print("F1 Score:" ,metrics.f1_score(y_test, y_predk)) 
    print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_test, y_predk)) 
    y_pred_probk = xgb_clf.predict_proba(X_test)[:, 1] 
    print("ROC_AUC_SCORE OF Predictied Value Probability:", 
metrics.roc_auc_score(y_test, y_pred_probk)) 
    Accuracy_Score = metrics.accuracy_score(y_test, y_predk) 
    F1_score = metrics.f1_score(y_test, y_predk) 
    ROC_AUC_SCORE=metrics.roc_auc_score(y_test, y_predk) 
    ROC_AUC_SCORE_PVP=metrics.roc_auc_score(y_test, 
y_pred_probk) 
    accuracy.append(Accuracy_Score) 
    F1_Score.append(F1_score) 
    ROC_AUC.append(ROC_AUC_SCORE) 





print("Average Accuracy for 10 Folds:", Accuracy) 
print("Average F1-Score for 10 Folds:", F1_SCORE) 
print("Average ROC_AUC for 10 Folds:", roc_auc) 
print("Average ROC_AUC_PVP for 10 Folds:", roc_auc_pvp) 








X_valid = dataset_Validation.iloc[:, 0:19].values 
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y_valid = dataset_Validation.iloc[:, 19].values 
X_valid = scaler.transform(X_valid) 
y_pred = xgb_clf.predict(X_valid) 
df = pd.DataFrame({'Actual': y_valid, 'Predicted': y_pred}) 
print(df.head(25)) 
print("***Evaluation Metrics of Validation dataset***") 
from sklearn import metrics 
Confusion_Matrix = metrics.confusion_matrix(y_valid, y_pred) 
print("Confusion Matrix:") 
print(metrics.confusion_matrix(y_valid, y_pred)) 
print("Accuracy Score:",metrics.accuracy_score(y_valid, y_pred)) 
print("Misclassification Rate (Classification error):", 1 - 
metrics.accuracy_score(y_valid, y_pred)) 
print("Sensitivity:", metrics.recall_score(y_valid, y_pred)) 
print("Specificity:", (Confusion_Matrix[0][0] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("False Positive Rate:", (Confusion_Matrix[0][1] / 
(Confusion_Matrix[0][0] + Confusion_Matrix[0][1]))) 
print("Precision:", metrics.precision_score(y_valid, y_pred)) 
print("F1 Score:" ,metrics.f1_score(y_valid, y_pred)) 
fpr, tpr, thresholds = metrics.roc_curve(y_valid, y_pred) 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 
print("ROC_AUC_SCORE of Predicted 
Value:",metrics.roc_auc_score(y_valid, y_pred)) 
y_pred_prob = xgb_clf.predict_proba(X_valid)[:, 1] 




plt.rcParams['font.size'] = 12 
plt.title('ROC curve for ED High Utilizers classifier') 
plt.xlabel('False Positive Rate (1 - Specificity)') 
plt.ylabel('True Positive Rate (Sensitivity)') 
plt.grid(True) 
plt.show() 





Appendix M. Hot Spot Analysis FMOLHS ED High Utilizers Count By 








1  East Baton Rouge  58 Hot Spot 99% 
10  East Baton Rouge  88 Hot Spot 99% 
11.02  East Baton Rouge  67 Hot Spot 99% 
11.03  East Baton Rouge  77 Hot Spot 99% 
11.04  East Baton Rouge  174 Hot Spot 99% 
16  East Baton Rouge  59 Hot Spot 99% 
17  East Baton Rouge  54 Hot Spot 99% 
18  East Baton Rouge  75 Hot Spot 99% 
19  East Baton Rouge  11 Hot Spot 99% 
2  East Baton Rouge  207 Hot Spot 99% 
20  East Baton Rouge  12 Hot Spot 99% 
201  West Baton Rouge  58 Hot Spot 99% 
202  West Baton Rouge  48 Hot Spot 99% 
203  West Baton Rouge  103 Hot Spot 99% 
204.01  West Baton Rouge  36 Hot Spot 99% 
204.02  West Baton Rouge  33 Hot Spot 99% 
22  East Baton Rouge  37 Hot Spot 99% 
23  East Baton Rouge  8 Hot Spot 99% 
24  East Baton Rouge  71 Hot Spot 99% 
25  East Baton Rouge  66 Hot Spot 99% 
26.01  East Baton Rouge  14 Hot Spot 99% 
26.02  East Baton Rouge  78 Hot Spot 99% 
27  East Baton Rouge  49 Hot Spot 99% 
28.01  East Baton Rouge  5 Hot Spot 99% 
28.02  East Baton Rouge  4 Hot Spot 99% 
3  East Baton Rouge  123 Hot Spot 99% 
30  East Baton Rouge  95 Hot Spot 99% 
301.01  Ascension  49 Hot Spot 99% 
301.02  Ascension  25 Hot Spot 99% 
301.03  Ascension  32 Hot Spot 99% 
302.03  Ascension  47 Hot Spot 99% 
302.04  Ascension  79 Hot Spot 99% 
302.05  Ascension  59 Hot Spot 99% 
302.06  Ascension  83 Hot Spot 99% 
303  Ascension  138 Hot Spot 99% 
304.01  Ascension  87 Hot Spot 99% 
304.02  Ascension  125 Hot Spot 99% 










306  Ascension  80 Hot Spot 99% 
309  Ascension  18 Hot Spot 99% 
31.01  East Baton Rouge  83 Hot Spot 99% 
31.03  East Baton Rouge  31 Hot Spot 99% 
310  Ascension  28 Hot Spot 99% 
32.01  East Baton Rouge  53 Hot Spot 99% 
32.02  East Baton Rouge  26 Hot Spot 99% 
33  East Baton Rouge  86 Hot Spot 99% 
34  East Baton Rouge  197 Hot Spot 99% 
35.01  East Baton Rouge  31 Hot Spot 99% 
35.04  East Baton Rouge  140 Hot Spot 99% 
35.05  East Baton Rouge  117 Hot Spot 99% 
35.06  East Baton Rouge  82 Hot Spot 99% 
35.07  East Baton Rouge  65 Hot Spot 99% 
36.01  East Baton Rouge  45 Hot Spot 99% 
36.03  East Baton Rouge  43 Hot Spot 99% 
36.04  East Baton Rouge  137 Hot Spot 99% 
37.01  East Baton Rouge  46 Hot Spot 99% 
37.02  East Baton Rouge  75 Hot Spot 99% 
37.03  East Baton Rouge  61 Hot Spot 99% 
38.01  East Baton Rouge  128 Hot Spot 99% 
38.02  East Baton Rouge  43 Hot Spot 99% 
38.04  East Baton Rouge  23 Hot Spot 99% 
38.05  East Baton Rouge  86 Hot Spot 99% 
39.04  East Baton Rouge  63 Hot Spot 99% 
39.06  East Baton Rouge  43 Hot Spot 99% 
39.07  East Baton Rouge  36 Hot Spot 99% 
39.08  East Baton Rouge  31 Hot Spot 99% 
39.09  East Baton Rouge  51 Hot Spot 99% 
39.1  East Baton Rouge  49 Hot Spot 99% 
4  East Baton Rouge  90 Hot Spot 99% 
40.05  East Baton Rouge  86 Hot Spot 99% 
40.06  East Baton Rouge  34 Hot Spot 99% 
40.09  East Baton Rouge  57 Hot Spot 99% 
40.1  East Baton Rouge  24 Hot Spot 99% 
40.11  East Baton Rouge  141 Hot Spot 99% 
40.13  East Baton Rouge  79 Hot Spot 99% 
40.14  East Baton Rouge  55 Hot Spot 99% 
40.15  East Baton Rouge  167 Hot Spot 99% 
40.16  East Baton Rouge  49 Hot Spot 99% 










402.01  Livingston  411 Hot Spot 99% 
402.02  Livingston  143 Hot Spot 99% 
403.01  Livingston  192 Hot Spot 99% 
403.03  Livingston  124 Hot Spot 99% 
403.04  Livingston  155 Hot Spot 99% 
404.01  Livingston  256 Hot Spot 99% 
404.02  Livingston  280 Hot Spot 99% 
405  Livingston  250 Hot Spot 99% 
406  Livingston  160 Hot Spot 99% 
407  Livingston  71 Hot Spot 99% 
408.02  Livingston  114 Hot Spot 99% 
408.04  Livingston  673 Hot Spot 99% 
408.05  Livingston  103 Hot Spot 99% 
408.06  Livingston  162 Hot Spot 99% 
409.01  Livingston  48 Hot Spot 99% 
409.02  Livingston  38 Hot Spot 99% 
42.01  East Baton Rouge  61 Hot Spot 99% 
42.03  East Baton Rouge  39 Hot Spot 99% 
42.04  East Baton Rouge  51 Hot Spot 99% 
42.05  East Baton Rouge  64 Hot Spot 99% 
43.01  East Baton Rouge  31 Hot Spot 99% 
43.02  East Baton Rouge  19 Hot Spot 99% 
44.01  East Baton Rouge  22 Hot Spot 99% 
44.02  East Baton Rouge  29 Hot Spot 99% 
44.03  East Baton Rouge  21 Hot Spot 99% 
45.03  East Baton Rouge  76 Hot Spot 99% 
45.04  East Baton Rouge  36 Hot Spot 99% 
45.05  East Baton Rouge  69 Hot Spot 99% 
45.07  East Baton Rouge  17 Hot Spot 99% 
45.08  East Baton Rouge  16 Hot Spot 99% 
45.09  East Baton Rouge  53 Hot Spot 99% 
45.1  East Baton Rouge  41 Hot Spot 99% 
46.02  East Baton Rouge  33 Hot Spot 99% 
46.03  East Baton Rouge  15 Hot Spot 99% 
46.04  East Baton Rouge  25 Hot Spot 99% 
47  East Baton Rouge  27 Hot Spot 99% 
48  East Baton Rouge  20 Hot Spot 99% 
49  East Baton Rouge  18 Hot Spot 99% 
5  East Baton Rouge  132 Hot Spot 99% 
50  East Baton Rouge  4 Hot Spot 99% 











52  East Baton Rouge  65 Hot Spot 99% 
53  East Baton Rouge  202 Hot Spot 99% 
6.01  East Baton Rouge  71 Hot Spot 99% 
6.02  East Baton Rouge  116 Hot Spot 99% 
7.01  East Baton Rouge  63 Hot Spot 99% 
7.02  East Baton Rouge  74 Hot Spot 99% 
9  East Baton Rouge  108 Hot Spot 99% 
9512  St. Helena  31 Hot Spot 99% 
9514  East Feliciana  9 Hot Spot 99% 
9515.01  East Feliciana  4 Hot Spot 99% 
9515.02  East Feliciana  28 Hot Spot 99% 
9516  East Feliciana  14 Hot Spot 99% 
9518  West Feliciana  13 Hot Spot 99% 
9519  Pointe Coupee  24 Hot Spot 99% 
9521  Pointe Coupee  23 Hot Spot 99% 
9522  Pointe Coupee  16 Hot Spot 99% 
9523  Pointe Coupee  7 Hot Spot 99% 
9526  Iberville  36 Hot Spot 99% 
9527  Iberville  35 Hot Spot 99% 
9529  Iberville  26 Hot Spot 99% 
9530  Iberville  1 Hot Spot 99% 
9531.01  Iberville  20 Hot Spot 99% 
9531.02  Iberville  15 Hot Spot 99% 
9532  Iberville  78 Hot Spot 99% 
9536  Tangipahoa  1 Hot Spot 99% 
9538  Tangipahoa  4 Hot Spot 99% 
9539  Tangipahoa  8 Hot Spot 99% 
9540.01  Tangipahoa  2 Hot Spot 99% 
9540.02  Tangipahoa  5 Hot Spot 99% 
9541.01  Tangipahoa  8 Hot Spot 99% 
9541.02  Tangipahoa  3 Hot Spot 99% 
9543  Tangipahoa  6 Hot Spot 99% 
9544  Tangipahoa  1 Hot Spot 99% 
9545.01  Tangipahoa  2 Hot Spot 99% 
9545.02  Tangipahoa  1 Hot Spot 99% 
404  St. James  16 Hot Spot 95% 
9524  Pointe Coupee  14 Hot Spot 95% 
9547  Tangipahoa  1 Hot Spot 90% 
216.02  Lafourche  1 Cold Spot 90% 











407.05  St. Tammany  1 Cold Spot 90% 
708  St. John the Baptist  1 Cold Spot 90% 
9506  Washington  1 Cold Spot 90% 
9535  Tangipahoa  3 Cold Spot 90% 
9602  Acadia  1 Cold Spot 90% 
9604  St. Landry  2 Cold Spot 90% 
9610  St. Landry  1 Cold Spot 90% 
1.01  Terrebonne  1 Cold Spot 95% 
1.02  Terrebonne  2 Cold Spot 95% 
12  Lafayette  2 Cold Spot 95% 
14.02  Lafayette  1 Cold Spot 95% 
14.05  Lafayette  1 Cold Spot 95% 
14.06  Lafayette  2 Cold Spot 95% 
14.09  Lafayette  1 Cold Spot 95% 
14.11  Lafayette  1 Cold Spot 95% 
17  Terrebonne  1 Cold Spot 95% 
2.01  Terrebonne  1 Cold Spot 95% 
2.02  Terrebonne  2 Cold Spot 95% 
202  St. Martin  2 Cold Spot 95% 
204  St. Martin  1 Cold Spot 95% 
205  Lafourche  1 Cold Spot 95% 
205.02  St. Martin  1 Cold Spot 95% 
207.03  Lafourche  1 Cold Spot 95% 
217  Lafourche  1 Cold Spot 95% 
303.01  Iberia  1 Cold Spot 95% 
311  Iberia  1 Cold Spot 95% 
402  St. Mary  1 Cold Spot 95% 
403.05  St. Tammany  1 Cold Spot 95% 
404  St. Tammany  1 Cold Spot 95% 
405.02  St. Tammany  1 Cold Spot 95% 
411.03  St. Tammany  1 Cold Spot 95% 
5  Terrebonne  2 Cold Spot 95% 
711  St. John the Baptist  1 Cold Spot 95% 
9507  Vermilion  1 Cold Spot 95% 
9605  Acadia  2 Cold Spot 95% 
9607  Acadia  1 Cold Spot 95% 
9610  Acadia  1 Cold Spot 95% 
9613  St. Landry  1 Cold Spot 95% 
9616  St. Landry  2 Cold Spot 95% 
9618  St. Landry  1 Cold Spot 95% 
1  Lafayette  5 Cold Spot 99% 










10.01  Lafayette  2 Cold Spot 99% 
123  Orleans  1 Cold Spot 99% 
13.02  Orleans  1 Cold Spot 99% 
135  Orleans  1 Cold Spot 99% 
138  Orleans  1 Cold Spot 99% 
14.01  Orleans  1 Cold Spot 99% 
141  Orleans  1 Cold Spot 99% 
17.22  Orleans  1 Cold Spot 99% 
17.23  Orleans  1 Cold Spot 99% 
17.25  Orleans  1 Cold Spot 99% 
17.4  Orleans  2 Cold Spot 99% 
17.45  Orleans  1 Cold Spot 99% 
17.46  Orleans  1 Cold Spot 99% 
202.02  Jefferson  1 Cold Spot 99% 
205.08  Jefferson  1 Cold Spot 99% 
205.14  Jefferson  1 Cold Spot 99% 
206  Jefferson  3 Cold Spot 99% 
21.02  Lafayette  1 Cold Spot 99% 
22  Lafayette  1 Cold Spot 99% 
221.02  Jefferson  1 Cold Spot 99% 
231  Jefferson  1 Cold Spot 99% 
24.01  Orleans  1 Cold Spot 99% 
246  Jefferson  1 Cold Spot 99% 
251.02  Jefferson  2 Cold Spot 99% 
252.02  Jefferson  1 Cold Spot 99% 
261  Jefferson  1 Cold Spot 99% 
266  Jefferson  1 Cold Spot 99% 
27  Orleans  1 Cold Spot 99% 
270  Jefferson  1 Cold Spot 99% 
276.01  Jefferson  2 Cold Spot 99% 
277.01  Jefferson  2 Cold Spot 99% 
278.07  Jefferson  1 Cold Spot 99% 
30  Orleans  1 Cold Spot 99% 
33.03  Orleans  1 Cold Spot 99% 
37.01  Orleans  1 Cold Spot 99% 
37.02  Orleans  1 Cold Spot 99% 
408.01  St. Tammany  2 Cold Spot 99% 
408.03  St. Tammany  1 Cold Spot 99% 
412.12  St. Tammany  1 Cold Spot 99% 
45  Orleans  1 Cold Spot 99% 










6.11  Orleans  1 Cold Spot 99% 
6.12  Orleans  1 Cold Spot 99% 
6.13  Orleans  1 Cold Spot 99% 
60  Orleans  2 Cold Spot 99% 
623.01  St. Charles  1 Cold Spot 99% 
629  St. Charles  1 Cold Spot 99% 
63  Orleans  1 Cold Spot 99% 
702  St. John the Baptist  2 Cold Spot 99% 
703  St. John the Baptist  1 Cold Spot 99% 
85  Orleans  1 Cold Spot 99% 


































Appendix N. Cluster and Outlier Analysis of FMOLHS LA ED High Utilizers 
 
 










Appendix O. FMOLHS LA ED High Utilizers Map Summary Tables of  














# ED High 
Utilizers/total 
pop x 1000 
Not Significant 12518.64 50 241 239966 1.00 
Cluster High-High 4263.49 99 9723 591627 16.43 
Outlier Low-High 3655.92 43 845 212677 3.97 





























Appendix P. Cluster and Outlier Analysis Percentage Averages of SVI and 
ACS Data Based on FMOLHS LA ED High Utilizers 
 
 
Results /SVI data % 
averages 
High-High Low-High Low-Low 
Poverty 20.53 15.28 22.78 
Unemployment 7.80 6.31 8.00 
Per Capita Income 27071.31 32639.81 24797.44 
No High School Dip 14.13 10.60 18.42 
Age 65 12.71 15.47 14.43 
Age 17 23.97 21.24 23.64 
Disability 15.80 14.45 15.52 
Single Parent 12.03 8.96 12.35 
Minority 54.61 36.77 49.01 
Limited English 
Proficiency 
1.61 0.97 1.65 
Housing 10 or More 12.71 8.55 7.14 
Mobile Homes 9.68 12.12 12.67 
Crowded Housing 2.92 2.48 2.45 
No Vehicle 8.86 5.95 11.63 
Institutionalized Group 
Quarters 
2.01 4.85 2.86 
Socioeconomic Rank 0.45 0.33 0.56 
Household Composition 
Rank 
0.46 0.42 0.54 
Minority/Language 
Rank 
0.55 0.41 0.57 
Housing/Transportation 
Rank 
0.55 0.41 0.51 
Overall Rank 0.49 0.35 0.56 













Appendix Q. Cluster and Outlier Analysis FMOLHS ED High Utilizer Counts 
By Census Tracts across LA 
 




1  East Baton Rouge  58 HH 
1  Lafayette  5 LL 
1.01  Terrebonne  1 LL 
1.02  Terrebonne  2 LL 
10  East Baton Rouge  88 HH 
10.01  Lafayette  2 LL 
101  Rapides  1 LL 
104  Ouachita  1 LL 
105  Rapides  1 LL 
105.04  Ouachita  1 LL 
106.03  Ouachita  1 LL 
108  Ouachita  1 LL 
11.02  East Baton Rouge  67 HH 
11.03  East Baton Rouge  77 HH 
11.04  East Baton Rouge  174 HH 
12  Lafayette  2 LL 
12.02  Calcasieu  1 LL 
120  Rapides  1 LL 
122  Rapides  1 LL 
123  Orleans  1 LL 
13  Terrebonne  1 LL 
13.02  Orleans  1 LL 
135  Orleans  1 LL 
138  Orleans  1 LL 
14  Calcasieu  1 LL 
14.01  Orleans  1 LL 
14.02  Lafayette  1 LL 
14.05  Lafayette  1 LL 
14.06  Lafayette  2 LL 
14.09  Lafayette  1 LL 
14.11  Lafayette  1 LL 
141  Orleans  1 LL 
16  East Baton Rouge  59 HH 
17  Calcasieu  2 LL 
17  East Baton Rouge  54 HH 
17  Terrebonne  1 LL 
17.22  Orleans  1 LL 
17.23  Orleans  1 LL 
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17.25  Orleans  1 LL 
17.4  Orleans  2 LL 
17.45  Orleans  1 LL 
17.46  Orleans  1 LL 
18  East Baton Rouge  75 HH 
18.01  Calcasieu  1 LL 
19  East Baton Rouge  11 LH 
2  East Baton Rouge  207 HH 
2  Jefferson Davis  1 LL 
2.01  Terrebonne  1 LL 
2.02  Terrebonne  2 LL 
20  East Baton Rouge  12 LH 
201  West Baton Rouge  58 HH 
202  St. Martin  2 LL 
202  West Baton Rouge  48 HH 
202.02  Jefferson  1 LL 
203  West Baton Rouge  103 HH 
204  St. Martin  1 LL 
204.01  West Baton Rouge  36 HH 
204.02  West Baton Rouge  33 LH 
205  Lafourche  1 LL 
205.02  St. Martin  1 LL 
205.08  Jefferson  1 LL 
205.14  Jefferson  1 LL 
206  Jefferson  3 LL 
207.03  Lafourche  1 LL 
21.02  Lafayette  1 LL 
216.02  Lafourche  1 LL 
217  Lafourche  1 LL 
22  East Baton Rouge  37 HH 
22  Lafayette  1 LL 
221.02  Jefferson  1 LL 
23  East Baton Rouge  8 LH 
231  Jefferson  1 LL 
24  Calcasieu  1 LL 
24  East Baton Rouge  71 HH 
24.01  Orleans  1 LL 
246  Jefferson  1 LL 
25  East Baton Rouge  66 HH 
251.02  Jefferson  2 LL 
252.02  Jefferson  1 LL 








26.02  East Baton Rouge  78 HH 
261  Jefferson  1 LL 
266  Jefferson  1 LL 
27  Calcasieu  1 LL 
27  East Baton Rouge  49 HH 
27  Orleans  1 LL 
270  Jefferson  1 LL 
276.01  Jefferson  2 LL 
277.01  Jefferson  2 LL 
278.07  Jefferson  1 LL 
28.01  East Baton Rouge  5 LH 
28.02  East Baton Rouge  4 LH 
3  East Baton Rouge  123 HH 
30  East Baton Rouge  95 HH 
30  Orleans  1 LL 
301  Avoyelles  1 LL 
301  Iberia  1 LL 
301.01  Ascension  49 HH 
301.02  Ascension  25 LH 
301.03  Ascension  32 LH 
302.03  Ascension  47 HH 
302.04  Ascension  79 HH 
302.05  Ascension  59 HH 
302.06  Ascension  83 HH 
303  Ascension  138 HH 
303  Avoyelles  1 LL 
303.01  Iberia  1 LL 
304  Avoyelles  2 LL 
304.01  Ascension  87 HH 
304.02  Ascension  125 HH 
305  Ascension  66 HH 
306  Ascension  80 HH 
307  Avoyelles  1 LL 
309  Ascension  18 LH 
31.01  Calcasieu  2 LL 
31.01  East Baton Rouge  83 HH 
31.03  East Baton Rouge  31 LH 
310  Ascension  28 LH 
311  Iberia  1 LL 
32.01  East Baton Rouge  53 HH 
32.02  East Baton Rouge  26 LH 








33.03  Orleans  1 LL 
34  East Baton Rouge  197 HH 
35.01  East Baton Rouge  31 LH 
35.04  East Baton Rouge  140 HH 
35.05  East Baton Rouge  117 HH 
35.06  East Baton Rouge  82 HH 
35.07  East Baton Rouge  65 HH 
36.01  East Baton Rouge  45 HH 
36.03  East Baton Rouge  43 HH 
36.04  East Baton Rouge  137 HH 
37.01  East Baton Rouge  46 HH 
37.01  Orleans  1 LL 
37.02  East Baton Rouge  75 HH 
37.02  Orleans  1 LL 
37.03  East Baton Rouge  61 HH 
38.01  East Baton Rouge  128 HH 
38.02  East Baton Rouge  43 HH 
38.04  East Baton Rouge  23 LH 
38.05  East Baton Rouge  86 HH 
39.04  East Baton Rouge  63 HH 
39.06  East Baton Rouge  43 HH 
39.07  East Baton Rouge  36 HH 
39.08  East Baton Rouge  31 LH 
39.09  East Baton Rouge  51 HH 
39.1  East Baton Rouge  49 HH 
4  East Baton Rouge  90 HH 
4.02  Ouachita  1 LL 
40.05  East Baton Rouge  86 HH 
40.06  East Baton Rouge  34 HH 
40.09  East Baton Rouge  57 HH 
40.1  East Baton Rouge  24 LH 
40.11  East Baton Rouge  141 HH 
40.13  East Baton Rouge  79 HH 
40.14  East Baton Rouge  55 HH 
40.15  East Baton Rouge  167 HH 
40.16  East Baton Rouge  49 HH 
401  Livingston  74 HH 
401.02  St. Tammany  2 LL 
402  St. Mary  1 LL 
402.01  Livingston  411 HH 








403.01  Livingston  192 HH 
403.03  Livingston  124 HH 
403.04  Livingston  155 HH 
403.05  St. Tammany  1 LL 
404  St. Tammany  1 LL 
404.01  Livingston  256 HH 
404.02  Livingston  280 HH 
405  Livingston  250 HH 
405.02  St. Tammany  1 LL 
406  Livingston  160 HH 
407  Livingston  71 HH 
407  St. James  2 LL 
407.05  St. Tammany  1 LL 
408.01  St. Tammany  2 LL 
408.02  Livingston  114 HH 
408.03  St. Tammany  1 LL 
408.04  Livingston  673 HH 
408.05  Livingston  103 HH 
408.06  Livingston  162 HH 
409.01  Livingston  48 HH 
409.02  Livingston  38 HH 
411.03  St. Tammany  1 LL 
412.12  St. Tammany  1 LL 
414  St. Mary  2 LL 
42.01  East Baton Rouge  61 HH 
42.03  East Baton Rouge  39 HH 
42.04  East Baton Rouge  51 HH 
42.05  East Baton Rouge  64 HH 
43.01  East Baton Rouge  31 LH 
43.02  East Baton Rouge  19 LH 
44.01  East Baton Rouge  22 LH 
44.02  East Baton Rouge  29 LH 
44.03  East Baton Rouge  21 LH 
45  Orleans  1 LL 
45.03  East Baton Rouge  76 HH 
45.04  East Baton Rouge  36 HH 
45.05  East Baton Rouge  69 HH 
45.07  East Baton Rouge  17 LH 
45.08  East Baton Rouge  16 LH 
45.09  East Baton Rouge  53 HH 








46.02  East Baton Rouge  33 LH 
46.03  East Baton Rouge  15 LH 
46.04  East Baton Rouge  25 LH 
47  East Baton Rouge  27 LH 
48  East Baton Rouge  20 LH 
49  East Baton Rouge  18 LH 
5  Concordia  1 LL 
5  East Baton Rouge  132 HH 
5  Jefferson Davis  1 LL 
5  Terrebonne  2 LL 
50  East Baton Rouge  4 LH 
505  Assumption  2 LL 
51  East Baton Rouge  76 HH 
52  East Baton Rouge  65 HH 
53  East Baton Rouge  202 HH 
6  Calcasieu  1 LL 
6.01  East Baton Rouge  71 HH 
6.02  East Baton Rouge  116 HH 
6.07  Orleans  1 LL 
6.11  Orleans  1 LL 
6.12  Orleans  1 LL 
6.13  Orleans  1 LL 
60  Orleans  2 LL 
623.01  St. Charles  1 LL 
629  St. Charles  1 LL 
63  Orleans  1 LL 
7.01  East Baton Rouge  63 HH 
7.02  East Baton Rouge  74 HH 
702  St. John the Baptist  2 LL 
703  St. John the Baptist  1 LL 
705  St. John the Baptist  5 LL 
707  St. John the Baptist  1 LL 
708  St. John the Baptist  1 LL 
711  St. John the Baptist  1 LL 
85  Orleans  1 LL 
9  East Baton Rouge  108 HH 
9502  Washington  1 LL 
9503  Washington  2 LL 
9506  Morehouse  2 LL 
9506  Washington  1 LL 








9512  St. Helena  31 LH 
9515.01  East Feliciana  4 LH 
9515.02  East Feliciana  28 LH 
9516  East Feliciana  14 LH 
9518  West Feliciana  13 LH 
9520  Pointe Coupee  6 LL 
9521  Pointe Coupee  23 LH 
9522  Pointe Coupee  16 LH 
9526  Iberville  36 HH 
9527  Iberville  35 HH 
9529  Iberville  26 LH 
9530  Iberville  1 LH 
9531.01  Iberville  20 LH 
9531.02  Iberville  15 LH 
9532  Iberville  78 HH 
9532  Tangipahoa  1 LL 
9533  Tangipahoa  2 LL 
9535  Tangipahoa  3 LL 
9536  Tangipahoa  1 LH 
9546  Tangipahoa  2 LL 
9548  Tangipahoa  3 LL 
9601  St. Landry  3 LL 
9602  Acadia  1 LL 
9604  St. Landry  2 LL 
9605  Acadia  2 LL 
9607  Acadia  1 LL 
9610  Acadia  1 LL 
9610  St. Landry  1 LL 
9613  St. Landry  1 LL 
9616  St. Landry  2 LL 
9618  St. Landry  1 LL 












Appendix R. Spearman Correlation Scores between independent variables of 
Non-Institutionalized COVID Positive Patients Data 
 
Spearman (𝒓𝒔) BMI Age LOS Sex CPMI 
BMI *** -0.14 0.03 -0.16 0.11 
Age -0.14 *** 0.11 0.06 -0.85 
LOS 0.03 0.11 *** 0.04 -0.17 
Living_Status -0.01 0.19 0.18 0.07 -0.24 
Sex -0.16 0.06 0.04 *** -0.09 
COVID_results 0.14 -0.10 0.19 -0.02 0.08 
CPMI 0.11 -0.85 -0.17 -0.09 *** 
E_TOTPOP -0.01 -0.03 -0.05 0.01 0.03 
EP_POV 0.04 -0.01 0.09 -0.03 -0.01 
EP_UNEMP 0.06 -0.01 0.06 -0.04 -0.03 
EP_PCI -0.06 0.01 -0.08 0.03 0.01 
EP_NOHSDP 0.06 0.03 0.06 -0.01 -0.05 
EP_AGE65 -0.04 0.10 0.03 -0.01 -0.08 
EP_AGE17 0.04 -0.03 0.01 -0.01 0.03 
EP_DISABL 0.03 0.05 0.04 -0.02 -0.08 
EP_SNGPNT 0.04 -0.03 0.07 -0.03 0.01 
EP_MINRTY 0.07 -0.02 0.06 -0.04 -0.02 
EP_LIMENG -0.01 -0.02 -0.01 0.01 -0.01 
EP_MUNIT -0.03 -0.01 0.00 0.00 -0.01 
EP_MOBILE 0.02 -0.01 0.02 0.03 0.02 
EP_CROWD 0.02 0.01 0.02 -0.02 -0.02 
EP_NOVEH 0.05 0.00 0.05 -0.03 -0.03 
EP_GROUPQ 0.02 0.02 0.06 -0.01 -0.02 
RPL_THEME1 0.06 0.00 0.08 -0.03 -0.03 
RPL_THEME2 0.04 0.03 0.06 -0.03 -0.05 
RPL_THEME3 0.04 -0.03 0.04 -0.02 -0.02 
RPL_THEME4 0.04 0.01 0.06 -0.01 -0.03 
RPL_THEMES 0.06 0.01 0.08 -0.03 -0.04 
EP_UNINSUR 0.04 -0.02 0.04 -0.02 0.02 
EP_OCC_MBSA -0.07 0.00 -0.06 0.01 0.02 
EP_OCC_SER 0.04 -0.03 0.05 -0.02 -0.01 
EP_OCC_SAL_OF
F 
0.00 0.00 0.01 0.01 0.01 
EP_OCC_NRCM 0.01 0.03 0.03 0.03 -0.03 
EP_OCC_PTMM 0.07 -0.01 0.02 -0.03 0.00 
Auto_immun 0.01 0.05 0.02 -0.08 -0.07 





Spearman (𝒓𝒔) BMI Age LOS Sex CPMI 
CKD -0.03 0.19 0.15 0.06 -0.29 
CLD 0.02 0.04 0.01 0.00 -0.07 
CVD -0.02 0.24 0.13 0.08 -0.31 
Diabetes 0.09 0.23 0.11 0.02 -0.37 
ESRD -0.04 0.04 0.09 0.04 -0.12 
Hep_B -0.01 -0.01 0.00 0.02 0.00 
Hep_C -0.02 0.04 0.00 0.01 -0.05 
HIV 0.00 -0.03 0.01 0.01 -0.02 
HTN 0.07 0.37 0.11 0.01 -0.42 
Immunocompromis
ed 
0.01 0.01 0.02 -0.02 -0.04 
Obesity 0.37 0.02 0.18 -0.05 -0.10 
overweight -0.05 0.01 0.05 -0.01 -0.03 
PVD -0.05 0.10 0.05 0.02 -0.14 









































BMI -0.01 0.04 0.06 -0.06 0.06 -0.04 0.04 
Age -0.03 -0.01 -0.01 0.01 0.03 0.10 -0.03 
LOS -0.05 0.09 0.06 -0.08 0.06 0.03 0.01 
Living_Status -0.04 0.04 0.03 -0.05 0.04 0.01 0.00 
Sex 0.01 -0.03 -0.04 0.03 -0.01 -0.01 -0.01 
COVID_results -0.01 0.08 0.10 -0.08 0.06 -0.05 0.05 
CPMI 0.03 -0.01 -0.03 0.01 -0.05 -0.08 0.03 
E_TOTPOP *** -0.53 -0.31 0.50 -0.43 -0.35 0.22 
EP_POV -0.53 *** 0.63 -0.84 0.71 -0.05 0.04 
EP_UNEMP -0.31 0.63 *** -0.61 0.55 -0.07 0.14 
EP_PCI 0.50 -0.84 -0.61 *** -0.75 0.11 -0.18 
EP_NOHSDP -0.43 0.71 0.55 -0.75 *** 0.04 0.09 
EP_AGE65 -0.35 -0.05 -0.07 0.11 0.04 *** -0.50 
EP_AGE17 0.22 0.04 0.14 -0.18 0.09 -0.50 *** 
EP_DISABL -0.47 0.49 0.41 -0.50 0.61 0.29 -0.14 
EP_SNGPNT -0.14 0.58 0.43 -0.61 0.47 -0.30 0.43 
EP_MINRTY -0.35 0.63 0.55 -0.64 0.44 -0.12 0.12 
EP_LIMENG 0.23 -0.12 -0.14 0.16 -0.07 -0.12 -0.10 
EP_MUNIT 0.00 0.10 -0.01 0.02 -0.17 0.00 -0.18 
EP_MOBILE 0.10 -0.09 -0.06 0.00 0.28 0.03 0.12 
EP_CROWD -0.05 0.40 0.28 -0.41 0.38 -0.26 0.32 
EP_NOVEH -0.52 0.74 0.53 -0.64 0.63 0.09 -0.02 
EP_GROUPQ -0.22 0.28 0.14 -0.26 0.23 0.16 -0.20 
RPL_THEME1 -0.51 0.91 0.80 -0.91 0.86 -0.05 0.12 
RPL_THEME2 -0.39 0.57 0.47 -0.61 0.61 0.24 0.35 
RPL_THEME3 -0.04 0.32 0.24 -0.29 0.22 -0.17 0.00 
RPL_THEME4 -0.26 0.57 0.34 -0.52 0.52 -0.01 0.02 
RPL_THEMES -0.46 0.84 0.66 -0.83 0.79 0.01 0.14 
EP_UNINSUR -0.45 0.64 0.43 -0.65 0.59 -0.03 -0.06 
EP_OCC_MBSA 0.39 -0.66 -0.51 0.78 -0.74 0.04 -0.12 
EP_OCC_SER -0.37 0.70 0.52 -0.73 0.52 -0.11 0.05 
EP_OCC_SAL_OFF 0.00 -0.03 -0.03 0.00 -0.14 -0.07 0.07 
EP_OCC_NRCM 0.02 0.01 -0.02 -0.07 0.34 0.06 0.02 
EP_OCC_PTMM -0.20 0.27 0.30 -0.42 0.47 0.04 0.12 
Auto_immun 0.02 -0.03 -0.01 0.02 -0.03 0.01 -0.01 
CEVD 0.01 0.01 0.00 -0.01 0.01 -0.03 -0.01 
CKD 0.00 0.03 0.03 -0.03 0.04 0.03 -0.02 
CLD -0.01 -0.02 0.01 0.01 -0.01 0.02 -0.03 




















Diabetes -0.02 0.05 0.06 -0.06 0.06 0.01 -0.01 
ESRD -0.05 0.07 0.06 -0.06 0.06 0.02 -0.02 
Hep_B 0.01 0.01 0.01 -0.01 0.02 0.02 -0.02 
Hep_C -0.01 0.01 0.02 -0.02 0.04 0.00 -0.01 
HIV -0.03 0.03 0.05 -0.04 0.04 0.02 -0.02 
HTN -0.01 0.03 0.05 -0.03 0.04 0.04 -0.02 
Immunocompromised 0.03 -0.04 -0.02 0.04 -0.04 -0.01 0.00 
Obesity 0.04 0.04 0.08 -0.04 0.05 -0.04 0.01 
overweight 0.02 -0.03 -0.03 0.05 -0.03 0.04 -0.03 
PVD 0.00 0.01 0.01 0.00 0.02 0.01 0.01 














































BMI 0.03 0.04 0.07 -0.01 -0.03 0.02 0.02 
Age 0.05 -0.03 -0.02 -0.02 -0.01 -0.01 0.01 
LOS 0.04 0.07 0.06 -0.01 0.00 0.02 0.02 
Living_Status 0.03 0.03 0.06 0.02 -0.01 -0.02 0.03 
Sex -0.02 -0.03 -0.04 0.01 0.00 0.03 -0.02 
COVID_results 0.03 0.10 0.19 0.05 0.03 -0.08 0.03 
CPMI -0.08 0.01 -0.02 -0.01 -0.01 0.02 -0.02 
E_TOTPOP -0.47 -0.14 -0.35 0.23 0.00 0.10 -0.05 
EP_POV 0.49 0.58 0.63 -0.12 0.10 -0.09 0.40 
EP_UNEMP 0.41 0.43 0.55 -0.14 -0.01 -0.06 0.28 
EP_PCI -0.50 -0.61 -0.64 0.16 0.02 0.00 -0.41 
EP_NOHSDP 0.61 0.47 0.44 -0.07 -0.17 0.28 0.38 
EP_AGE65 0.29 -0.30 -0.12 -0.12 0.00 0.03 -0.26 
EP_AGE17 -0.14 0.43 0.12 -0.10 -0.18 0.12 0.32 
EP_DISABL *** 0.19 0.34 -0.09 -0.12 0.15 0.19 
EP_SNGPNT 0.19 *** 0.58 -0.05 0.12 -0.09 0.37 
EP_MINRTY 0.34 0.58 *** 0.06 0.28 -0.42 0.33 
EP_LIMENG -0.09 -0.05 0.06 *** 0.32 -0.06 0.07 
EP_MUNIT -0.12 0.12 0.28 0.32 *** -0.62 0.02 
EP_MOBILE 0.15 -0.09 -0.42 -0.06 -0.62 *** 0.07 
EP_CROWD 0.19 0.37 0.33 0.07 0.02 0.07 *** 
EP_NOVEH 0.50 0.47 0.63 -0.09 0.21 -0.17 0.30 
EP_GROUPQ 0.10 0.22 0.27 -0.01 0.31 -0.20 0.02 
RPL_THEME1 0.58 0.59 0.64 -0.14 -0.03 0.04 0.42 
RPL_THEME2 0.69 0.66 0.46 -0.16 -0.09 0.11 0.32 
RPL_THEME3 0.15 0.33 0.67 0.77 0.40 -0.30 0.27 
RPL_THEME4 0.29 0.45 0.46 0.11 0.44 -0.04 0.56 
RPL_THEMES 0.58 0.68 0.73 0.08 0.21 -0.04 0.53 
EP_UNINSUR 0.35 0.44 0.48 0.06 0.13 0.04 0.25 
EP_OCC_MBSA -0.52 -0.52 -0.53 0.05 0.08 -0.16 -0.40 
EP_OCC_SER 0.38 0.52 0.66 -0.02 0.21 -0.23 0.32 
EP_OCC_SAL_OFF -0.08 0.05 -0.01 -0.12 -0.05 -0.07 0.02 
EP_OCC_NRCM 0.19 -0.05 -0.22 0.13 -0.29 0.57 0.20 
EP_OCC_PTMM 0.41 0.31 0.27 -0.02 -0.21 0.31 0.13 
Auto_immun 0.00 -0.01 0.00 -0.01 0.00 0.00 -0.01 
CEVD 0.00 0.02 0.02 0.01 0.04 -0.02 0.04 
CKD 0.05 0.00 0.04 -0.01 -0.01 -0.01 0.02 
CLD 0.01 -0.02 0.00 0.03 0.04 -0.02 -0.01 




















Diabetes 0.07 0.03 0.08 0.01 0.01 -0.02 0.05 
ESRD 0.06 0.03 0.06 -0.02 0.01 -0.01 0.04 
Hep_B 0.04 0.02 0.04 0.03 0.04 -0.04 -0.02 
Hep_C 0.04 0.02 0.03 0.01 0.03 -0.03 -0.01 
HIV 0.06 0.02 0.05 0.02 0.04 -0.05 0.00 
HTN 0.08 0.03 0.08 -0.03 0.03 -0.05 0.02 
Immunocompromised -0.03 -0.03 -0.01 0.03 0.01 -0.02 -0.02 
Obesity 0.05 0.06 0.10 0.03 0.02 -0.04 0.04 
overweight -0.02 -0.03 -0.01 -0.02 0.01 -0.03 -0.02 
PVD 0.01 0.01 0.00 0.01 -0.01 -0.01 0.01 


















































BMI 0.05 0.02 0.06 0.04 0.04 0.04 0.06 
Age 0.00 0.02 0.00 0.03 -0.03 0.01 0.01 
LOS 0.05 0.06 0.08 0.06 0.04 0.06 0.08 
Living_Status 0.04 -0.01 0.05 0.03 0.06 0.01 0.05 
Sex -0.03 -0.01 -0.03 -0.03 -0.02 -0.01 -0.03 
COVID_results 0.09 0.00 0.09 0.07 0.17 0.03 0.11 
CPMI -0.03 -0.02 -0.03 -0.05 -0.02 -0.03 -0.04 
E_TOTPOP -0.52 -0.22 -0.51 -0.39 -0.04 -0.26 -0.46 
EP_POV 0.74 0.28 0.91 0.57 0.32 0.57 0.84 
EP_UNEMP 0.53 0.14 0.80 0.47 0.24 0.34 0.66 
EP_PCI -0.64 -0.26 -0.91 -0.61 -0.29 -0.52 -0.83 
EP_NOHSDP 0.63 0.23 0.86 0.61 0.22 0.52 0.79 
EP_AGE65 0.09 0.16 -0.05 0.24 -0.17 -0.01 0.01 
EP_AGE17 -0.02 -0.20 0.12 0.35 0.00 0.02 0.14 
EP_DISABL 0.50 0.10 0.58 0.69 0.15 0.29 0.58 
EP_SNGPNT 0.47 0.22 0.59 0.66 0.33 0.45 0.68 
EP_MINRTY 0.63 0.27 0.64 0.46 0.67 0.46 0.73 
EP_LIMENG -0.09 -0.01 -0.14 -0.16 0.77 0.11 0.08 
EP_MUNIT 0.21 0.31 -0.03 -0.09 0.40 0.44 0.21 
EP_MOBILE -0.17 -0.20 0.04 0.11 -0.30 -0.04 -0.04 
EP_CROWD 0.30 0.02 0.42 0.32 0.27 0.56 0.53 
EP_NOVEH *** 0.32 0.72 0.51 0.33 0.65 0.78 
EP_GROUPQ 0.32 *** 0.27 0.15 0.14 0.68 0.43 
RPL_THEME1 0.72 0.27 *** 0.65 0.30 0.56 0.89 
RPL_THEME2 0.51 0.15 0.65 *** 0.17 0.38 0.73 
RPL_THEME3 0.33 0.14 0.30 0.17 *** 0.36 0.52 
RPL_THEME4 0.65 0.68 0.56 0.38 0.36 *** 0.79 
RPL_THEMES 0.78 0.43 0.89 0.73 0.52 0.79 *** 
EP_UNINSUR 0.55 0.24 0.66 0.37 0.34 0.48 0.66 
EP_OCC_MBSA -0.55 -0.14 -0.76 -0.56 -0.29 -0.45 -0.72 
EP_OCC_SER 0.57 0.18 0.71 0.44 0.40 0.42 0.68 
EP_OCC_SAL_OFF -0.04 -0.04 -0.06 -0.04 -0.07 -0.08 -0.08 
EP_OCC_NRCM -0.03 -0.07 0.12 0.14 -0.06 0.13 0.11 
EP_OCC_PTMM 0.24 0.08 0.42 0.43 0.15 0.21 0.41 
Auto_immun -0.03 0.01 -0.02 -0.01 -0.01 -0.01 -0.02 
CEVD 0.01 0.00 0.01 -0.01 0.02 0.03 0.02 
CKD 0.02 0.01 0.04 0.03 0.02 0.01 0.04 























CVD 0.03 0.01 0.04 0.04 0.01 0.04 0.04 
Diabetes 0.05 0.01 0.07 0.05 0.06 0.04 0.07 
ESRD 0.07 0.03 0.07 0.04 0.03 0.06 0.07 
Hep_B 0.03 0.01 0.01 0.02 0.04 0.02 0.03 
Hep_C 0.02 -0.02 0.03 0.02 0.02 0.00 0.03 
HIV 0.04 0.02 0.05 0.04 0.05 0.02 0.05 
HTN 0.05 0.00 0.04 0.06 0.02 0.02 0.05 
Immunocompromised -0.05 0.00 -0.04 -0.03 0.01 -0.02 -0.03 
Obesity 0.04 0.00 0.06 0.04 0.08 0.03 0.06 
overweight -0.02 0.01 -0.04 -0.03 -0.02 -0.02 -0.04 
PVD 0.01 -0.01 0.02 0.02 0.01 0.00 0.01 












































BMI 0.04 -0.07 0.04 0.00 0.01 0.07 0.01 
Age -0.02 0.00 -0.03 0.00 0.03 -0.01 0.05 
LOS 0.04 -0.06 0.05 0.01 0.03 0.02 0.02 
Living_Status 0.03 -0.06 0.05 -0.02 0.02 0.03 0.01 
Sex -0.02 0.01 -0.02 0.01 0.03 -0.03 -0.08 
COVID_results 0.07 -0.08 0.10 -0.02 -0.03 0.06 -0.05 
CPMI 0.02 0.02 -0.01 0.01 -0.03 0.00 -0.07 
E_TOTPOP -0.45 0.39 -0.37 0.00 0.02 -0.20 0.02 
EP_POV 0.64 -0.66 0.70 -0.03 0.01 0.27 -0.03 
EP_UNEMP 0.43 -0.51 0.52 -0.03 -0.02 0.30 -0.01 
EP_PCI -0.65 0.78 -0.73 0.00 -0.07 -0.42 0.02 
EP_NOHSDP 0.59 -0.74 0.52 -0.14 0.34 0.47 -0.03 
EP_AGE65 -0.03 0.04 -0.11 -0.07 0.06 0.04 0.01 
EP_AGE17 -0.06 -0.12 0.05 0.07 0.02 0.12 -0.01 
EP_DISABL 0.35 -0.52 0.38 -0.08 0.19 0.41 0.00 
EP_SNGPNT 0.44 -0.52 0.52 0.05 -0.05 0.31 -0.01 
EP_MINRTY 0.48 -0.53 0.66 -0.01 -0.22 0.27 0.00 
EP_LIMENG 0.06 0.05 -0.02 -0.12 0.13 -0.02 -0.01 
EP_MUNIT 0.13 0.08 0.21 -0.05 -0.29 -0.21 0.00 
EP_MOBILE 0.04 -0.16 -0.23 -0.07 0.57 0.31 0.00 
EP_CROWD 0.25 -0.40 0.32 0.02 0.20 0.13 -0.01 
EP_NOVEH 0.55 -0.55 0.57 -0.04 -0.03 0.24 -0.03 
EP_GROUPQ 0.24 -0.14 0.18 -0.04 -0.07 0.08 0.01 
RPL_THEME1 0.66 -0.76 0.71 -0.06 0.12 0.42 -0.02 
RPL_THEME2 0.37 -0.56 0.44 -0.04 0.14 0.43 -0.01 
RPL_THEME3 0.34 -0.29 0.40 -0.07 -0.06 0.15 -0.01 
RPL_THEME4 0.48 -0.45 0.42 -0.08 0.13 0.21 -0.01 
RPL_THEMES 0.66 -0.72 0.68 -0.08 0.11 0.41 -0.02 
EP_UNINSUR *** -0.63 0.55 -0.08 0.20 0.31 -0.03 
EP_OCC_MBSA -0.63 *** -0.68 -0.06 -0.30 -0.63 0.02 
EP_OCC_SER 0.55 -0.68 *** -0.13 -0.14 0.22 -0.01 
EP_OCC_SAL_OFF -0.08 -0.06 -0.13 *** -0.26 -0.16 -0.01 
EP_OCC_NRCM 0.20 -0.30 -0.14 -0.26 *** 0.22 0.01 
EP_OCC_PTMM 0.31 -0.63 0.22 -0.16 0.22 *** 0.00 
Auto_immun -0.03 0.02 -0.01 -0.01 0.01 0.00 *** 
CEVD 0.01 -0.02 0.02 -0.02 0.01 0.00 0.02 
CKD 0.01 -0.05 0.05 -0.02 0.02 0.02 0.01 
CLD 0.03 -0.02 0.01 -0.01 0.01 0.03 0.05 




















Diabetes 0.04 -0.07 0.08 -0.03 0.02 0.03 -0.01 
ESRD 0.04 -0.06 0.05 0.03 0.01 0.00 0.00 
Hep_B 0.00 -0.04 0.03 -0.01 0.01 0.04 -0.02 
Hep_C 0.01 -0.02 0.02 -0.03 0.01 0.02 0.01 
HIV 0.02 -0.05 0.05 -0.03 0.00 0.03 -0.02 
HTN 0.01 -0.06 0.04 0.00 0.01 0.04 0.06 
Immunocompromised -0.04 0.02 0.01 -0.02 -0.01 0.00 0.14 
Obesity 0.01 -0.09 0.08 0.01 0.01 0.06 0.04 
overweight -0.04 0.04 -0.02 -0.01 -0.02 -0.03 0.00 
PVD 0.01 0.01 0.01 0.00 -0.01 -0.01 0.00 




































BMI -0.07 -0.03 0.02 -0.02 0.09 -0.04 -0.01 
Age 0.14 0.19 0.04 0.24 0.23 0.04 -0.01 
LOS 0.05 0.15 0.01 0.13 0.11 0.09 0.00 
Living_Status 0.11 0.16 0.02 0.13 0.14 0.11 0.02 
Sex 0.04 0.06 0.00 0.08 0.02 0.04 0.02 
COVID_results 0.02 0.01 -0.01 -0.01 0.07 0.04 0.00 
CPMI -0.17 -0.29 -0.07 -0.31 -0.37 -0.12 0.00 
E_TOTPOP 0.01 0.00 -0.01 -0.01 -0.02 -0.05 0.01 
EP_POV 0.01 0.03 -0.02 0.03 0.05 0.07 0.01 
EP_UNEMP 0.00 0.03 0.01 0.04 0.06 0.06 0.01 
EP_PCI -0.01 -0.03 0.01 -0.02 -0.06 -0.06 -0.01 
EP_NOHSDP 0.01 0.04 -0.01 0.04 0.06 0.06 0.02 
EP_AGE65 -0.03 0.03 0.02 0.02 0.01 0.02 0.02 
EP_AGE17 -0.01 -0.02 -0.03 0.00 -0.01 -0.02 -0.02 
EP_DISABL 0.00 0.05 0.01 0.04 0.07 0.06 0.04 
EP_SNGPNT 0.02 0.00 -0.02 0.03 0.03 0.03 0.02 
EP_MINRTY 0.02 0.04 0.00 0.02 0.08 0.06 0.04 
EP_LIMENG 0.01 -0.01 0.03 -0.01 0.01 -0.02 0.03 
EP_MUNIT 0.04 -0.01 0.04 0.01 0.01 0.01 0.04 
EP_MOBILE -0.02 -0.01 -0.02 0.01 -0.02 -0.01 -0.04 
EP_CROWD 0.04 0.02 -0.01 0.04 0.05 0.04 -0.02 
EP_NOVEH 0.01 0.02 0.00 0.03 0.05 0.07 0.03 
EP_GROUPQ 0.00 0.01 0.00 0.01 0.01 0.03 0.01 
RPL_THEME1 0.01 0.04 -0.01 0.04 0.07 0.07 0.01 
RPL_THEME2 -0.01 0.03 -0.01 0.04 0.05 0.04 0.02 
RPL_THEME3 0.02 0.02 0.02 0.01 0.06 0.03 0.04 
RPL_THEME4 0.03 0.01 0.01 0.04 0.04 0.06 0.02 
RPL_THEMES 0.02 0.04 0.00 0.04 0.07 0.07 0.03 
EP_UNINSUR 0.01 0.01 0.03 0.01 0.04 0.04 0.00 
EP_OCC_MBSA -0.02 -0.05 -0.02 -0.05 -0.07 -0.06 -0.04 
EP_OCC_SER 0.02 0.05 0.01 0.03 0.08 0.05 0.03 
EP_OCC_SAL_OFF -0.02 -0.02 -0.01 -0.01 -0.03 0.03 -0.01 
EP_OCC_NRCM 0.01 0.02 0.01 0.02 0.02 0.01 0.01 
EP_OCC_PTMM 0.00 0.02 0.03 0.02 0.03 0.00 0.04 
Auto_immun 0.02 0.01 0.05 0.01 -0.01 0.00 -0.02 
CEVD *** 0.16 0.00 0.18 0.13 0.05 0.00 
CKD 0.16 *** 0.03 0.35 0.28 0.31 0.04 
CLD 0.00 0.03 *** 0.04 0.06 0.01 0.07 









Diabetes 0.13 0.28 0.06 0.24 *** 0.12 0.01 
ESRD 0.05 0.31 0.01 0.15 0.12 *** 0.05 
Hep_B 0.00 0.04 0.07 0.00 0.01 0.05 *** 
Hep_C 0.02 0.02 0.15 0.02 0.02 0.02 0.14 
HIV 0.00 0.05 0.02 0.00 0.03 0.06 0.26 
HTN 0.16 0.26 0.08 0.28 0.38 0.09 0.02 
Immunocompromised 0.06 0.02 -0.01 0.03 0.02 -0.01 -0.01 
Obesity 0.02 0.10 0.02 0.12 0.23 0.06 -0.01 
overweight 0.00 0.01 -0.01 0.00 0.01 -0.01 -0.01 
PVD 0.09 0.15 0.04 0.21 0.12 0.09 0.02 














































BMI -0.02 0.00 0.07 0.01 0.37 -0.05 -0.05 0.00 
Age 0.04 -0.03 0.37 0.01 0.02 0.01 0.10 0.09 
LOS 0.00 0.01 0.11 0.02 0.18 0.05 0.05 0.03 
Living_Status 0.02 0.03 0.12 0.01 0.09 0.01 0.05 0.06 
Sex 0.01 0.01 0.01 -0.02 -0.05 -0.01 0.02 -0.02 
COVID_results -0.04 0.00 -0.02 -0.01 0.19 0.03 0.00 -0.07 
CPMI -0.05 -0.02 -0.42 -0.04 -0.10 -0.03 -0.14 -0.20 
E_TOTPOP -0.01 -0.03 -0.01 0.03 0.04 0.02 0.00 0.00 
EP_POV 0.01 0.03 0.03 -0.04 0.04 -0.03 0.01 0.02 
EP_UNEMP 0.02 0.05 0.05 -0.02 0.08 -0.03 0.01 0.01 
EP_PCI -0.02 -0.04 -0.03 0.04 -0.04 0.05 0.00 0.00 
EP_NOHSDP 0.04 0.04 0.04 -0.04 0.05 -0.03 0.02 0.03 
EP_AGE65 0.00 0.02 0.04 -0.01 -0.04 0.04 0.01 0.01 
EP_AGE17 -0.01 -0.02 -0.02 0.00 0.01 -0.03 0.01 0.01 
EP_DISABL 0.04 0.06 0.08 -0.03 0.05 -0.02 0.01 0.02 
EP_SNGPNT 0.02 0.02 0.03 -0.03 0.06 -0.03 0.01 0.04 
EP_MINRTY 0.03 0.05 0.08 -0.01 0.10 -0.01 0.00 0.00 
EP_LIMENG 0.01 0.02 -0.03 0.03 0.03 -0.02 0.01 0.01 
EP_MUNIT 0.03 0.04 0.03 0.01 0.02 0.01 -0.01 0.00 
EP_MOBILE -0.03 -0.05 -0.05 -0.02 -0.04 -0.03 -0.01 0.02 
EP_CROWD -0.01 0.00 0.02 -0.02 0.04 -0.02 0.01 0.03 
EP_NOVEH 0.02 0.04 0.05 -0.05 0.04 -0.02 0.01 0.01 
EP_GROUPQ -0.02 0.02 0.00 0.00 0.00 0.01 -0.01 0.00 
RPL_THEME1 0.03 0.05 0.04 -0.04 0.06 -0.04 0.02 0.02 
RPL_THEME2 0.02 0.04 0.06 -0.03 0.04 -0.03 0.02 0.04 
RPL_THEME3 0.02 0.05 0.02 0.01 0.08 -0.02 0.01 0.01 
RPL_THEME4 0.00 0.02 0.02 -0.02 0.03 -0.02 0.00 0.02 
RPL_THEMES 0.03 0.05 0.05 -0.03 0.06 -0.04 0.01 0.02 
EP_UNINSUR 0.01 0.02 0.01 -0.04 0.01 -0.04 0.01 0.01 
EP_OCC_MBSA -0.02 -0.05 -0.06 0.02 -0.09 0.04 0.01 -0.02 
EP_OCC_SER 0.02 0.05 0.04 0.01 0.08 -0.02 0.01 0.01 
EP_OCC_SAL_OF
F 
-0.03 -0.03 0.00 -0.02 0.01 -0.01 0.00 -0.02 
EP_OCC_NRCM 0.01 0.00 0.01 -0.01 0.01 -0.02 -0.01 0.04 
EP_OCC_PTMM 0.02 0.03 0.04 0.00 0.06 -0.03 -0.01 0.02 
Auto_immun 0.01 -0.02 0.06 0.14 0.04 0.00 0.00 0.03 
CEVD 0.02 0.00 0.16 0.06 0.02 0.00 0.09 0.03 



















CLD 0.15 0.02 0.08 -0.01 0.02 -0.01 0.04 0.01 
CVD 0.02 0.00 0.28 0.03 0.12 0.00 0.21 0.15 
Diabetes 0.02 0.03 0.38 0.02 0.23 0.01 0.12 0.07 
ESRD 0.02 0.06 0.09 -0.01 0.06 -0.01 0.09 0.02 
Hep_B 0.14 0.26 0.02 -0.01 -0.01 -0.01 0.02 0.00 
Hep_C *** 0.09 0.07 -0.01 -0.01 -0.01 0.05 0.02 
HIV 0.09 *** 0.03 -0.01 0.01 -0.01 0.01 0.03 
HTN 0.07 0.03 *** 0.01 0.24 0.02 0.12 0.13 
Immunocompromis
ed 
-0.01 -0.01 0.01 *** 0.03 -0.01 -0.01 0.02 
Obesity -0.01 0.01 0.24 0.03 *** -0.03 0.01 0.09 
overweight -0.01 -0.01 0.02 -0.01 -0.03 *** 0.00 -0.01 
PVD 0.05 0.01 0.12 -0.01 0.01 0.00 *** 0.07 






















































56.31 50.76 5.55 22.34 33.97 59.00 28.59 53.39 
Asian 0.58 0.51 0.07 0.29 0.29 62.15 17.43 50.16 
Other 1.27 1.12 0.15 0.58 0.69 69.38 16.99 54.17 
Unknown 5.22 4.97 0.25 2.50 2.72 69.56 8.83 53.23 
Hispanic 3.63 3.59 0.04 1.81 1.81 74.11 23.95 42.49 
Patient Type 
ED 21.25 20.70 0.54 8.12 13.13 88.52 31.75 44.68 
Admit 32.67 24.44 8.23 16.39 16.28 49.45 31.66 64.85 
Outpatient 
/UC 
46.08 44.89 1.20 18.06 28.03 45.17 17.52 54.50 
Smoking Status 
Never 62.94 57.61 5.33 22.19 40.75 57.50 27.22 53.67 
Former 20.56 16.79 3.77 11.17 9.39 40.54 28.01 65.49 
Current 7.65 6.96 0.69 4.79 2.86 56.92 24.80 53.26 
Unknown 8.85 8.67 0.18 4.42 4.42 78.00 4.21 50.57 
Age Category 
11 to 20 2.83 2.79 0.04 1.16 1.67 85.36 19.89 19.54 
21 to 30 11.24 11.17 0.07 4.24 7.00 75.73 23.72 26.39 
31 to 40 11.71 11.57 0.15 4.39 7.32 76.60 26.68 35.92 
41 to 50 14.10 13.67 0.44 5.66 8.45 68.14 27.61 46.35 
51 to 60 18.02 16.46 1.56 7.47 10.55 66.66 26.68 56.28 
61 to 70 18.35 15.99 2.36 9.35 8.99 50.84 25.67 65.77 
71 to 80 12.26 9.72 2.54 6.24 6.02 30.15 24.80 75.48 
81 to 90 8.67 6.56 2.10 3.37 5.29 12.40 22.04 85.57 
91 to 100 2.72 1.99 0.73 0.65 2.07 5.98 16.23 93.66 
101 to 110 0.11 0.11 0.00 0.04 0.07 0.00 6.16 102.81 
Institutionalized 
No 79.91 74.00 5.91 32.70 47.21 62.18 25.89 51.28 





























Noninstitutionalized 79.91 74.00 5.91 32.70 47.21 62.18 25.89 51.28 
Nursing Home 17.91 14.14 3.77 8.12 9.79 25.93 21.35 75.55 
Rehab/Mental 
Health 
0.29 0.22 0.07 0.29 0.00 56.22 27.16 71.97 
Prison/Jail 1.89 1.67 0.22 1.45 0.44 67.98 30.35 57.19 
Gender 
Male 42.57 36.77 5.80 42.57 57.43 54.66 23.66 56.52 
Female 57.43 53.26 4.17 0.00 0.00 56.61 26.28 55.26 
Living Status 
Deceased 9.97 0.00 9.97 5.80 4.17 36.26 30.23 71.55 



















































34.63 21.14 10.04 8.96 6.02 16.82 6.67 10.37 
Asian 0.15 0.11 0.04 0.04 0.11 0.04 0.07 0.04 
Other 0.40 0.18 0.11 0.11 0.07 0.15 0.04 0.15 
Unknown 1.34 0.47 0.36 0.36 0.18 0.44 0.29 0.36 
Hispanic 0.76 0.65 0.18 0.25 0.07 0.80 0.15 0.15 
Patient Type 
ED 8.77 4.68 1.81 1.12 0.98 3.81 1.78 1.49 
Admit 25.49 16.42 10.99 9.57 6.42 11.39 6.67 9.39 
Outpatient /UC 22.08 10.62 4.79 3.99 2.76 9.79 3.73 4.71 
Smoking Status 
Never 34.88 19.33 8.92 8.12 4.89 17.48 6.16 8.09 
Former 15.77 9.25 6.60 4.97 3.77 6.13 3.88 5.18 
Current 4.64 2.72 1.78 1.34 1.16 1.23 1.96 2.18 
Unknown 1.05 0.44 0.29 0.25 0.33 0.15 0.18 0.15 
Living Status 
Deceased 8.16 5.62 4.06 3.95 2.43 3.26 2.32 3.01 
Alive 48.19 26.11 13.52 10.73 7.72 21.72 9.86 12.58 
Gender 
Male 24.66 14.03 8.74 7.76 5.40 8.56 5.00 7.47 
Female 31.69 17.69 8.85 6.93 4.75 16.42 7.18 8.12 
Age Category 
11 to 20 0.15 0.11 0.00 0.00 0.04 0.33 0.15 0.07 
21 to 30 0.87 0.58 0.04 0.07 0.07 1.56 0.76 0.29 
31 to 40 2.61 1.60 0.15 0.36 0.07 3.08 0.73 0.83 
41 to 50 7.32 3.66 0.18 0.94 0.44 4.86 1.27 1.45 
51 to 60 11.57 6.53 0.54 2.07 1.63 6.20 2.18 3.95 
61 to 70 13.92 8.96 0.36 4.13 3.30 5.29 2.68 3.81 
71 to 80 10.48 5.98 0.36 3.41 2.54 2.65 2.43 3.23 
81 to 90 7.11 3.44 0.11 2.72 1.74 0.91 1.56 1.45 
91 to 100 2.21 0.87 0.04 0.94 0.29 0.11 0.44 0.47 
101 to 110 0.11 0.00 0.00 0.04 0.04 0.00 0.00 0.04 
Institutionalized 
No 38.98 22.63 10.26 8.56 4.79 21.14 8.12 10.66 






















Non_Institutionalized 38.98 22.63 10.26 8.56 4.79 21.14 8.12 10.66 
Nursing Home 15.95 8.52 6.93 5.77 5.11 3.19 3.70 4.50 
Rehab/Mental Health 0.18 0.11 0.07 0.07 0.04 0.00 0.07 0.00 

























































13.97 5.18 29321.70 11.53 13.75 23.03 
Black or 
AfricanAmerican 
21.38 7.75 21712.82 15.06 12.43 22.17 
Asian 12.95 4.83 31446.75 10.09 14.25 23.77 
Other 16.16 5.89 23521.69 11.04 11.86 19.39 
Unknown 18.86 5.87 25118.06 13.99 13.99 22.44 
Hispanic 18.13 6.39 25051.42 13.27 12.13 23.10 
Patient Type 
ED 21.17 7.49 21859.39 15.17 12.00 22.46 
Admit 18.98 6.97 23137.72 14.98 12.55 21.74 
Outpatient /UC 17.09 6.18 26903.71 12.11 13.65 23.00 
Smoking Status 
Never 18.52 6.82 24581.58 13.62 12.69 22.73 
Former 17.73 6.57 25077.44 13.65 13.27 21.94 
Current 20.36 7.19 24940.34 13.18 13.12 21.97 
Unknown 19.40 5.89 23345.71 14.81 13.80 22.33 
Living Status 
Deceased 18.19 6.76 24076.03 13.98 13.45 21.70 
Alive 18.62 6.71 24659.85 13.67 12.88 22.56 
Gender 
Male 18.20 6.58 24947.05 13.98 12.98 22.14 









































14.48 12.45 55.64 1.20 7.91 9.24 2.60 
Asian 13.32 10.25 36.88 1.59 8.68 13.58 2.16 
Other 11.47 9.46 36.46 0.68 8.68 7.44 2.34 
Unknown 13.83 11.11 43.23 1.31 8.14 12.79 2.20 
Hispanic 12.33 11.26 43.12 2.73 7.09 14.04 2.56 
Patient Type 
ED 13.04 12.48 46.94 1.00 5.41 11.70 2.45 
Admit 14.11 11.91 49.98 1.05 7.07 10.71 2.65 
Outpatient 
/UC 
13.85 10.81 43.93 1.50 9.58 10.77 2.14 
Smoking Status 
Never 13.51 11.64 47.65 1.25 7.64 10.71 2.42 
Former 14.14 11.35 44.98 1.19 8.21 10.97 2.19 
Current 14.50 11.73 48.36 1.21 10.17 7.71 2.52 
Unknown 14.04 10.96 40.74 1.39 6.78 15.39 2.40 
Living Status 
Deceased 14.17 11.65 47.62 1.24 7.66 10.80 2.40 
Alive 13.71 11.51 46.43 1.25 7.90 10.96 2.37 
Gender 
Male 13.71 11.44 45.26 1.24 7.90 11.56 2.27 











































5.93 2.81 0.31 0.40 0.43 0.45 0.36 
Black or African 
American 
9.70 3.75 0.49 0.51 0.54 0.53 0.53 
Asian 6.81 3.29 0.25 0.40 0.51 0.45 0.33 
Other 6.43 4.67 0.37 0.36 0.42 0.46 0.39 
Unknown 8.78 4.64 0.41 0.46 0.48 0.50 0.45 
Hispanic 6.47 2.80 0.41 0.38 0.54 0.48 0.43 
Patient Type 
ED 8.73 3.42 0.48 0.48 0.47 0.52 0.51 
Admit 8.12 5.38 0.45 0.47 0.51 0.53 0.49 
Outpatient /UC 8.09 2.11 0.37 0.45 0.51 0.47 0.42 
Smoking Status 
Never 7.97 3.24 0.42 0.46 0.50 0.49 0.46 
Former 8.36 4.20 0.41 0.47 0.50 0.50 0.45 
Current 9.99 3.53 0.43 0.49 0.52 0.54 0.49 
Unknown 8.32 3.25 0.44 0.47 0.47 0.51 0.47 
Living Status 
Deceased 8.15 4.24 0.43 0.47 0.52 0.51 0.48 
Alive 8.24 3.37 0.42 0.46 0.50 0.50 0.46 
Gender 
Male 8.22 4.53 0.42 0.45 0.50 0.50 0.46 

















































10.88 26.76 20.33 20.44 9.40 13.78 1.51 
Asian 8.73 40.18 15.33 22.46 9.25 12.57 1.19 
Other 7.95 31.98 16.07 19.65 7.80 10.15 1.66 
Unknown 10.63 31.99 19.39 20.78 10.64 12.29 2.28 
Hispanic 12.92 29.16 19.72 21.88 11.33 13.88 1.31 
Patient Type 
ED 10.70 26.62 19.15 20.58 9.55 13.67 1.55 
Admit 10.12 28.50 19.65 20.55 10.13 13.25 1.72 
Outpatient 
/UC 
10.26 32.62 18.45 21.20 10.06 13.08 1.46 
Smoking Status 
Never 10.24 29.86 19.02 20.92 9.89 13.36 1.47 
Former 9.98 30.66 18.95 20.82 9.97 12.85 1.60 
Current 10.13 31.08 18.74 20.77 8.78 13.05 1.43 
Unknown 11.67 28.49 19.09 20.55 11.58 13.71 2.25 
Living Status 
Deceased 10.24 29.54 18.97 20.61 10.15 13.42 1.52 
Alive 10.31 30.05 18.99 20.88 9.95 13.24 1.57 
Gender 
Male 10.19 30.32 19.01 20.84 10.26 13.07 1.68 















































33.45 32.59 0.86 14.44 19.02 52.99 25.79 52.96 
Asian 0.59 0.59 0.00 0.25 0.34 47.77 16.49 52.85 
Other 1.04 1.03 0.01 0.49 0.55 66.62 12.67 54.78 
Unknown 5.37 5.32 0.05 2.33 3.03 75.30 5.12 52.79 
Hispanic 1.66 1.66 0.01 0.85 0.81 60.71 19.91 46.60 
Patient Type 
ED 14.29 14.15 0.15 5.99 8.31 86.63 29.80 45.85 
Admit 27.75 25.81 1.95 14.15 13.61 49.87 29.06 62.96 
Outpatient 
/UC 
57.96 57.67 0.28 23.38 34.58 41.09 18.26 55.17 
Smoking Status 
Never 47.66 46.70 0.96 16.92 30.74 47.15 25.15 54.94 
Former 22.87 21.96 0.90 12.29 10.58 33.45 26.89 63.87 
Current 18.89 18.39 0.50 9.67 9.22 58.61 24.63 51.54 
Unknown 10.58 10.57 0.01 4.64 5.94 83.57 1.11 51.71 
Age_Category 
11 to 20 2.16 2.14 0.01 0.82 1.34 77.15 18.17 19.69 
21 to 30 10.19 10.16 0.03 4.17 6.02 75.21 21.04 26.25 
31 to 40 12.53 12.43 0.11 4.73 7.81 67.29 22.79 36.12 
41 to 50 13.99 13.83 0.16 5.31 8.68 64.14 24.05 46.13 
51 to 60 17.64 17.35 0.29 7.96 9.68 54.42 23.56 56.32 
61 to 70 20.13 19.56 0.57 9.91 10.22 43.81 23.48 65.87 
71 to 80 14.13 13.50 0.63 6.99 7.14 26.56 24.20 75.59 
81 to 90 7.31 6.85 0.45 3.03 4.28 14.01 20.51 85.38 
91 to 100 1.87 1.76 0.12 0.60 1.28 5.27 18.25 93.99 
101 to 110 0.04 0.03 0.01 0.01 0.03 0.90 11.43 101.56 
Institutionalized 
No 91.58 89.57 2.01 39.30 52.28 51.53 23.48 54.45 































91.58 89.57 2.01 39.30 52.28 51.53 23.48 54.45 
Nursing 
Home 




0.16 0.15 0.01 0.05 0.11 23.81 15.32 72.77 
Prison/Jail 0.63 0.62 0.01 0.47 0.16 62.44 26.73 54.96 
Gender 
Male 43.51 42.21 1.31 43.51 0.00 49.46 22.33 57.08 
Female 56.49 55.42 1.07 0.00 56.49 50.48 23.35 55.17 
Living Status 
Deceased 2.38 0.00 2.38 1.31 1.07 32.17 27.54 69.58 























































18.30 8.68 4.75 4.17 1.87 4.19 4.75 5.78 
Asian 0.25 0.18 0.05 0.07 0.03 0.04 0.05 0.09 
Other 0.41 0.15 0.12 0.05 0.05 0.09 0.09 0.07 
Unknown 1.41 0.69 0.52 0.36 0.20 0.31 0.42 0.44 
Hispanic 0.68 0.35 0.15 0.12 0.07 0.10 0.20 0.20 
Patient Type 
ED 6.23 2.68 1.45 1.09 0.56 1.42 2.08 1.87 
Admit 15.96 8.06 5.59 4.53 2.07 3.87 4.95 5.79 
Outpatient /UC 27.40 12.75 6.88 5.26 2.91 6.31 7.73 7.73 
Smoking Status 
Never 24.52 11.61 6.10 5.37 2.71 5.99 6.20 6.63 
Former 13.55 6.47 4.47 3.14 1.51 3.11 4.62 4.60 
Current 9.30 4.32 2.57 1.85 1.03 1.93 3.38 3.42 
Unknown 2.21 1.09 0.78 0.51 0.30 0.58 0.56 0.74 
Living Status 
Deceased 1.53 0.72 0.65 0.48 0.18 0.29 0.49 0.55 
Alive 48.05 22.77 13.27 10.39 5.37 11.31 14.27 14.84 
Gender 
Male 21.88 10.38 6.52 4.80 2.57 4.70 6.07 6.48 
Female 27.71 13.10 7.40 6.07 2.97 6.91 8.69 8.91 
Age Category 
11 to 20 0.50 0.28 0.18 0.15 0.09 0.17 0.26 0.24 
21 to 30 2.84 1.50 0.85 0.75 0.31 1.01 1.28 1.09 
31 to 40 4.28 1.94 0.98 0.81 0.41 1.45 1.48 1.65 
41 to 50 6.35 2.77 1.54 1.23 0.62 1.74 1.74 2.00 
51 to 60 8.96 4.32 2.35 1.82 1.04 2.19 2.59 3.02 
61 to 70 11.75 5.73 3.15 2.25 1.30 2.41 3.50 3.57 
71 to 80 8.87 4.69 2.96 2.35 1.04 1.81 2.44 2.30 
81 to 90 4.81 1.87 1.53 1.25 0.59 0.69 1.19 1.19 
91 to 100 1.18 0.38 0.36 0.25 0.14 0.13 0.28 0.32 
101 to 110 0.03 0.01 0.01 0.01 0.01 0.01 0.00 0.01 
Institutionalized 
No 44.55 20.99 12.43 9.71 4.79 10.81 13.55 13.90 






















Non_Institutionalized 44.55 20.99 12.43 9.71 4.79 10.81 13.55 13.90 
Nursing Home 4.64 2.31 1.38 1.08 0.73 0.74 1.11 1.33 
Rehab/Mental Health 0.09 0.06 0.01 0.02 0.01 0.02 0.03 0.04 



















































25.53 9.00 23022.96 17.05 13.59 24.82 
Asian 13.40 6.14 33603.43 9.57 15.53 22.62 
Other 16.20 5.83 28084.64 14.87 14.86 24.43 
Unknown 20.25 6.85 26727.51 15.10 14.74 23.99 
Hispanic 19.44 6.79 27046.50 13.54 13.54 23.94 
Patient Type 
    ED 21.89 7.75 25420.57 15.75 13.68 24.89 
Admit 20.61 7.43 26141.99 15.67 14.07 24.24 
Outpatient 
/UC 
17.45 6.22 28421.49 13.16 14.49 24.19 
Smoking Status 
Never 18.51 6.63 28006.27 13.58 14.18 24.28 
Former 18.00 6.63 27698.24 14.20 14.27 24.26 
Current 20.67 7.43 26004.09 15.47 13.82 24.55 
Unknown 20.03 6.55 26138.84 14.95 15.35 24.04 
Living Status 
Deceased 20.21 6.94 26798.80 14.77 14.38 23.97 
Alive 18.93 6.77 27373.64 14.21 14.26 24.31 
Gender 
Male 18.96 6.81 27208.90 14.34 14.29 24.19 



































24.82 15.98 14.00 61.77 1.12 8.71 10.09 
Asian 22.62 13.66 9.06 36.77 1.49 12.31 8.82 
Other 24.43 14.43 10.11 33.77 1.32 5.85 16.74 
Unknown 23.99 14.68 10.91 37.94 1.30 7.06 14.42 
Hispanic 23.94 13.59 11.46 40.91 1.56 6.96 13.72 
Patient Type 
ED 24.89 14.31 12.74 44.06 0.92 6.47 14.30 
Admit 24.24 15.15 11.81 45.38 1.10 7.08 13.79 
Outpatient 
/UC 
24.19 14.05 10.71 37.46 1.07 6.85 14.57 
Smoking Status 
Never 24.28 14.04 11.23 40.89 1.06 7.14 13.67 
Former 24.26 14.57 11.04 39.47 1.04 6.52 14.96 
Current 24.55 15.07 12.19 44.28 1.09 7.37 14.36 
Unknown 24.04 14.37 10.60 35.16 1.03 5.43 15.79 
Living Status 
Deceased 23.97 15.35 11.45 45.19 1.29 9.07 12.53 
Alive 24.31 14.37 11.30 40.49 1.05 6.81 14.36 
Gender 
Male 24.19 14.43 11.31 40.85 1.02 6.74 14.50 















































11.52 3.87 0.57 0.56 0.56 0.60 0.60 
Asian 7.12 1.63 0.29 0.39 0.50 0.41 0.34 
Other 5.95 1.78 0.40 0.48 0.45 0.52 0.44 
Unknown 7.44 2.58 0.46 0.48 0.45 0.54 0.48 
Hispanic 7.21 3.26 0.42 0.43 0.49 0.52 0.45 
Patient Type 
ED 9.24 3.00 0.49 0.50 0.45 0.54 0.50 
Admit 8.66 3.20 0.47 0.49 0.47 0.55 0.49 
Outpatient 
/UC 
7.01 2.19 0.38 0.45 0.42 0.48 0.41 
Smoking Status 
Never 7.57 2.50 0.41 0.45 0.44 0.50 0.43 
Former 7.52 2.47 0.41 0.47 0.44 0.50 0.43 
Current 8.91 2.88 0.47 0.50 0.46 0.54 0.49 
Unknown 7.32 2.70 0.45 0.48 0.40 0.53 0.45 
Living Status 
Deceased 9.34 2.97 0.44 0.49 0.51 0.54 0.48 
Alive 7.75 2.58 0.42 0.47 0.44 0.51 0.44 
Gender 
Male 7.83 2.93 0.43 0.47 0.44 0.51 0.45 















































12.22 28.49 23.20 22.80 10.13 15.30 1.67 
Asian 8.85 40.45 16.21 22.22 9.31 11.77 1.27 
Other 9.67 33.03 17.83 22.72 12.62 13.75 2.31 
Unknown 11.12 33.16 19.08 22.31 11.61 13.82 2.69 
Hispanic 11.30 33.44 18.78 22.43 11.51 13.81 1.71 
Patient Type 
ED 11.39 30.73 20.11 23.39 10.90 14.86 1.60 
Admit 10.99 31.02 20.16 22.56 11.66 14.50 1.87 
Outpatient 
/UC 
10.22 34.19 18.12 22.63 11.32 13.73 1.87 
Smoking Status 
Never 10.40 33.53 18.72 22.79 10.98 13.91 1.73 
Former 10.37 32.98 18.70 22.61 11.73 13.97 1.78 
Current 11.15 30.85 20.19 22.58 11.56 14.80 1.69 
Unknown 11.02 32.77 18.52 22.89 11.86 13.98 2.65 
Living Status 
Deceased 0.48 10.99 31.91 20.34 21.96 11.52 14.23 
Alive 0.44 10.59 32.84 18.94 22.74 11.35 14.10 
Gender 
Male 0.45 10.60 32.80 18.96 22.72 11.38 14.09 









































46.39 36.28 10.11 19.13 27.26 22.33 25.28 77.10 
Black or African 
American 
43.68 34.84 8.84 24.73 18.95 24.00 33.29 70.34 
Asian 0.54 0.18 0.36 0.54 0.00 16.37 25.83 67.49 
Other 1.26 1.08 0.18 0.36 0.90 15.51 40.95 78.69 
Unknown 6.86 6.32 0.54 3.43 3.43 12.97 43.05 74.33 
Hispanic 1.26 1.08 0.18 0.90 0.36 21.01 34.95 65.59 
Patient Type 
ED 3.79 3.07 0.72 1.99 1.81 28.52 54.74 71.28 
Admit 50.72 35.92 14.80 28.70 22.02 29.90 33.93 70.90 
Outpatient /UC 45.49 40.79 4.69 18.41 27.08 13.26 24.25 77.20 
Smoking Status 
Never 48.92 39.89 9.03 19.13 29.78 28.65 21.59 76.45 
Former 31.23 22.74 8.48 17.33 13.90 26.61 25.48 73.47 
Current 13.18 11.01 2.17 8.48 4.69 39.21 22.33 63.91 
Unknown 6.68 6.14 0.54 4.15 2.53 42.31 12.31 75.15 
Age Category 
21 to 30 0.36 0.36 0.00 0.18 0.18 28.61 90.15 28.24 
31 to 40 1.26 1.26 0.00 0.72 0.54 29.48 88.56 34.23 
41 to 50 3.79 3.43 0.36 2.53 1.26 28.18 81.94 46.14 
51 to 60 10.47 8.48 1.99 6.50 3.97 25.54 62.61 57.07 
61 to 70 24.73 19.13 5.60 15.16 9.57 23.66 44.50 66.54 
71 to 80 25.27 20.04 5.23 13.18 12.09 23.24 20.61 75.75 
81 to 90 25.63 20.40 5.23 9.57 16.06 20.26 10.00 85.70 
91 to 100 7.94 6.14 1.81 1.08 6.86 14.03 5.52 93.18 
101 to 110 0.54 0.54 0.00 0.18 0.36 6.16 0.00 102.81 
Institution Group 
Nursing Home 89.17 70.40 18.77 40.43 48.74 25.93 21.35 75.55 
Rehab/Mental 
Health 
1.44 1.08 0.36 1.44 0.00 56.22 27.16 71.97 
Prison/Jail 9.39 8.30 1.08 7.22 2.17 67.98 30.35 57.19 
Gender 
Male 49.10 36.64 12.45 49.10 0.00 38.04 21.92 70.34 
Female 50.90 43.14 7.76 0.00 50.90 22.87 22.63 77.10 
Living Status 
Deceased 20.22 0.00 20.22 12.45 7.76 25.32 27.41 75.28 
Alive 79.78 79.78 0.00 36.64 43.14 31.58 20.98 73.40 
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38.63 22.56 16.43 13.72 13.72 8.66 7.04 5.05 8.66 
Asian 0.54 0.36 0.18 0.18 0.54 0.00 0.18 0.00 0.18 
Other 0.90 0.18 0.36 0.18 0.18 0.00 0.00 0.00 0.00 
Unknown 4.69 1.99 1.44 1.44 0.90 0.54 0.72 0.36 0.54 
Hispanic 1.08 0.72 0.36 0.72 0.00 0.36 0.18 0.18 0.00 
Patient Type 
ED 2.53 1.62 0.90 0.72 1.26 0.54 0.54 0.36 0.00 
Admit 42.96 25.63 21.12 16.97 15.52 12.82 12.45 5.96 9.93 
Outpatient /UC 40.97 18.05 14.44 12.82 9.93 5.78 7.22 2.53 5.78 
Smoking Status 
Never 43.32 22.56 18.23 15.34 11.37 9.75 7.22 3.25 5.78 
Former 26.71 14.62 12.27 10.47 9.57 7.04 6.86 3.61 5.78 
Current 12.64 6.68 4.69 3.79 4.15 1.99 5.78 1.99 3.97 
Unknown 3.79 1.44 1.26 0.90 1.62 0.36 0.36 0.00 0.18 
Living Status 
Deceased 17.51 10.65 9.93 9.03 6.50 4.15 5.60 2.53 3.25 
Alive 68.95 34.66 26.53 21.48 20.22 14.98 14.62 6.32 12.45 
Age Category 
21 to 30 0.00 0.00 0.00 0.00 0.18 0.18 0.00 0.00 0.00 
31 to 40 0.54 0.36 0.00 0.00 0.00 0.36 0.18 0.00 0.00 
41 to 50 2.71 0.90 0.72 0.36 0.18 1.99 0.54 0.18 0.36 
51 to 60 9.75 4.87 3.07 1.99 3.79 3.43 1.99 0.36 3.07 
61 to 70 21.66 13.54 8.48 8.30 8.66 5.78 4.69 2.35 5.60 
71 to 80 22.92 13.18 11.19 8.84 7.94 5.23 7.04 3.61 3.97 
81 to 90 21.84 9.75 9.75 8.30 4.87 1.81 4.33 1.62 2.35 
91 to 100 6.50 2.71 3.07 2.53 0.90 0.36 1.44 0.72 0.18 
101 to 110 0.54 0.00 0.18 0.18 0.18 0.00 0.00 0.00 0.18 
Institution Group 
Nursing Home 79.42 42.42 34.48 28.70 25.45 15.88 18.41 8.66 13.72 
Rehab/Mental 
Health 
0.90 0.54 0.36 0.36 0.18 0.00 0.36 0.00 0.00 




Appendix AA. Summary of COVID Positive Non Institutionalized Patients 



























59.48 54.90 4.58 21.73 37.75 63.74 29.44 50.26 
Asian 0.59 0.59 0.00 0.23 0.36 70.53 17.67 46.16 
Other 1.27 1.13 0.14 0.64 0.64 76.48 17.36 48.04 
Unknown 4.81 4.63 0.18 2.27 2.54 79.07 7.34 45.67 
Hispanic 4.22 4.22 0.00 2.04 2.18 77.06 24.17 40.75 
Patient Type 
ED 25.64 25.14 0.50 9.66 15.97 89.78 31.87 43.69 
Admit 28.13 21.73 6.40 13.29 14.84 56.49 32.45 62.11 
Outpatient /UC 46.23 45.92 0.32 17.97 28.27 50.34 18.57 48.89 
Smoking Status 
Never 66.47 62.07 4.40 22.96 43.51 62.83 28.26 49.46 
Former 17.88 15.29 2.59 9.62 8.26 46.66 29.12 61.99 
Current 6.26 5.94 0.32 3.86 2.40 66.29 26.12 47.62 
Unknown 9.39 9.30 0.09 4.49 4.90 84.38 2.76 46.18 
Age Category 
11 to 20 3.54 3.49 0.05 1.45 2.09 85.36 19.89 19.54 
21 to 30 13.97 13.88 0.09 5.31 8.71 75.64 23.69 26.38 
31 to 40 14.34 14.16 0.18 5.49 9.03 76.33 26.62 35.96 
41 to 50 16.70 16.24 0.45 7.08 10.25 67.35 27.57 46.36 
51 to 60 19.92 18.47 1.45 9.35 12.21 67.20 26.84 56.18 
61 to 70 16.74 15.20 1.54 11.71 8.85 53.20 26.42 65.48 
71 to 80 8.98 7.12 1.86 7.80 4.49 36.89 25.9 75.29 
81 to 90 4.40 3.09 1.32 4.22 2.59 15.91 24.64 85.38 
91 to 100 1.41 0.95 0.45 0.82 0.86 6.64 19.34 94.33 
Gender 
Male 40.93 36.80 4.13 40.93 0.00 59.68 24.18 52.36 
Female 59.07 55.81 3.27 0.00 59.07 63.92 27.07 50.53 
Living Status 
Deceased 7.40 0.00 7.40 4.13 3.27 43.78 32.17 68.98 


































33.62 20.78 8.44 7.76 4.08 18.87 6.58 9.53 
Asian 0.05 0.05 0.00 0.00 0.00 0.05 0.05 0.00 
Other 0.27 0.18 0.05 0.09 0.05 0.18 0.05 0.18 
Unknown 0.50 0.09 0.09 0.09 0.00 0.41 0.18 0.23 
Hispanic 0.68 0.64 0.14 0.14 0.09 0.91 0.14 0.14 
Patient Type 
ED 10.34 5.44 2.04 1.23 0.91 4.63 2.09 1.77 
Admit 21.10 14.11 8.44 7.71 4.13 11.03 5.22 7.76 
Outpatient 
/UC 
17.33 8.76 2.36 1.77 0.95 10.80 2.86 3.81 
Smoking Status 
Never 26.13 15.83 6.85 5.90 3.27 15.29 5.40 6.94 
Former 8.98 4.63 2.86 1.72 1.00 4.13 1.77 2.99 
Current 8.80 4.85 2.04 1.81 1.13 4.45 1.81 2.09 
Unknown 4.85 2.99 1.09 1.27 0.59 2.59 1.18 1.32 
Living Status 
Deceased 5.81 4.36 2.59 2.68 1.41 3.04 1.50 2.31 
Alive 42.97 23.96 10.25 8.03 4.58 23.41 8.67 11.03 
Gender 
Male 20.46 12.43 6.99 6.08 3.18 8.76 3.81 5.81 
Female 28.31 15.88 5.85 4.63 2.81 17.70 6.35 7.53 
Age Category 
11 to 20 0.18 0.14 0.00 0.00 0.05 0.41 0.18 0.09 
21 to 30 1.09 0.73 0.05 0.09 0.05 1.91 0.95 0.36 
31 to 40 3.13 1.91 0.23 0.45 0.09 3.77 0.86 1.04 
41 to 50 8.48 4.36 0.95 1.09 0.50 5.58 1.45 1.68 
51 to 60 12.02 6.94 2.31 2.09 1.09 6.90 2.22 4.08 
61 to 70 11.98 7.80 3.99 3.09 1.95 5.17 2.18 2.77 
71 to 80 7.35 4.17 2.95 2.04 1.18 2.00 1.27 2.13 
81 to 90 3.40 1.86 1.95 1.32 0.95 0.68 0.86 0.82 
91 to 100 1.13 0.41 0.41 0.54 0.14 0.05 0.18 0.36 
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Appendix AC. Summary of COVID Positive Non-Institutionalized Patients 























22.00 8.07 20716.56 15.37 11.85 22.52 
Asian 13.72 4.84 31079.08 11.07 13.30 24.41 
Other 17.10 6.35 22138.82 11.09 11.36 19.10 
Unknown 19.42 6.36 24655.11 14.30 13.73 23.20 
Hispanic 18.04 6.37 25241.70 13.19 11.99 23.33 
Patient Type 
 ED 21.34 7.52 21708.80 15.19 11.96 22.46 
Admit 20.21 7.48 21982.33 14.51 12.05 22.21 
Outpatient 
/UC 
17.39 6.43 26005.21 12.94 12.94 23.37 
Smoking Status 
Never 19.08 7.09 23895.22 13.85 12.29 22.97 
Former 18.90 7.03 24048.04 13.88 12.58 22.48 
Current 21.53 7.65 22722.17 14.05 11.88 22.34 
Unknown 19.01 5.94 23076.08 14.75 13.42 22.64 
Living Status 
Deceased 19.91 7.22 21411.54 14.43 12.52 21.45 
Alive 19.14 6.99 23960.68 13.92 12.41 22.92 
Gender 
Male 18.60 6.84 24664.17 13.70 12.51 22.76 


































14.12 12.67 56.94 1.07 6.16 9.55 2.76 
Asian 12.73 11.05 37.67 1.42 5.19 16.68 2.62 
Other 11.21 8.82 34.69 0.45 6.84 8.42 2.41 
Unknown 13.63 10.88 42.65 1.15 5.91 13.98 2.44 
Hispanic 12.05 11.09 42.19 2.77 6.55 14.05 2.57 
Patient Type 
ED 13.01 12.47 47.07 0.99 5.17 11.72 2.46 
Admit 14.14 11.72 51.04 1.04 5.99 10.38 2.84 
Outpatient 
/UC 
13.34 10.98 44.11 1.15 6.44 12.23 2.40 
Smoking Status 
Never 13.30 11.71 48.09 1.10 6.19 11.12 2.54 
Former 14.01 11.38 45.13 0.90 5.62 11.86 2.50 
Current 13.79 12.08 49.47 0.97 6.77 8.94 2.76 
Unknown 13.52 10.58 39.28 1.30 4.76 16.02 2.44 
Living Status 
Deceased 13.77 11.48 48.88 0.97 4.94 11.55 2.65 
Alive 13.45 11.58 46.65 1.09 6.07 11.58 2.53 
Gender 
Male 13.37 11.25 44.65 1.11 5.88 11.98 2.41 











































9.11 2.81 0.51 0.51 0.53 0.52 0.54 
Asian 5.85 3.84 0.26 0.39 0.49 0.49 0.35 
Other 5.70 2.39 0.39 0.36 0.37 0.46 0.39 
Unknown 7.62 2.38 0.43 0.47 0.45 0.47 0.45 
Hispanic 6.12 2.06 0.41 0.37 0.54 0.48 0.42 
Patient Type 
ED 8.77 3.18 0.48 0.48 0.47 0.52 0.51 
Admit 8.06 1.88 0.47 0.49 0.49 0.49 0.49 
Outpatient 
/UC 
6.69 2.21 0.39 0.45 0.47 0.46 0.42 
Smoking Status 
Never 7.53 2.55 0.44 0.46 0.48 0.48 0.46 
Former 7.64 1.69 0.43 0.48 0.46 0.48 0.46 
Current 9.12 2.63 0.47 0.49 0.50 0.53 0.51 
Unknown 7.08 2.18 0.44 0.47 0.44 0.50 0.46 
Living Status 
Deceased 7.93 2.32 0.46 0.48 0.48 0.48 0.49 
Alive 7.58 2.37 0.44 0.47 0.48 0.48 0.46 
Gender 
Male 7.33 2.12 0.42 0.45 0.48 0.47 0.45 



























































10.80 24.81 20.31 20.34 9.40 14.21 1.44 
Asian 8.72 38.34 14.63 23.55 10.00 13.25 1.23 
Other 7.61 29.00 14.65 20.33 7.57 10.53 1.50 
Unknown 10.80 29.67 18.84 21.37 11.17 13.25 2.25 
Hispanic 13.01 29.21 19.53 21.65 11.42 13.86 1.30 
Patient Type 
ED 10.72 26.34 19.11 20.53 9.48 13.71 1.53 
Admit 10.19 25.90 19.48 20.07 9.97 13.42 1.48 
Outpatient 
/UC 
9.86 30.50 18.07 21.54 10.27 13.91 1.53 
Smoking Status 
Never 10.12 28.42 18.95 20.93 9.82 13.74 1.45 
Former 9.70 27.87 18.26 20.94 9.88 13.38 1.44 
Current 9.92 27.35 18.66 20.55 9.03 13.60 1.43 
Unknown 11.59 27.23 18.21 20.51 11.98 14.33 2.18 
Living Status 
Deceased 9.88 25.05 19.00 19.58 10.12 13.95 1.46 
Alive 10.19 28.39 18.72 20.97 9.97 13.70 1.52 
Gender 
Male 10.00 28.68 18.42 20.93 10.21 13.54 1.51 
Female 10.29 27.76 18.96 20.83 9.83 13.85 1.52 
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Appendix AD. Hot Spot Analysis FMOLHS Positive Institutionalized Patients 








11.02 East Baton Rouge 15 Hot Spot 99% 
17 East Baton Rouge 6 Hot Spot 95% 
18 East Baton Rouge 86 Hot Spot 95% 
202 West Baton Rouge 2 Hot Spot 95% 
24 East Baton Rouge 5 Hot Spot 95% 
26.02 East Baton Rouge 16 Hot Spot 95% 
302.04 Ascension 4 Hot Spot 95% 
303 Ascension 7 Hot Spot 95% 
304.02 Ascension 1 Hot Spot 95% 
310 Ascension 28 Hot Spot 95% 
37.02 East Baton Rouge 8 Hot Spot 95% 
37.03 East Baton Rouge 1 Hot Spot 95% 
38.02 East Baton Rouge 5 Hot Spot 95% 
38.04 East Baton Rouge 2 Hot Spot 95% 
38.05 East Baton Rouge 7 Hot Spot 95% 
39.09 East Baton Rouge 2 Hot Spot 95% 
40.16 East Baton Rouge 16 Hot Spot 95% 
406 Livingston 21 Hot Spot 95% 
407 Livingston 15 Hot Spot 95% 
408.04 Livingston 1 Hot Spot 95% 
45.03 East Baton Rouge 8 Hot Spot 95% 
45.04 East Baton Rouge 22 Hot Spot 95% 
45.05 East Baton Rouge 1 Hot Spot 95% 
45.09 East Baton Rouge 13 Hot Spot 95% 
45.10 East Baton Rouge 20 Hot Spot 90% 
48 East Baton Rouge 6 Hot Spot 90% 
53 East Baton Rouge 1 Hot Spot 90% 
9529 Iberville 1 Hot Spot 90% 
9531.01 Iberville 48 Hot Spot 90% 
9531.02 Iberville 22 Hot Spot 90% 










Appendix AE. Hot Spot Analysis FMOLHS Positive Non-Institutionalized 








1  East Baton Rouge  4 Hot Spot 99%  
10  East Baton Rouge  7 Hot Spot 99%  
11.02  East Baton Rouge  2 Hot Spot 99%  
11.03  East Baton Rouge  4 Hot Spot 99%  
11.04  East Baton Rouge  5 Hot Spot 99%  
16  East Baton Rouge  3 Hot Spot 99%  
17  East Baton Rouge  2 Hot Spot 99%  
18  East Baton Rouge  4 Hot Spot 99%  
19  East Baton Rouge  4 Hot Spot 99%  
2  East Baton Rouge  12 Hot Spot 99%  
20  East Baton Rouge  2 Hot Spot 99%  
201  West Baton Rouge  7 Hot Spot 99%  
202  West Baton Rouge  2 Hot Spot 99%  
203  West Baton Rouge  4 Hot Spot 99%  
204.01  West Baton Rouge  16 Hot Spot 99%  
204.02  West Baton Rouge  14 Hot Spot 99%  
205  Lafourche  1 Hot Spot 99%  
210  St. Martin  1 Hot Spot 99%  
22  East Baton Rouge  4 Hot Spot 99%  
23  East Baton Rouge  1 Hot Spot 99%  
24  East Baton Rouge  5 Hot Spot 99%  
25  East Baton Rouge  3 Hot Spot 99%  
26.01  East Baton Rouge  3 Hot Spot 99%  
26.02  East Baton Rouge  7 Hot Spot 99%  
27  East Baton Rouge  3 Hot Spot 99%  
28.02  East Baton Rouge  1 Hot Spot 99%  
3  East Baton Rouge  6 Hot Spot 99%  
3  Terrebonne  1 Hot Spot 99%  
30  East Baton Rouge  3 Hot Spot 99%  
301  Iberia  4 Hot Spot 99%  
301.01  Ascension  9 Hot Spot 99%  
301.02  Ascension  14 Hot Spot 99%  
301.03  Ascension  4 Hot Spot 99%  
302.03  Ascension  5 Hot Spot 99%  
302.04  Ascension  21 Hot Spot 99%  
302.05  Ascension  24 Hot Spot 99%  
302.06  Ascension  22 Hot Spot 99%  






Parish Positive Count Confidence Result 
304.01  Ascension  22 Hot Spot 99%  
304.02  Ascension  57 Hot Spot 99%  
305  Ascension  8 Hot Spot 99%  
306  Ascension  25 Hot Spot 99%  
309  Ascension  17 Hot Spot 99%  
31.01  East Baton Rouge  8 Hot Spot 99%  
310  Ascension  40 Hot Spot 99%  
32.01  East Baton Rouge  7 Hot Spot 99%  
32.02  East Baton Rouge  5 Hot Spot 99%  
33  East Baton Rouge  16 Hot Spot 99%  
34  East Baton Rouge  18 Hot Spot 99%  
35.01  East Baton Rouge  5 Hot Spot 99%  
35.04  East Baton Rouge  16 Hot Spot 99%  
35.05  East Baton Rouge  13 Hot Spot 99%  
35.06  East Baton Rouge  21 Hot Spot 99%  
35.07  East Baton Rouge  14 Hot Spot 99%  
36.01  East Baton Rouge  4 Hot Spot 99%  
36.03  East Baton Rouge  4 Hot Spot 99%  
36.04  East Baton Rouge  10 Hot Spot 99%  
37.01  East Baton Rouge  3 Hot Spot 99%  
37.02  East Baton Rouge  7 Hot Spot 99%  
37.03  East Baton Rouge  7 Hot Spot 99%  
38.01  East Baton Rouge  12 Hot Spot 99%  
38.02  East Baton Rouge  3 Hot Spot 99%  
38.04  East Baton Rouge  3 Hot Spot 99%  
38.05  East Baton Rouge  9 Hot Spot 99%  
39.04  East Baton Rouge  7 Hot Spot 99%  
39.06  East Baton Rouge  3 Hot Spot 99%  
39.07  East Baton Rouge  5 Hot Spot 99%  
39.08  East Baton Rouge  2 Hot Spot 99%  
39.09  East Baton Rouge  4 Hot Spot 99%  
39.1  East Baton Rouge  4 Hot Spot 99%  
4  East Baton Rouge  11 Hot Spot 99%  
40.05  East Baton Rouge  10 Hot Spot 99%  
40.06  East Baton Rouge  12 Hot Spot 99%  
40.09  East Baton Rouge  8 Hot Spot 99%  
40.1  East Baton Rouge  2 Hot Spot 99%  
40.11  East Baton Rouge  9 Hot Spot 99%  
40.13  East Baton Rouge  1 Hot Spot 99%  
40.14  East Baton Rouge  7 Hot Spot 99%  
40.15  East Baton Rouge  14 Hot Spot 99%  










401  Livingston  1 Hot Spot 99%  
401  St. James  10 Hot Spot 99%  
402  St. James  4 Hot Spot 99%  
402  St. Mary  1 Hot Spot 99%  
402.01  Livingston  2 Hot Spot 99%  
402.02  Livingston  2 Hot Spot 99%  
403  St. James  3 Hot Spot 99%  
403.01  Livingston  8 Hot Spot 99%  
403.03  Livingston  7 Hot Spot 99%  
403.04  Livingston  5 Hot Spot 99%  
404  St. James  14 Hot Spot 99%  
404.01  Livingston  5 Hot Spot 99%  
404.02  Livingston  7 Hot Spot 99%  
405  Livingston  7 Hot Spot 99%  
405  St. James  17 Hot Spot 99%  
406  Livingston  7 Hot Spot 99%  
406  St. James  6 Hot Spot 99%  
407  Livingston  4 Hot Spot 99%  
407  St. James  2 Hot Spot 99%  
408.02  Livingston  4 Hot Spot 99%  
408.04  Livingston  15 Hot Spot 99%  
408.05  Livingston  3 Hot Spot 99%  
408.06  Livingston  5 Hot Spot 99%  
409.02  Livingston  4 Hot Spot 99%  
414  St. Mary  1 Hot Spot 99%  
42.01  East Baton Rouge  12 Hot Spot 99%  
42.04  East Baton Rouge  2 Hot Spot 99%  
42.05  East Baton Rouge  11 Hot Spot 99%  
43.01  East Baton Rouge  5 Hot Spot 99%  
43.02  East Baton Rouge  2 Hot Spot 99%  
44.01  East Baton Rouge  7 Hot Spot 99%  
44.02  East Baton Rouge  4 Hot Spot 99%  
44.03  East Baton Rouge  3 Hot Spot 99%  
45.03  East Baton Rouge  8 Hot Spot 99%  
45.04  East Baton Rouge  8 Hot Spot 99%  
45.05  East Baton Rouge  9 Hot Spot 99%  
45.07  East Baton Rouge  6 Hot Spot 99%  
45.08  East Baton Rouge  6 Hot Spot 99%  
45.09  East Baton Rouge  6 Hot Spot 99%  
45.1  East Baton Rouge  9 Hot Spot 99%  
46.02  East Baton Rouge  8 Hot Spot 99%  










46.04  East Baton Rouge  13 Hot Spot 99%  
47  East Baton Rouge  5 Hot Spot 99%  
48  East Baton Rouge  1 Hot Spot 99%  
49  East Baton Rouge  2 Hot Spot 99%  
5  East Baton Rouge  11 Hot Spot 99%  
50  East Baton Rouge  2 Hot Spot 99%  
501  Assumption  29 Hot Spot 99%  
502  Assumption  3 Hot Spot 99%  
503  Assumption  38 Hot Spot 99%  
504  Assumption  24 Hot Spot 99%  
505  Assumption  11 Hot Spot 99%  
506  Assumption  5 Hot Spot 99%  
51  East Baton Rouge  3 Hot Spot 99%  
52  East Baton Rouge  8 Hot Spot 99%  
53  East Baton Rouge  4 Hot Spot 99%  
6.01  East Baton Rouge  7 Hot Spot 99%  
6.02  East Baton Rouge  13 Hot Spot 99%  
7.01  East Baton Rouge  2 Hot Spot 99%  
7.02  East Baton Rouge  10 Hot Spot 99%  
702  St. John the Baptist  2 Hot Spot 99%  
705  St. John the Baptist  1 Hot Spot 99%  
707  St. John the Baptist  1 Hot Spot 99%  
708  St. John the Baptist  1 Hot Spot 99%  
709  St. John the Baptist  1 Hot Spot 99%  
711  St. John the Baptist  1 Hot Spot 99%  
9  East Baton Rouge  9 Hot Spot 99%  
9512  St. Helena  1 Hot Spot 99%  
9515.01  East Feliciana  3 Hot Spot 99%  
9515.02  East Feliciana  9 Hot Spot 99%  
9516  East Feliciana  3 Hot Spot 99%  
9522  Pointe Coupee  2 Hot Spot 99%  
9527  Iberville  12 Hot Spot 99%  
9529  Iberville  22 Hot Spot 99%  
9530  Iberville  3 Hot Spot 99%  
9531.01  Iberville  10 Hot Spot 99%  
9531.02  Iberville  7 Hot Spot 99%  
9532  Iberville  15 Hot Spot 99%  
9541.02  Tangipahoa  1 Hot Spot 99%  
9544  Tangipahoa  1 Hot Spot 99%  
2  West Carroll  7 Hot Spot 95%  
201  St. Martin  4 Hot Spot 95%  










410  St. Mary  2 Hot Spot 95%  
7  Terrebonne  1 Hot Spot 95%  
8  Terrebonne  1 Hot Spot 95%  
9502  Morehouse  5 Hot Spot 95%  
9503  Morehouse  7 Hot Spot 95%  
9504  Morehouse  4 Hot Spot 95%  
9505  Morehouse  2 Hot Spot 95%  
9506  Morehouse  4 Hot Spot 95%  
9526  Iberville  3 Hot Spot 95%  
9601  Lincoln  2 Hot Spot 95%  
9601  Union  12 Hot Spot 95%  
9602  Union  4 Hot Spot 95%  
9603  Union  1 Hot Spot 95%  
9604  Union  7 Hot Spot 95%  
9606  Lincoln  1 Hot Spot 95%  
9609  Lincoln  1 Hot Spot 95%  
102.02  Ouachita  24 Hot Spot 90%  
104  Ouachita  10 Hot Spot 90%  
105.03  Ouachita  3 Hot Spot 90%  
2  Caldwell  1 Hot Spot 90%  
3  Caldwell  2 Hot Spot 90%  
9502  Franklin  1 Hot Spot 90%  
9507  Morehouse  1 Hot Spot 90%  
9508  Morehouse  13 Hot Spot 90%  
9546  Tangipahoa  1 Hot Spot 90%  
9605  Union  8 Hot Spot 90%  
9607  Lincoln  2 Hot Spot 90%  
9701  Jackson  1 Hot Spot 90%  
9701  Richland  2 Hot Spot 90%  
9703  Jackson  3 Hot Spot 90%  
9703  Richland  6 Hot Spot 90%  
9705  Richland  11 Hot Spot 90%  
1  Catahoula  1 Cold Spot 90%  
2  Tensas  2 Cold Spot 90%  
204.01  Grant  1 Cold Spot 90%  
9507  Washington  1 Cold Spot 90%  
120  Rapides  1 Cold Spot 95%  
125  Rapides  1 Cold Spot 95%  
218.04  Jefferson  1 Cold Spot 95%  
25.03  Orleans  1 Cold Spot 95%  
269  Jefferson  1 Cold Spot 95%  










306  Iberia  2 Cold Spot 95%  
410.03  St. Tammany  1 Cold Spot 95%  
9506  Washington  1 Cold Spot 95%  
1  Lafayette  3 Cold Spot 99%  
10.01  Lafayette  5 Cold Spot 99%  
10.02  Lafayette  2 Cold Spot 99%  
10.03  Lafayette  3 Cold Spot 99%  
11  Lafayette  6 Cold Spot 99%  
12  Lafayette  9 Cold Spot 99%  
13  Lafayette  2 Cold Spot 99%  
14.01  Lafayette  9 Cold Spot 99%  
14.02  Lafayette  5 Cold Spot 99%  
14.03  Lafayette  6 Cold Spot 99%  
14.04  Lafayette  10 Cold Spot 99%  
14.05  Lafayette  7 Cold Spot 99%  
14.06  Lafayette  10 Cold Spot 99%  
14.07  Lafayette  2 Cold Spot 99%  
14.09  Lafayette  5 Cold Spot 99%  
14.1  Lafayette  14 Cold Spot 99%  
17  Lafayette  3 Cold Spot 99%  
17.25  Orleans  1 Cold Spot 99%  
18.01  Lafayette  1 Cold Spot 99%  
18.02  Lafayette  5 Cold Spot 99%  
19.01  Lafayette  7 Cold Spot 99%  
19.02  Lafayette  1 Cold Spot 99%  
19.03  Lafayette  9 Cold Spot 99%  
19.04  Lafayette  1 Cold Spot 99%  
19.05  Lafayette  2 Cold Spot 99%  
2  Lafayette  3 Cold Spot 99%  
20.01  Lafayette  9 Cold Spot 99%  
20.02  Lafayette  4 Cold Spot 99%  
202  St. Martin  13 Cold Spot 99%  
203.01  St. Martin  1 Cold Spot 99%  
203.02  St. Martin  2 Cold Spot 99%  
204  St. Martin  2 Cold Spot 99%  
205.01  St. Martin  1 Cold Spot 99%  
205.02  St. Martin  4 Cold Spot 99%  
206  St. Martin  3 Cold Spot 99%  
208  St. Martin  5 Cold Spot 99%  
209  St. Martin  1 Cold Spot 99%  
21.01  Lafayette  4 Cold Spot 99%  










21.03  Lafayette  4 Cold Spot 99%  
21.04  Lafayette  1 Cold Spot 99%  
22  Lafayette  2 Cold Spot 99%  
303  Avoyelles  1 Cold Spot 99%  
303.01  Iberia  5 Cold Spot 99%  
304  Iberia  2 Cold Spot 99%  
305  Iberia  1 Cold Spot 99%  
308  Iberia  2 Cold Spot 99%  
309  Avoyelles  1 Cold Spot 99%  
310  Iberia  2 Cold Spot 99%  
311  Iberia  3 Cold Spot 99%  
312  Iberia  2 Cold Spot 99%  
313  Iberia  5 Cold Spot 99%  
316  Iberia  3 Cold Spot 99%  
6  Jefferson Davis  1 Cold Spot 99%  
6.03  Lafayette  2 Cold Spot 99%  
6.04  Lafayette  1 Cold Spot 99%  
7  Lafayette  3 Cold Spot 99%  
8  Lafayette  2 Cold Spot 99%  
9  Lafayette  3 Cold Spot 99%  
9501  Evangeline  3 Cold Spot 99%  
9501  Vermilion  1 Cold Spot 99%  
9503  Evangeline  1 Cold Spot 99%  
9504  Evangeline  1 Cold Spot 99%  
9505  Vermilion  1 Cold Spot 99%  
9506  Evangeline  1 Cold Spot 99%  
9506  Vermilion  2 Cold Spot 99%  
9507  Evangeline  1 Cold Spot 99%  
9508  Vermilion  1 Cold Spot 99%  
9509.02  Vermilion  2 Cold Spot 99%  
9510.01  Vermilion  1 Cold Spot 99%  
9510.02  Vermilion  1 Cold Spot 99%  
9601  Acadia  4 Cold Spot 99%  
21.04  Lafayette  1 Cold Spot 99%  
22  Lafayette  2 Cold Spot 99%  
303  Avoyelles  1 Cold Spot 99%  
303.01  Iberia  5 Cold Spot 99%  
304  Iberia  2 Cold Spot 99%  
305  Iberia  1 Cold Spot 99%  
308  Iberia  2 Cold Spot 99%  
309  Avoyelles  1 Cold Spot 99%  










311  Iberia  3 Cold Spot 99%  
312  Iberia  2 Cold Spot 99%  
313  Iberia  5 Cold Spot 99%  
316  Iberia  3 Cold Spot 99%  
6  Jefferson Davis  1 Cold Spot 99%  
6.03  Lafayette  2 Cold Spot 99%  
6.04  Lafayette  1 Cold Spot 99%  
7  Lafayette  3 Cold Spot 99%  
8  Lafayette  2 Cold Spot 99%  
9  Lafayette  3 Cold Spot 99%  
9501  Evangeline  3 Cold Spot 99%  
9501  Vermilion  1 Cold Spot 99%  
9503  Evangeline  1 Cold Spot 99%  
9504  Evangeline  1 Cold Spot 99%  
9505  Vermilion  1 Cold Spot 99%  
9506  Evangeline  1 Cold Spot 99%  
9506  Vermilion  2 Cold Spot 99%  
9507  Evangeline  1 Cold Spot 99%  
9508  Vermilion  1 Cold Spot 99%  
9509.02  Vermilion  2 Cold Spot 99%  
9510.01  Vermilion  1 Cold Spot 99%  
9510.02  Vermilion  1 Cold Spot 99%  
9601  Acadia  4 Cold Spot 99%  
9602  Acadia  3 Cold Spot 99%  
9603  Acadia  2 Cold Spot 99%  
312  Iberia  2 Cold Spot 99%  
313  Iberia  5 Cold Spot 99%  
316  Iberia  3 Cold Spot 99%  
6  Jefferson Davis  1 Cold Spot 99%  
6.03  Lafayette  2 Cold Spot 99%  
6.04  Lafayette  1 Cold Spot 99%  
7  Lafayette  3 Cold Spot 99%  
8  Lafayette  2 Cold Spot 99%  
9  Lafayette  3 Cold Spot 99%  
9501  Evangeline  3 Cold Spot 99%  
9501  Vermilion  1 Cold Spot 99%  
9503  Evangeline  1 Cold Spot 99%  
9504  Evangeline  1 Cold Spot 99%  
9505  Vermilion  1 Cold Spot 99%  
9506  Evangeline  1 Cold Spot 99%  
9506  Vermilion  2 Cold Spot 99%  










9508  Vermilion  1 Cold Spot 99%  
9509.02  Vermilion  2 Cold Spot 99%  
9510.01  Vermilion  1 Cold Spot 99%  
9510.02  Vermilion  1 Cold Spot 99%  
9601  Acadia  4 Cold Spot 99%  
9602  Acadia  3 Cold Spot 99%  
9603  Acadia  2 Cold Spot 99%  
9604  Acadia  2 Cold Spot 99%  
9605  St. Landry  3 Cold Spot 99%  
9606  Acadia  2 Cold Spot 99%  
9607  Acadia  5 Cold Spot 99%  
9608  Acadia  1 Cold Spot 99%  
9608  St. Landry  1 Cold Spot 99%  
9609  Acadia  3 Cold Spot 99%  
9610  Acadia  1 Cold Spot 99%  
9611  St. Landry  3 Cold Spot 99%  
9612  St. Landry  1 Cold Spot 99%  
9613  St. Landry  1 Cold Spot 99%  
9614  St. Landry  1 Cold Spot 99%  
9615  St. Landry  1 Cold Spot 99%  
9617  St. Landry  1 Cold Spot 99%  
9618  St. Landry  8 Cold Spot 99%  















Appendix AF. Cluster and Outlier Analysis of FMOLHS COVID 


















Appendix AG. Map Summary tables of Cluster and Outlier Analysis 



















Cluster High-High 727.33 6 92 41493 2.22 
Outlier Low-High 289.48 6 15 47661 0.31 
Cluster Low-Low 15.99 1 4 8004 0.50 
Not Significant 4282.36 58 443 277094 1.60 
 















Cluster High-High 7073.04 92 1293 550087 2.35 
Outlier High-Low 553.88 11 105 90607 1.16 
Outlier Low-High 7685.54 64 210 301195 0.70 
Cluster Low-Low 8738.46 97 207 474513 0.44 





















SVI data % averages 
High-High  High-Low  Low-High  Low-Low  
Poverty 21.34 15.14 19.21 23.78 
Unemployment 7.28 4.64 6.90 7.82 
Per Capita Income 25156 30694 26408 23008 
No High School Dip 14.44 13.00 16.70 19.98 
Age 65 13.13 10.52 15.39 14.26 
Age 17 25.30 26.57 24.06 25.18 
Disability 14.19 11.42 15.46 15.59 
Single Parent 13.37 11.89 11.29 12.36 
Minority 51.44 31.56 36.43 42.91 
Limited English 
Proficiency 
0.93 1.95 0.93 1.65 
Housing 10 or More 5.47 8.24 3.57 5.18 
Mobile Homes 13.02 16.39 19.60 15.17 
Crowded Housing 2.87 3.55 2.94 3.04 
No Vehicle 8.22 4.56 7.32 10.58 
Institutionalized Group 
Quarters 
3.38 0.25 2.26 2.27 
Socioeconomic Rank 0.47 0.33 0.44 0.58 
Household Composition 
Rank 
0.51 0.35 0.51 0.56 
Minority/Language 
Rank 
0.50 0.59 0.36 0.52 
Housing/Transportation 
Rank 
0.52 0.48 0.48 0.61 
Overall Rank 0.50 0.39 0.44 0.60 
Uninsured 10.81 10.43 10.07 12.81 
Management, Business, 
Science & Art 
Occupations 
30.80 36.01 29.16 27.40 
Service Occupations 20.68 15.94 18.67 22.26 
Sales & Office 
Occupations 









14.95 11.48 15.53 15.14 
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Appendix AI. Cluster and Outlier Analysis FMOLHS Positive 








11.02  East Baton Rouge  6 LH 
12  Lafayette  4 LL 
17  East Baton Rouge  20 HH 
302.04  Ascension  1 LH 
303  Ascension  5 LH 
310  Ascension  15 HH 
38.04  East Baton Rouge  1 LH 
40.16  East Baton Rouge  1 LH 
45.09  East Baton Rouge  21 HH 
45.1  East Baton Rouge  15 HH 
9529  Iberville  8 HH 
9531.02  Iberville  1 LH 




















Appendix AJ. Cluster and Outlier Analysis FMOLHS Positive Non-
Institutionalized Patients Counts By Census Tracts across LA 
 
Census Tract ID Parish Positive Count Result 
1 Ouachita 13 HH 
101.01 Ouachita 9 HH 
101.02 Ouachita 20 HH 
102.01 Ouachita 21 HH 
102.02 Ouachita 24 HH 
103.01 Ouachita 10 HH 
103.02 Ouachita 8 HH 
104 Ouachita 10 HH 
105.04 Ouachita 12 HH 
106.03 Ouachita 14 HH 
106.04 Ouachita 14 HH 
107 Ouachita 7 HH 
108 Ouachita 8 HH 
109 Ouachita 22 HH 
110 Ouachita 18 HH 
111 Ouachita 11 HH 
14 Ouachita 12 HH 
17 Ouachita 14 HH 
2 East Baton Rouge 12 HH 
2 Ouachita 14 HH 
204.01 West Baton Rouge 16 HH 
204.02 West Baton Rouge 14 HH 
301.01 Ascension 9 HH 
301.02 Ascension 14 HH 
302.04 Ascension 21 HH 
302.05 Ascension 24 HH 
302.06 Ascension 22 HH 
303 Ascension 62 HH 
304.01 Ascension 22 HH 
304.02 Ascension 57 HH 
305 Ascension 8 HH 
306 Ascension 25 HH 
309 Ascension 17 HH 
31.01 East Baton Rouge 8 HH 
310 Ascension 40 HH 
32.01 East Baton Rouge 7 HH 
33 East Baton Rouge 16 HH 
34 East Baton Rouge 18 HH 




Census Tract ID Parish Positive Count Result 
35.05 East Baton Rouge 13 HH 
35.07  East Baton Rouge  14 HH 
4  East Baton Rouge  11 HH 
4.01  Ouachita  7 HH 
4.02  Ouachita  7 HH 
40.06  East Baton Rouge  12 HH 
40.09  East Baton Rouge  8 HH 
40.11  East Baton Rouge  9 HH 
40.14  East Baton Rouge  7 HH 
40.15  East Baton Rouge  14 HH 
40.16  East Baton Rouge  9 HH 
401  St. James  10 HH 
403.01  Livingston  8 HH 
403.03  Livingston  7 HH 
404  St. James  14 HH 
404.02  Livingston  7 HH 
405  Livingston  7 HH 
405  St. James  17 HH 
406  Livingston  7 HH 
408.04  Livingston  15 HH 
42.01  East Baton Rouge  12 HH 
42.05  East Baton Rouge  11 HH 
44.01  East Baton Rouge  7 HH 
45.03  East Baton Rouge  8 HH 
45.04  East Baton Rouge  8 HH 
45.05  East Baton Rouge  9 HH 
45.1  East Baton Rouge  9 HH 
46.02  East Baton Rouge  8 HH 
46.04  East Baton Rouge  13 HH 
5  Ouachita  8 HH 
501  Assumption  29 HH 
503  Assumption  38 HH 
504  Assumption  24 HH 
505  Assumption  11 HH 
52.04  Ouachita  17 HH 
53.01  Ouachita  12 HH 
54  Ouachita  8 HH 
55  Ouachita  9 HH 
58  Ouachita  7 HH 
6  Ouachita  18 HH 
6.01  East Baton Rouge  7 HH 
9  Ouachita  8 HH 




Census Tract ID Parish Positive Count Result 
9515.02  East Feliciana  9 HH 
9527  Iberville  12 HH 
9529  Iberville  22 HH 
9531.01  Iberville  10 HH 
9531.02  Iberville  7 HH 
9532  Iberville  15 HH 
9601  Union  12 HH 
9604  Union  7 HH 
9605  Union  8 HH 
9705  Richland  11 HH 
12  Lafayette  9 HL 
14.01  Lafayette  9 HL 
14.04  Lafayette  10 HL 
14.05  Lafayette  7 HL 
14.06  Lafayette  10 HL 
14.1  Lafayette  14 HL 
19.01  Lafayette  7 HL 
19.03  Lafayette  9 HL 
20.01  Lafayette  9 HL 
202  St. Martin  13 HL 
9618  St. Landry  8 HL 
1  East Baton Rouge  4 LH 
105.02  Ouachita  1 LH 
105.03  Ouachita  3 LH 
11  Ouachita  4 LH 
15  Ouachita  6 LH 
202  West Baton Rouge  2 LH 
203  West Baton Rouge  4 LH 
205  Lafourche  1 LH 
210  St. Martin  1 LH 
3  East Baton Rouge  6 LH 
30  East Baton Rouge  3 LH 
301  Iberia  4 LH 
301.03  Ascension  4 LH 
302.03  Ascension  5 LH 
32.02  East Baton Rouge  5 LH 
35.01  East Baton Rouge  5 LH 
36.03  East Baton Rouge  4 LH 
39.06  East Baton Rouge  3 LH 
40.1  East Baton Rouge  2 LH 
401  Livingston  1 LH 




Census Tract ID Parish Positive Count Result 
402  St. Mary  1 LH 
402.01  Livingston  2 LH 
402.02  Livingston  2 LH 
403  St. James  3 LH 
403.04  Livingston  5 LH 
404.01  Livingston  5 LH 
406  St. James  6 LH 
407  Livingston  4 LH 
407  St. James  2 LH 
408.02  Livingston  4 LH 
408.05  Livingston  3 LH 
408.06  Livingston  5 LH 
409.02  Livingston  4 LH 
42.04  East Baton Rouge  2 LH 
43.01  East Baton Rouge  5 LH 
43.02  East Baton Rouge  2 LH 
44.02  East Baton Rouge  4 LH 
44.03  East Baton Rouge  3 LH 
45.08  East Baton Rouge  6 LH 
45.09  East Baton Rouge  6 LH 
46.03  East Baton Rouge  4 LH 
47  East Baton Rouge  5 LH 
502  Assumption  3 LH 
506  Assumption  5 LH 
51  Ouachita  4 LH 
52.01  Ouachita  1 LH 
52.03  Ouachita  5 LH 
53.02  Ouachita  6 LH 
59  Ouachita  1 LH 
7  Ouachita  1 LH 
7.01  East Baton Rouge  2 LH 
711  St. John the Baptist  1 LH 
9502  Morehouse  5 LH 
9506  Morehouse  4 LH 
9507  Morehouse  1 LH 
9512  St. Helena  1 LH 
9515.01  East Feliciana  3 LH 
9516  East Feliciana  3 LH 
9522  Pointe Coupee  2 LH 
9530  Iberville  3 LH 
9541.02  Tangipahoa  1 LH 




Census Tract ID Parish Positive Count Result 
9706  Richland  1 LH 
1  Catahoula  1 LL 
1  Lafayette  3 LL 
10.01  Lafayette  5 LL 
10.02  Lafayette  2 LL 
10.03  Lafayette  3 LL 
11  Lafayette  6 LL 
120  Rapides  1 LL 
125  Rapides  1 LL 
13  Lafayette  2 LL 
14.02  Lafayette  5 LL 
14.03  Lafayette  6 LL 
14.07  Lafayette  2 LL 
14.09  Lafayette  5 LL 
17  Lafayette  3 LL 
17.25  Orleans  1 LL 
18.01  Lafayette  1 LL 
18.02  Lafayette  5 LL 
19.02  Lafayette  1 LL 
19.04  Lafayette  1 LL 
19.05  Lafayette  2 LL 
2  Concordia  2 LL 
2  Lafayette  3 LL 
2  Tensas  2 LL 
20.02  Lafayette  4 LL 
203.01  St. Martin  1 LL 
203.02  St. Martin  2 LL 
204  St. Martin  2 LL 
204.01  Grant  1 LL 
205.01  St. Martin  1 LL 
205.02  St. Martin  4 LL 
206  St. Martin  3 LL 
208  St. Martin  5 LL 
209  St. Martin  1 LL 
21.01  Lafayette  4 LL 
21.02  Lafayette  2 LL 
21.03  Lafayette  4 LL 
21.04  Lafayette  1 LL 
218.04  Jefferson  1 LL 
22  Lafayette  2 LL 
22.01  Calcasieu  1 LL 




Census Tract ID Parish Positive Count Result 
26  Calcasieu  1 LL 
269  Jefferson  1 LL 
277.01  Jefferson  1 LL 
303  Avoyelles  1 LL 
303.01  Iberia  5 LL 
304  Iberia  2 LL 
305  Iberia  1 LL 
306  Iberia  2 LL 
308  Iberia  2 LL 
309  Avoyelles  1 LL 
310  Iberia  2 LL 
311  Iberia  3 LL 
312  Iberia  2 LL 
313  Iberia  5 LL 
316  Iberia  3 LL 
410.03  St. Tammany  1 LL 
6  Jefferson Davis  1 LL 
6.03  Lafayette  2 LL 
6.04  Lafayette  1 LL 
7  Lafayette  3 LL 
8  Lafayette  2 LL 
9  Lafayette  3 LL 
9501  Evangeline  3 LL 
9501  Vermilion  1 LL 
9503  Evangeline  1 LL 
9504  Evangeline  1 LL 
9505  Vermilion  1 LL 
9506  Evangeline  1 LL 
9506  Vermilion  2 LL 
9506  Washington  1 LL 
9507  Evangeline  1 LL 
9507  Washington  1 LL 
9508  Vermilion  1 LL 
9509.02  Vermilion  2 LL 
9510.01  Vermilion  1 LL 
9510.02  Vermilion  1 LL 
9601  Acadia  4 LL 
9602  Acadia  3 LL 
9603  Acadia  2 LL 
9604  Acadia  2 LL 
9604  Madison  1 LL 




Census Tract ID Parish Positive Count Result 
9605  St. Landry  3 LL 
9606  Acadia  2 LL 
9607  Acadia  5 LL 
9608  Acadia  1 LL 
9608  St. Landry  1 LL 
9609  Acadia  3 LL 
9610  Acadia  1 LL 
9611  St. Landry  3 LL 
9612  St. Landry  1 LL 
9613  St. Landry  1 LL 
9614  St. Landry  1 LL 
9615  St. Landry  1 LL 
9617  St. Landry  1 LL 
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